38807002,Disorder: Primary malignant neoplasm (disorder),775140014,Preferred,0
38807002,Malignant neoplastic disease (primary),197410015,Preferred,0
38807002,CA - Cancer,491788012,Acceptable,0
38807002,Cancer,491786011,Acceptable,0
38807002,Malignant neoplasm,491787019,Acceptable,0
86049000,"Malignant neoplasm, primary (morphologic abnormality)",828230015,Preferred,1
86049000,"Neoplasm, malignant (primary)",506904011,Preferred,1
86049000,Blastoma,142663011,Acceptable,1
86049000,Cancer,142666015,Acceptable,1
86049000,Cancer morphology,1235086017,Acceptable,1
86049000,Malignancy,142665016,Acceptable,1
86049000,Malignant neoplasm,201257013,Acceptable,1
86049000,"Malignant neoplasm, primary",2774235011,Acceptable,1
86049000,Malignant tumor morphology,1218517017,Acceptable,1
86049000,Malignant tumour morphology,1217029017,Acceptable,1
86049000,"Neoplasm, malignant",142662018,Acceptable,1
86049000,"Tumor, malignant",142670011,Acceptable,1
86049000,"Tumour, malignant",142669010,Acceptable,1
86049000,"Unclassified tumor, malignant",142667012,Acceptable,1
86049000,"Unclassified tumour, malignant",201256016,Acceptable,1
363346000,Malignant neoplastic disease (disorder),1195193017,Preferred,2
363346000,Malignant neoplastic disease,1208875016,Preferred,2
363346000,CA - Cancer,1228479013,Acceptable,2
363346000,Cancer,1228478017,Acceptable,2
363346000,Malignant neoplasm,1228480011,Acceptable,2
363346000,Malignant tumor,482492018,Acceptable,2
363346000,Malignant tumour,482491013,Acceptable,2
187597000,(Neoplasms) or (cancers) (disorder),2716569013,Preferred,3
187597000,(Neoplasms) or (cancers),288340015,Preferred,3
187597000,Cancers,288341016,Acceptable,3
187597000,Neoplasms,288342011,Acceptable,3
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2718595015,Preferred,4
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),249744017,Preferred,4
160284006,FH: Cancer,249749010,Acceptable,4
160284006,FH: Cancer - *,249746015,Acceptable,4
160284006,FH: Carcinoma - *,249748019,Acceptable,4
160284006,FH: Malignant disease,249752019,Acceptable,4
160284006,FH: Neoplasia - *,249751014,Acceptable,4
160284006,FH: Neoplasm - *,249745016,Acceptable,4
160284006,FH: cancer,249753012,Acceptable,4
160284006,FH: carcinoma - *,249750010,Acceptable,4
160284006,FH: neoplasia,249747012,Acceptable,4
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2718595015,Preferred,5
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),249744017,Preferred,5
160284006,FH: Cancer,249749010,Acceptable,5
160284006,FH: Cancer - *,249746015,Acceptable,5
160284006,FH: Carcinoma - *,249748019,Acceptable,5
160284006,FH: Malignant disease,249752019,Acceptable,5
160284006,FH: Neoplasia - *,249751014,Acceptable,5
160284006,FH: Neoplasm - *,249745016,Acceptable,5
160284006,FH: cancer,249753012,Acceptable,5
160284006,FH: carcinoma - *,249750010,Acceptable,5
160284006,FH: neoplasia,249747012,Acceptable,5
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2709100011,Preferred,6
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),218766012,Preferred,6
137687004,FH: Cancer,218772012,Acceptable,6
137687004,FH: Cancer - *,218773019,Acceptable,6
137687004,FH: Carcinoma - *,218774013,Acceptable,6
137687004,FH: Malignant disease,218770016,Acceptable,6
137687004,FH: Neoplasia - *,218768013,Acceptable,6
137687004,FH: Neoplasm - *,218769017,Acceptable,6
137687004,FH: cancer,218767015,Acceptable,6
137687004,FH: carcinoma - *,218771017,Acceptable,6
137687004,FH: neoplasia,218775014,Acceptable,6
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2709100011,Preferred,7
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),218766012,Preferred,7
137687004,FH: Cancer,218772012,Acceptable,7
137687004,FH: Cancer - *,218773019,Acceptable,7
137687004,FH: Carcinoma - *,218774013,Acceptable,7
137687004,FH: Malignant disease,218770016,Acceptable,7
137687004,FH: Neoplasia - *,218768013,Acceptable,7
137687004,FH: Neoplasm - *,218769017,Acceptable,7
137687004,FH: cancer,218767015,Acceptable,7
137687004,FH: carcinoma - *,218771017,Acceptable,7
137687004,FH: neoplasia,218775014,Acceptable,7
161426000,H/O: neoplasm (& [malignant] or [carcinoma]) (situation),2749072019,Preferred,8
161426000,H/O: neoplasm (& [malignant] or [carcinoma]),251554010,Preferred,8
161426000,H/O: cancer,251559017,Acceptable,8
161426000,H/O: carcinoma,251560010,Acceptable,8
161426000,H/O: malignancy,251555011,Acceptable,8
161426000,H/O: malignant neoplasm (*),251556012,Acceptable,8
161426000,H/O: mitotic lesion,251558013,Acceptable,8
161426000,H/O: neoplasm,251557015,Acceptable,8
372130007,Malignant neoplasm of skin (disorder),1197423015,Preferred,9
372130007,Malignant neoplasm of skin,1210707014,Preferred,9
372130007,Cancer of skin,3036168010,Acceptable,9
372130007,Skin cancer,2536564013,Acceptable,9
735385007,Microsatellite instability-high solid malignant tumor (disorder),3514362015,Preferred,10
735385007,Microsatellite instability-high solid malignant tumour,3514364019,Preferred,10
735385007,MSI-H cancer,3514368016,Acceptable,10
735385007,MSI-H solid malignant tumor,3514369012,Acceptable,10
735385007,Microsatellite instability-high solid malignant tumor,3514363013,Acceptable,10
735385007,Mismatch repair deficient solid malignant tumor,3515907014,Acceptable,10
735385007,Mismatch repair deficient solid malignant tumour,3515908016,Acceptable,10
735385007,dMMR cancer,3514365018,Acceptable,10
735385007,dMMR solid malignant tumor,3514366017,Acceptable,10
46347006,Squamous cell carcinoma of horn (morphologic abnormality),783686016,Preferred,11
46347006,Squamous cell carcinoma of horn,77269018,Preferred,11
46347006,Carcinoma of horn,77270017,Acceptable,11
46347006,Horn cancer,77271018,Acceptable,11
266987004,History of malignant neoplasm (situation),2986533011,Preferred,12
266987004,H/O: malignant neoplasm,2575880014,Preferred,12
266987004,H/O: cancer,397821018,Acceptable,12
266987004,H/O: malignancy,397819011,Acceptable,12
266987004,H/O: mitotic lesion,397820017,Acceptable,12
266987004,History of cancer,3687193010,Acceptable,12
266987004,History of malignant neoplasm,2986363018,Acceptable,12
187875007,Malignant neoplasm lung: [of bronchus or lung NOS] or [lung cancer] (disorder),2733548014,Preferred,13
187875007,Malignant neoplasm lung: [of bronchus or lung NOS] or [lung cancer],288833011,Preferred,13
187875007,Lung cancer,288835016,Acceptable,13
187875007,Malignant neoplasm of bronchus or lung NOS,288834017,Acceptable,13
269466003,Malignant tumor of bone and articular cartilage (disorder),662330011,Preferred,14
269466003,Malignant tumour of bone and articular cartilage,403694019,Preferred,14
269466003,Bone cancer,403692015,Acceptable,14
269466003,CA - Bone cancer,403690011,Acceptable,14
269466003,Malignant bone tumor,403696017,Acceptable,14
269466003,Malignant bone tumour,403693013,Acceptable,14
269466003,Malignant neoplasm of bone and articular cartilage,403691010,Acceptable,14
269466003,Malignant tumor of bone and articular cartilage,403695018,Acceptable,14
363346000,Malignant neoplastic disease (disorder),1195193017,Preferred,15
363346000,Malignant neoplastic disease,1208875016,Preferred,15
363346000,CA - Cancer,1228479013,Acceptable,15
363346000,Cancer,1228478017,Acceptable,15
363346000,Malignant neoplasm,1228480011,Acceptable,15
363346000,Malignant tumor,482492018,Acceptable,15
363346000,Malignant tumour,482491013,Acceptable,15
138699008,H/O: neoplasm (& [malignant] or [carcinoma]) (situation),2715482012,Preferred,16
138699008,H/O: neoplasm (& [malignant] or [carcinoma]),220050019,Preferred,16
138699008,H/O: cancer,220054011,Acceptable,16
138699008,H/O: carcinoma,220053017,Acceptable,16
138699008,H/O: malignancy,220051015,Acceptable,16
138699008,H/O: malignant neoplasm (*),220052010,Acceptable,16
138699008,H/O: mitotic lesion,220056013,Acceptable,16
138699008,H/O: neoplasm,220055012,Acceptable,16
38807002,Disorder: Primary malignant neoplasm (disorder),775140014,Preferred,17
38807002,Malignant neoplastic disease (primary),197410015,Preferred,17
38807002,CA - Cancer,491788012,Acceptable,17
38807002,Cancer,491786011,Acceptable,17
38807002,Malignant neoplasm,491787019,Acceptable,17
93880001,Primary malignant neoplasm of lung (disorder),837706010,Preferred,18
93880001,Primary malignant neoplasm of lung,510792012,Preferred,18
93880001,Lung cancer,3288586014,Acceptable,18
363511009,Malignant tumour of skin (disorder),2718835012,Preferred,19
363511009,Malignant tumour of skin,482809014,Preferred,19
363511009,CA - Skin cancer,1228628013,Acceptable,19
363511009,Malignant tumor of skin,482808018,Acceptable,19
363511009,Skin cancer,1228629017,Acceptable,19
363350007,Malignant tumor of cecum (disorder),755165010,Preferred,20
363350007,Malignant tumour of caecum,482499010,Preferred,20
363350007,CA - Cancer of caecum,1216462014,Acceptable,20
363350007,CA - Cancer of cecum,1217953013,Acceptable,20
363350007,Cancer of caecum,1216463016,Acceptable,20
363350007,Cancer of cecum,1217954019,Acceptable,20
363350007,Cecal cancer,3288530014,Acceptable,20
363350007,Malignant neoplasm of caecum,1216464010,Acceptable,20
363350007,Malignant neoplasm of cecum,1217952015,Acceptable,20
363350007,Malignant tumor of cecum,482500018,Acceptable,20
735385007,Microsatellite instability-high solid malignant tumor (disorder),3514362015,Preferred,21
735385007,Microsatellite instability-high solid malignant tumour,3514364019,Preferred,21
735385007,MSI-H cancer,3514368016,Acceptable,21
735385007,MSI-H solid malignant tumor,3514369012,Acceptable,21
735385007,Microsatellite instability-high solid malignant tumor,3514363013,Acceptable,21
735385007,Mismatch repair deficient solid malignant tumor,3515907014,Acceptable,21
735385007,Mismatch repair deficient solid malignant tumour,3515908016,Acceptable,21
735385007,dMMR cancer,3514365018,Acceptable,21
735385007,dMMR solid malignant tumor,3514366017,Acceptable,21
93897007,Primary malignant neoplasm of mouth (disorder),837726014,Preferred,22
93897007,Primary malignant neoplasm of mouth,510812017,Preferred,22
93897007,CA - Mouth cancer,510819014,Acceptable,22
93897007,Cancer of oral cavity,510818018,Acceptable,22
93897007,Malignant tumor of mouth,510813010,Acceptable,22
93897007,Malignant tumor of oral cavity,510814016,Acceptable,22
93897007,Malignant tumour of mouth,510815015,Acceptable,22
93897007,Malignant tumour of oral cavity,510816019,Acceptable,22
93897007,Mouth cancer,510817011,Acceptable,22
30883001,Infection by Pythium insidiosum (disorder),761941015,Preferred,23
30883001,Infection by Pythium insidiosum,51686014,Preferred,23
30883001,Equine dermal granuloma,51691010,Acceptable,23
30883001,Hyphomycosis destruens equi,51690011,Acceptable,23
30883001,Infection by Hyphomyces destruens,51687017,Acceptable,23
30883001,Pythiosis,51688010,Acceptable,23
30883001,Swamp cancer,51689019,Acceptable,23
363505006,Malignant tumor of oral cavity (disorder),755337019,Preferred,24
363505006,Malignant tumour of oral cavity,482797011,Preferred,24
363505006,CA - Mouth cancer,1228612015,Acceptable,24
363505006,Cancer of oral cavity,1228611010,Acceptable,24
363505006,Malignant neoplasm of mouth,2984473018,Acceptable,24
363505006,Malignant tumor of mouth,1217990014,Acceptable,24
363505006,Malignant tumor of oral cavity,482796019,Acceptable,24
363505006,Malignant tumour of mouth,1216500017,Acceptable,24
363505006,Mouth cancer,1228613013,Acceptable,24
93870000,Malignant neoplasm of liver (disorder),837694010,Preferred,25
93870000,Malignant neoplasm of liver,155343014,Preferred,25
93870000,CA - Liver cancer,510772017,Acceptable,25
93870000,Liver cancer,510773010,Acceptable,25
93870000,Malignant tumor of liver,510775015,Acceptable,25
93870000,Malignant tumour of liver,510776019,Acceptable,25
363518003,Malignant tumor of kidney (disorder),755351019,Preferred,26
363518003,Malignant tumour of kidney,482823011,Preferred,26
363518003,CA - Cancer of kidney,1228636016,Acceptable,26
363518003,CA - Renal cancer,1228635017,Acceptable,26
363518003,Malignant tumor of kidney,482824017,Acceptable,26
363518003,Renal cancer,2990214011,Acceptable,26
363518003,Renal malignant tumor,1217992018,Acceptable,26
363518003,Renal malignant tumour,1216502013,Acceptable,26
363382005,Malignant tumor of gum (disorder),755200011,Preferred,27
363382005,Malignant tumour of gum,482561017,Preferred,27
363382005,CA - Cancer of gum,1228515012,Acceptable,27
363382005,Cancer of gum,1228514011,Acceptable,27
363382005,Malignant tumor of alveolar mucosa,1217961015,Acceptable,27
363382005,Malignant tumor of gingiva,1217962010,Acceptable,27
363382005,Malignant tumor of gum,482560016,Acceptable,27
363382005,Malignant tumour of alveolar mucosa,1216471017,Acceptable,27
363382005,Malignant tumour of gingiva,1216472012,Acceptable,27
363348004,Malignant tumor of lip (disorder),755163015,Preferred,28
363348004,Malignant tumour of lip,482495016,Preferred,28
363348004,CA - Cancer of lip,1228481010,Acceptable,28
363348004,Cancer of lip,1228482015,Acceptable,28
363348004,Malignant tumor of lip,482496015,Acceptable,28
93869001,Primary malignant neoplasm of lip (disorder),837692014,Preferred,29
93869001,Primary malignant neoplasm of lip,510765018,Preferred,29
93869001,CA - Cancer of lip,510768016,Acceptable,29
93869001,Cancer of lip,510767014,Acceptable,29
93869001,Malignant tumor of lip,510766017,Acceptable,29
93869001,Malignant tumour of lip,510769012,Acceptable,29
34563004,Fear of getting cancer (finding),766101012,Preferred,30
34563004,Fear of getting cancer,485869017,Preferred,30
34563004,Cancer phobia,485870016,Acceptable,30
34563004,Fear of cancer,57679013,Acceptable,30
191730005,Cancer phobia (disorder),2721593017,Preferred,31
191730005,Cancer phobia,295001015,Preferred,31
191730005,Cancer phobia (disorder),2721593017,Preferred,32
191730005,Cancer phobia,295001015,Preferred,32
93819009,Primary malignant neoplasm of gum (disorder),837632011,Preferred,33
93819009,Primary malignant neoplasm of gum,510673018,Preferred,33
93819009,CA - Cancer of gum,510678010,Acceptable,33
93819009,Cancer of gum,510677017,Acceptable,33
93819009,Malignant tumor of alveolar mucosa,510674012,Acceptable,33
93819009,Malignant tumor of gingiva,510675013,Acceptable,33
93819009,Malignant tumor of gum,510676014,Acceptable,33
93819009,Malignant tumour of alveolar mucosa,510681017,Acceptable,33
93819009,Malignant tumour of gingiva,510679019,Acceptable,33
93819009,Malignant tumour of gum,510680016,Acceptable,33
300930008,Cancer phobia (finding),2757412015,Preferred,34
300930008,Cancer phobia,442129012,Preferred,34
254837009,Malignant neoplasm of breast (disorder),3446623016,Preferred,35
254837009,Malignant tumour of breast,379664012,Preferred,35
254837009,Breast cancer,379662011,Acceptable,35
254837009,CA - Breast cancer,379663018,Acceptable,35
254837009,Malignant neoplasm of breast,3446624010,Acceptable,35
254837009,Malignant tumor of breast,379661016,Acceptable,35
363483004,Malignant tumor of pineal gland (disorder),755312012,Preferred,36
363483004,Malignant tumour of pineal gland,482752019,Preferred,36
363483004,Cancer of pineal gland,3036239017,Acceptable,36
363483004,Malignant tumor of pineal gland,482753012,Acceptable,36
363483004,Pineal cancer,3036221014,Acceptable,36
34563004,Fear of getting cancer (finding),766101012,Preferred,37
34563004,Fear of getting cancer,485869017,Preferred,37
34563004,Cancer phobia,485870016,Acceptable,37
34563004,Fear of cancer,57679013,Acceptable,37
363351006,Malignant tumor of rectum (disorder),755166011,Preferred,38
363351006,Malignant tumour of rectum,482502014,Preferred,38
363351006,CA - Cancer of rectum,1228487014,Acceptable,38
363351006,Malignant tumor of rectum,482501019,Acceptable,38
363351006,Rectal cancer,1228486017,Acceptable,38
300930008,Cancer phobia (finding),2757412015,Preferred,39
300930008,Cancer phobia,442129012,Preferred,39
363455001,Malignant tumor of urinary bladder (disorder),755282018,Preferred,40
363455001,Malignant tumour of urinary bladder,482706014,Preferred,40
363455001,Bladder cancer,1228584017,Acceptable,40
363455001,CA - Bladder cancer,1228586015,Acceptable,40
363455001,Malignant neoplasm of urinary bladder,1228585016,Acceptable,40
363455001,Malignant tumor of urinary bladder,482707017,Acceptable,40
363455001,NGB - New growth of bladder,1228583011,Acceptable,40
371973000,Malignant neoplasm of uterus (disorder),1197266013,Preferred,41
371973000,Malignant neoplasm of uterus,1210562019,Preferred,41
371973000,CA - Cancer of uterus,1229105017,Acceptable,41
371973000,Cancer of uterus,3036191014,Acceptable,41
371973000,Malignant tumor of uterus,1218023018,Acceptable,41
371973000,Malignant tumour of uterus,1216533010,Acceptable,41
371973000,Uterine cancer,3036277011,Acceptable,41
275937001,Family history of cancer (situation),2610546015,Preferred,42
275937001,Family history of cancer,411910010,Preferred,42
275937001,FH: Malignant disease,411912019,Acceptable,42
255080008,Carcinoma of stomach (disorder),646063017,Preferred,43
255080008,Carcinoma of stomach,380127016,Preferred,43
255080008,CA - Cancer of stomach,380123017,Acceptable,43
255080008,Cancer of stomach,380126013,Acceptable,43
255080008,Gastric cancer,380125012,Acceptable,43
255080008,Gastric carcinoma,380124011,Acceptable,43
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2718595015,Preferred,44
160284006,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),249744017,Preferred,44
160284006,FH: Cancer,249749010,Acceptable,44
160284006,FH: Cancer - *,249746015,Acceptable,44
160284006,FH: Carcinoma - *,249748019,Acceptable,44
160284006,FH: Malignant disease,249752019,Acceptable,44
160284006,FH: Neoplasia - *,249751014,Acceptable,44
160284006,FH: Neoplasm - *,249745016,Acceptable,44
160284006,FH: cancer,249753012,Acceptable,44
160284006,FH: carcinoma - *,249750010,Acceptable,44
160284006,FH: neoplasia,249747012,Acceptable,44
187759003,Malignant neoplasm of colon (& NOS) (disorder),2716260011,Preferred,45
187759003,Malignant neoplasm of colon (& NOS),288672013,Preferred,45
187759003,Colonic cancer,288673015,Acceptable,45
187759003,Malignant neoplasm of colon NOS,288674014,Acceptable,45
372130007,Malignant neoplasm of skin (disorder),1197423015,Preferred,46
372130007,Malignant neoplasm of skin,1210707014,Preferred,46
372130007,Cancer of skin,3036168010,Acceptable,46
372130007,Skin cancer,2536564013,Acceptable,46
34563004,Fear of getting cancer (finding),766101012,Preferred,47
34563004,Fear of getting cancer,485869017,Preferred,47
34563004,Cancer phobia,485870016,Acceptable,47
34563004,Fear of cancer,57679013,Acceptable,47
363478007,Malignant tumor of thyroid gland (disorder),755307011,Preferred,48
363478007,Malignant tumour of thyroid gland,482743011,Preferred,48
363478007,Malignant tumor of thyroid gland,482742018,Acceptable,48
363478007,Thyroid Ca,1228593016,Acceptable,48
363478007,Thyroid cancer,1228592014,Acceptable,48
258232002,Cancer staging (tumor staging),649622014,Preferred,49
258232002,Cancer staging,384309018,Preferred,49
399326009,Malignant tumor of urinary bladder (disorder),1767246018,Preferred,50
399326009,Malignant tumour of urinary bladder,1773307015,Preferred,50
399326009,Bladder cancer,1786810016,Acceptable,50
399326009,CA - Bladder cancer,1786812012,Acceptable,50
399326009,Malignant neoplasm of urinary bladder,1786811017,Acceptable,50
399326009,Malignant tumor of urinary bladder,1774593018,Acceptable,50
94074003,Primary malignant neoplasm of stomach (disorder),837941015,Preferred,51
94074003,Primary malignant neoplasm of stomach,511083010,Preferred,51
94074003,CA - Cancer of stomach,511087011,Acceptable,51
94074003,Cancer of stomach,511088018,Acceptable,51
94074003,Gastric cancer,511086019,Acceptable,51
94074003,Malignant tumor of stomach,511084016,Acceptable,51
94074003,Malignant tumour of stomach,511085015,Acceptable,51
109355002,Carcinoma in situ (disorder),2658887011,Preferred,52
109355002,Carcinoma in situ,2659784018,Preferred,52
109355002,Cancer in situ,3036320012,Acceptable,52
363349007,Malignant tumor of stomach (disorder),755164014,Preferred,53
363349007,Malignant tumour of stomach,482498019,Preferred,53
363349007,CA - Cancer of stomach,1228485018,Acceptable,53
363349007,Cancer of stomach,1228483013,Acceptable,53
363349007,Gastric cancer,1228484019,Acceptable,53
363349007,Malignant tumor of stomach,482497012,Acceptable,53
363443007,Malignant tumor of ovary (disorder),755268018,Preferred,54
363443007,Malignant tumour of ovary,482684016,Preferred,54
363443007,CA - Cancer of ovary,1228569014,Acceptable,54
363443007,Cancer of ovary,1228570010,Acceptable,54
363443007,Malignant tumor of ovary,482685015,Acceptable,54
363443007,Ovarian cancer,3035729016,Acceptable,54
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]) (situation),2709100011,Preferred,55
137687004,FH: Neoplasm - * (& [carcinoma - *] or [cancer]),218766012,Preferred,55
137687004,FH: Cancer,218772012,Acceptable,55
137687004,FH: Cancer - *,218773019,Acceptable,55
137687004,FH: Carcinoma - *,218774013,Acceptable,55
137687004,FH: Malignant disease,218770016,Acceptable,55
137687004,FH: Neoplasia - *,218768013,Acceptable,55
137687004,FH: Neoplasm - *,218769017,Acceptable,55
137687004,FH: cancer,218767015,Acceptable,55
137687004,FH: carcinoma - *,218771017,Acceptable,55
137687004,FH: neoplasia,218775014,Acceptable,55
363350007,Malignant tumor of cecum (disorder),755165010,Preferred,56
363350007,Malignant tumour of caecum,482499010,Preferred,56
363350007,CA - Cancer of caecum,1216462014,Acceptable,56
363350007,CA - Cancer of cecum,1217953013,Acceptable,56
363350007,Cancer of caecum,1216463016,Acceptable,56
363350007,Cancer of cecum,1217954019,Acceptable,56
363350007,Cecal cancer,3288530014,Acceptable,56
363350007,Malignant neoplasm of caecum,1216464010,Acceptable,56
363350007,Malignant neoplasm of cecum,1217952015,Acceptable,56
363350007,Malignant tumor of cecum,482500018,Acceptable,56
363438000,Malignant tumor of vertebral column (disorder),755263010,Preferred,57
363438000,Malignant tumour of vertebral column,482675016,Preferred,57
363438000,CA - Cancer of spine,1228562017,Acceptable,57
363438000,Cancer of spine,1228563010,Acceptable,57
363438000,Malignant neoplasm of spine,1228564016,Acceptable,57
363438000,Malignant tumor of vertebral column,482674017,Acceptable,57
254900004,Carcinoma of prostate (disorder),645858013,Preferred,58
254900004,Carcinoma of prostate,379766015,Preferred,58
254900004,CA - Carcinoma of prostate,379767012,Acceptable,58
254900004,Prostate cancer,3036967016,Acceptable,58
254900004,Prostate carcinoma,379768019,Acceptable,58
877241000000104,FH: malignant neoplasm of lung,2264221000000119,Preferred,59
877241000000104,FH: malignant neoplasm of lung,2264231000000117,Preferred,59
877241000000104,FH: lung cancer,2264241000000114,Acceptable,59
363432004,Malignant tumor of trachea (disorder),755255014,Preferred,60
363432004,Malignant tumour of trachea,482663014,Preferred,60
363432004,CA - Cancer of trachea,1228559015,Acceptable,60
363432004,Malignant tracheal tumor,3289017011,Acceptable,60
363432004,Malignant tracheal tumour,3289020015,Acceptable,60
363432004,Malignant tumor of trachea,482662016,Acceptable,60
363432004,Tracheal cancer,1228558011,Acceptable,60
877231000000108,Family history of malignant neoplasm of lung (situation),2264191000000114,Preferred,61
877231000000108,FH: Malignant neoplasm of lung,2264201000000111,Preferred,61
877231000000108,FH: Lung cancer,2264211000000113,Acceptable,61
363354003,Malignant tumor of cervix (disorder),755170015,Preferred,62
363354003,Malignant tumour of cervix,482507015,Preferred,62
363354003,Cancer of cervix,1228490015,Acceptable,62
363354003,Cancer of the uterine cervix,3036162011,Acceptable,62
363354003,Cervical cancer,3036569013,Acceptable,62
363354003,Malignant neoplasm of cervix,1228491016,Acceptable,62
363354003,Malignant neoplasm of cervix uteri,1228493018,Acceptable,62
363354003,Malignant tumor of cervix,482508013,Acceptable,62
363367000,Malignant tumor of vulva (disorder),755184013,Preferred,63
363367000,Malignant tumour of vulva,482534017,Preferred,63
363367000,Cancer of vulva,1228503013,Acceptable,63
363367000,Malignant tumor of vulva,482533011,Acceptable,63
363500001,Multiple malignancy (disorder),755331018,Preferred,64
363500001,Multiple malignancy,482787019,Preferred,64
363500001,CA - Multiple cancer,1228610011,Acceptable,64
363500001,Multiple cancer,1228609018,Acceptable,64
363443007,Malignant tumor of ovary (disorder),755268018,Preferred,65
363443007,Malignant tumour of ovary,482684016,Preferred,65
363443007,CA - Cancer of ovary,1228569014,Acceptable,65
363443007,Cancer of ovary,1228570010,Acceptable,65
363443007,Malignant tumor of ovary,482685015,Acceptable,65
363443007,Ovarian cancer,3035729016,Acceptable,65
93838000,Primary malignant neoplasm of intestinal tract (disorder),837655014,Preferred,66
93838000,Primary malignant neoplasm of intestinal tract,510710017,Preferred,66
93838000,CA - Cancer of bowel,510715010,Acceptable,66
93838000,CA - Cancer of intestine,510712013,Acceptable,66
93838000,Cancer of bowel,510716011,Acceptable,66
93838000,Cancer of intestine,510714014,Acceptable,66
93838000,Intestinal cancer,510713015,Acceptable,66
93838000,Malignant neoplasm of intestine,201694010,Acceptable,66
93838000,Malignant tumor of intestine,510711018,Acceptable,66
93838000,Malignant tumour of intestine,510717019,Acceptable,66
363406005,Malignant neoplasm of colon (disorder),3446618016,Preferred,67
363406005,Malignant tumour of colon,482611019,Preferred,67
363406005,CA - Cancer of colon,1228535013,Acceptable,67
363406005,Cancer of colon,1228536014,Acceptable,67
363406005,Malignant neoplasm of colon,3446619012,Acceptable,67
363406005,Malignant tumor of colon,482612014,Acceptable,67
48120004,Cancer hospital (environment),785653018,Preferred,68
48120004,Cancer hospital,80188010,Preferred,68
363403002,Malignant tumor of duodenum (disorder),755223014,Preferred,69
363403002,Malignant tumour of duodenum,482606016,Preferred,69
363403002,Duodenal cancer,1228534012,Acceptable,69
363403002,Malignant tumor of duodenum,482605017,Acceptable,69
94070007,Primary malignant neoplasm of vertebral column (disorder),837936011,Preferred,70
94070007,Primary malignant neoplasm of vertebral column,511078019,Preferred,70
94070007,CA - Cancer of spine,511075016,Acceptable,70
94070007,Cancer of spine,511076015,Acceptable,70
94070007,Malignant neoplasm of spine,155589015,Acceptable,70
94070007,Malignant tumor of vertebral column,511079010,Acceptable,70
94070007,Malignant tumour of vertebral column,511077012,Acceptable,70
363508008,Malignant tumor of intestine (disorder),755340019,Preferred,71
363508008,Malignant tumour of intestine,482802017,Preferred,71
363508008,CA - Cancer of bowel,1228621019,Acceptable,71
363508008,CA - Cancer of intestine,1228618016,Acceptable,71
363508008,Cancer of bowel,1228620018,Acceptable,71
363508008,Cancer of intestine,1228616017,Acceptable,71
363508008,Intestinal cancer,1228619012,Acceptable,71
363508008,Malignant neoplasm of intestine,1228617014,Acceptable,71
363508008,Malignant tumor of intestine,482803010,Acceptable,71
93954003,Primary malignant neoplasm of penis (disorder),837796015,Preferred,72
93954003,Primary malignant neoplasm of penis,510913011,Preferred,72
93954003,CA - Cancer of penis,510917012,Acceptable,72
93954003,Cancer of penis,510916015,Acceptable,72
93954003,Malignant tumor of penis,510914017,Acceptable,72
93954003,Malignant tumour of penis,510918019,Acceptable,72
93954003,Penile Ca,510915016,Acceptable,72
363516004,Malignant tumor of penis (disorder),755349018,Preferred,73
363516004,Malignant tumour of penis,482819015,Preferred,73
363516004,CA - Cancer of penis,1228634018,Acceptable,73
363516004,Ca penis,1228633012,Acceptable,73
363516004,Cancer of penis,1228631014,Acceptable,73
363516004,Malignant tumor of penis,482820014,Acceptable,73
363516004,Penile Ca,1228632019,Acceptable,73
444589003,Malignant neoplasm detection during interval between recommended screening examinations (finding),2868811015,Preferred,74
444589003,Malignant neoplasm detection during interval between recommended screening examinations,2870614013,Preferred,74
444589003,Interval cancer,2870602017,Acceptable,74
363511009,Malignant tumour of skin (disorder),2718835012,Preferred,75
363511009,Malignant tumour of skin,482809014,Preferred,75
363511009,CA - Skin cancer,1228628013,Acceptable,75
363511009,Malignant tumor of skin,482808018,Acceptable,75
363511009,Skin cancer,1228629017,Acceptable,75
363458004,Malignant tumor of ureter (disorder),755285016,Preferred,76
363458004,Malignant tumour of ureter,482713014,Preferred,76
363458004,Cancer of ureter,1228587012,Acceptable,76
363458004,Malignant tumor of ureter,482712016,Acceptable,76
363458004,Ureter Ca,1228588019,Acceptable,76
392747007,Cancer confirmed (situation),2734574012,Preferred,77
392747007,Cancer confirmed,1486723010,Preferred,77
386604001,Cancer registrar (occupation),1460783011,Preferred,78
386604001,Cancer registrar,1480746015,Preferred,78
393139007,Cancer care plan (qualifier value),2751639010,Preferred,79
393139007,Cancer care plan,1487108019,Preferred,79
393139007,Cancer care plan (qualifier value),2751639010,Preferred,80
393139007,Cancer care plan,1487108019,Preferred,80
94130002,Primary malignant neoplasm of vagina (disorder),838009014,Preferred,81
94130002,Primary malignant neoplasm of vagina,511168019,Preferred,81
94130002,Cancer of vagina,511166015,Acceptable,81
94130002,Malignant tumor of vagina,511169010,Acceptable,81
94130002,Malignant tumour of vagina,511167012,Acceptable,81
269466003,Malignant tumor of bone and articular cartilage (disorder),662330011,Preferred,82
269466003,Malignant tumour of bone and articular cartilage,403694019,Preferred,82
269466003,Bone cancer,403692015,Acceptable,82
269466003,CA - Bone cancer,403690011,Acceptable,82
269466003,Malignant bone tumor,403696017,Acceptable,82
269466003,Malignant bone tumour,403693013,Acceptable,82
269466003,Malignant neoplasm of bone and articular cartilage,403691010,Acceptable,82
269466003,Malignant tumor of bone and articular cartilage,403695018,Acceptable,82
363350007,Malignant tumor of cecum (disorder),755165010,Preferred,83
363350007,Malignant tumour of caecum,482499010,Preferred,83
363350007,CA - Cancer of caecum,1216462014,Acceptable,83
363350007,CA - Cancer of cecum,1217953013,Acceptable,83
363350007,Cancer of caecum,1216463016,Acceptable,83
363350007,Cancer of cecum,1217954019,Acceptable,83
363350007,Cecal cancer,3288530014,Acceptable,83
363350007,Malignant neoplasm of caecum,1216464010,Acceptable,83
363350007,Malignant neoplasm of cecum,1217952015,Acceptable,83
363350007,Malignant tumor of cecum,482500018,Acceptable,83
389278006,FH: Bowel cancer (situation),2751719015,Preferred,84
389278006,FH: Bowel cancer,1483315015,Preferred,84
363445000,Malignant tumor of vagina (disorder),755271014,Preferred,85
363445000,Malignant tumour of vagina,482688018,Preferred,85
363445000,Cancer of vagina,1228571014,Acceptable,85
363445000,Malignant tumor of vagina,482689014,Acceptable,85
93937006,Primary malignant neoplasm of tonsil (disorder),837775010,Preferred,86
93937006,Primary malignant neoplasm of tonsil,510874014,Preferred,86
93937006,CA - Cancer of tonsil,510881019,Acceptable,86
93937006,Cancer of tonsil,510882014,Acceptable,86
93937006,Malignant neoplasm of palatine tonsil,155434016,Acceptable,86
93937006,Malignant tumor of faucial tonsil,510875010,Acceptable,86
93937006,Malignant tumor of palatine tonsil,510877019,Acceptable,86
93937006,Malignant tumor of tonsil,510876011,Acceptable,86
93937006,Malignant tumour of faucial tonsil,510880018,Acceptable,86
93937006,Malignant tumour of palatine tonsil,510878012,Acceptable,86
93937006,Malignant tumour of tonsil,510879016,Acceptable,86
394090000,Cancer care plan (regime/therapy),2743230019,Preferred,87
394090000,Cancer care plan,1487937016,Preferred,87
394090000,Cancer care plan (regime/therapy),2743230019,Preferred,88
394090000,Cancer care plan,1487937016,Preferred,88
389278006,FH: Bowel cancer (situation),2751719015,Preferred,89
389278006,FH: Bowel cancer,1483315015,Preferred,89
363433009,Malignant tumor of pleura (disorder),755256010,Preferred,90
363433009,Malignant tumour of pleura,482664015,Preferred,90
363433009,CA - Cancer of pleura,1228561012,Acceptable,90
363433009,Cancer of pleura,1228560013,Acceptable,90
363433009,Malignant tumor of pleura,482665019,Acceptable,90
390017006,FH: Bowel cancer (situation),2755772014,Preferred,91
390017006,FH: Bowel cancer,1484053012,Preferred,91
93859007,Primary malignant neoplasm of larynx (disorder),837680014,Preferred,92
93859007,Primary malignant neoplasm of larynx,510748010,Preferred,92
93859007,CA - Cancer of larynx,510750019,Acceptable,92
93859007,Cancer of larynx,510752010,Acceptable,92
93859007,Laryngeal cancer,510751015,Acceptable,92
93859007,Malignant tumor of larynx,510749019,Acceptable,92
93859007,Malignant tumour of larynx,510753017,Acceptable,92
363429002,Malignant tumor of larynx (disorder),755252012,Preferred,93
363429002,Malignant tumour of larynx,482656014,Preferred,93
363429002,CA - Cancer of larynx,1228554013,Acceptable,93
363429002,Cancer of larynx,1228556010,Acceptable,93
363429002,Laryngeal cancer,1228555014,Acceptable,93
363429002,Malignant tumor of larynx,482657017,Acceptable,93
363429002,Malignant tumor of larynx (disorder),755252012,Preferred,94
363429002,Malignant tumour of larynx,482656014,Preferred,94
363429002,CA - Cancer of larynx,1228554013,Acceptable,94
363429002,Cancer of larynx,1228556010,Acceptable,94
363429002,Laryngeal cancer,1228555014,Acceptable,94
363429002,Malignant tumor of larynx,482657017,Acceptable,94
243072006,Cancer education (procedure),2570865018,Preferred,95
243072006,Cancer education,2575827010,Preferred,95
243072006,Advice on cancer,363541010,Acceptable,95
162572001,Suspected malignancy (situation),2607678010,Preferred,96
162572001,Suspected malignancy,253466010,Preferred,96
162572001,Suspected cancer,1784764013,Acceptable,96
363354003,Malignant tumor of cervix (disorder),755170015,Preferred,97
363354003,Malignant tumour of cervix,482507015,Preferred,97
363354003,Cancer of cervix,1228490015,Acceptable,97
363354003,Cancer of the uterine cervix,3036162011,Acceptable,97
363354003,Cervical cancer,3036569013,Acceptable,97
363354003,Malignant neoplasm of cervix,1228491016,Acceptable,97
363354003,Malignant neoplasm of cervix uteri,1228493018,Acceptable,97
363354003,Malignant tumor of cervix,482508013,Acceptable,97
243072006,Cancer education (procedure),2570865018,Preferred,98
243072006,Cancer education,2575827010,Preferred,98
243072006,Advice on cancer,363541010,Acceptable,98
395082007,Cancer care plan (qualifier value),1469022019,Preferred,99
395082007,Cancer care plan,1488781019,Preferred,99
781382000,Malignant neoplasm of colon and/or rectum (disorder),3746899019,Preferred,100
781382000,Malignant neoplasm of colon and/or rectum,3746900012,Preferred,100
781382000,Colorectal cancer,3746849018,Acceptable,100
722731000000100,Colorectal cancer (qualifier value),1698911000000110,Preferred,101
722731000000100,Colorectal cancer,1580471000000119,Preferred,101
363418001,Malignant tumor of pancreas (disorder),755240017,Preferred,102
363418001,Malignant tumour of pancreas,482635012,Preferred,102
363418001,CA - Cancer of pancreas,1228545010,Acceptable,102
363418001,CA - Pancreatic cancer,1228547019,Acceptable,102
363418001,Malignant tumor of pancreas,482636013,Acceptable,102
363418001,Pancreatic cancer,1228546011,Acceptable,102
363421004,Malignant neoplasm of omentum (disorder),755243015,Preferred,103
363421004,Malignant neoplasm of omentum,482641017,Preferred,103
363421004,CA - Cancer of omentum,1228551017,Acceptable,103
363421004,Cancer of omentum,1228550016,Acceptable,103
187730003,(Malignant neoplasm of oesophagus NOS or oesophageal cancer (disorder),2716572018,Preferred,104
187730003,(Malignant neoplasm of oesophagus NOS or oesophageal cancer,288617011,Preferred,104
187730003,(Malignant neoplasm of esophagus NOS or esophageal cancer,288616019,Acceptable,104
187730003,Esophageal cancer,288621016,Acceptable,104
187730003,Malignant neoplasm of esophagus NOS,288620015,Acceptable,104
187730003,Malignant neoplasm of oesophagus NOS,288618018,Acceptable,104
187730003,Oesophageal cancer,288619014,Acceptable,104
363507003,Malignant neoplasm of pharynx (disorder),3321137016,Preferred,105
363507003,Malignant tumour of pharynx,482801012,Preferred,105
363507003,CA - Cancer of pharynx,1228615018,Acceptable,105
363507003,Cancer of pharynx,1228614019,Acceptable,105
363507003,Malignant neoplasm of pharynx,3321140016,Acceptable,105
363507003,Malignant tumor of pharynx,482800013,Acceptable,105
275862002,Family history of breast cancer (situation),2610172016,Preferred,106
275862002,Family history of breast cancer,411826010,Preferred,106
275862002,FH: Breast cancer,411827018,Acceptable,106
103089002,Cancer antigen 50 (substance),548082019,Preferred,107
103089002,Cancer antigen 50,166587012,Preferred,107
103089002,CA 50 - Carbohydrate antigen 50,1218922013,Acceptable,107
103089002,Carbohydrate antigen 50,1218921018,Acceptable,107
336461000000101,Colorectal cancer - National Public Health Classification (administrative concept),624281000000113,Preferred,108
336461000000101,Colorectal cancer,624271000000111,Preferred,108
160287004,FH: neoplasm of breast (& cancer) (situation),2689973012,Preferred,109
160287004,FH: neoplasm of breast (& cancer),249765011,Preferred,109
160287004,FH: * - breast,249763016,Acceptable,109
160287004,FH: Breast cancer,249764010,Acceptable,109
94091004,Primary malignant neoplasm of the peritoneum (disorder),837962019,Preferred,110
94091004,Primary malignant neoplasm of the peritoneum,511111016,Preferred,110
94091004,CA - Cancer of peritoneum,511114012,Acceptable,110
94091004,Cancer of peritoneum,511113018,Acceptable,110
94091004,Malignant tumor of peritoneum,511112011,Acceptable,110
94091004,Malignant tumour of peritoneum,511116014,Acceptable,110
94091004,Peritoneal cancer,511115013,Acceptable,110
363454002,Malignant tumor of scrotum (disorder),755281013,Preferred,111
363454002,Malignant tumour of scrotum,482705013,Preferred,111
363454002,CA - Cancer of scrotum,1228580014,Acceptable,111
363454002,Cancer of scrotum,1228581013,Acceptable,111
363454002,Malignant scrotal tumor,1217982014,Acceptable,111
363454002,Malignant scrotal tumour,1216492017,Acceptable,111
363454002,Malignant tumor of scrotum,482704012,Acceptable,111
363454002,Scrotal Ca,1228582018,Acceptable,111
401123009,Cancer care review (regime/therapy),1769044015,Preferred,112
401123009,Cancer care review,1780324019,Preferred,112
449421003,Malignant neoplasm of placenta (disorder),2898825014,Preferred,113
449421003,Malignant neoplasm of placenta,2899891016,Preferred,113
449421003,Cancer of placenta,2899890015,Acceptable,113
363481002,Malignant tumor of parathyroid gland (disorder),755310016,Preferred,114
363481002,Malignant tumour of parathyroid gland,482748019,Preferred,114
363481002,Malignant tumor of parathyroid gland,482749010,Acceptable,114
363481002,Parathyroid cancer,1228595011,Acceptable,114
275108004,Family history: Stomach cancer (situation),2610447010,Preferred,115
275108004,FH: Stomach cancer,411037010,Preferred,115
275108004,Family history: Stomach cancer,2669930014,Acceptable,115
137688009,FH: neoplasm of gastrointestinal tract (& [stomach]) (situation),2709099015,Preferred,116
137688009,FH: neoplasm of gastrointestinal tract (& [stomach]),218779015,Preferred,116
137688009,FH: * - gastrointestinal tract,218776010,Acceptable,116
137688009,FH: Stomach cancer,218777018,Acceptable,116
137688009,FH: stomach cancer,218778011,Acceptable,116
363493006,Malignant tumor of bronchus (disorder),755323011,Preferred,117
363493006,Malignant tumour of bronchus,482773019,Preferred,117
363493006,CA - Cancer of bronchus,1228605012,Acceptable,117
363493006,Cancer of bronchus,1228606013,Acceptable,117
363493006,Malignant tumor of bronchus,482774013,Acceptable,117
428997004,Psychosocial counseling about cancer (procedure),2689035010,Preferred,118
428997004,Cancer counselling,2695648015,Preferred,118
428997004,Psychosocial cancer counseling,2694510014,Acceptable,118
428997004,Psychosocial cancer counselling,2695375015,Acceptable,118
428997004,Psychosocial counseling about cancer,2694877014,Acceptable,118
428997004,Psychosocial counselling about cancer,2694219011,Acceptable,118
93679002,Primary malignant neoplasm of appendix (disorder),837462011,Preferred,119
93679002,Primary malignant neoplasm of appendix,510445012,Preferred,119
93679002,Appendiceal cancer,3288311013,Acceptable,119
103084007,Cancer antigen 125 (substance),548027011,Preferred,120
103084007,Cancer antigen 125,166582018,Preferred,120
103084007,CA 125 - Carbohydrate antigen 125,1218914018,Acceptable,120
103084007,Carbohydrate antigen 125,1218913012,Acceptable,120
363450006,Malignant tumor of foreskin (disorder),755276016,Preferred,121
363450006,Malignant tumour of foreskin,482697019,Preferred,121
363450006,Cancer of foreskin,1228576016,Acceptable,121
363450006,Malignant neoplasm of foreskin,1228577013,Acceptable,121
363450006,Malignant neoplasm of prepuce (foreskin),1228575017,Acceptable,121
363450006,Malignant tumor of foreskin,482696011,Acceptable,121
363450006,Malignant tumor of prepuce,1217981019,Acceptable,121
363450006,Malignant tumour of prepuce,1216491012,Acceptable,121
363448003,Malignant tumor of prostate (disorder),755274018,Preferred,122
363448003,Malignant tumour of prostate,482693015,Preferred,122
363448003,CA - Cancer of prostate,1228572019,Acceptable,122
363448003,Cancer of prostate,1228573012,Acceptable,122
363448003,Malignant prostatic tumor,1217980018,Acceptable,122
363448003,Malignant prostatic tumour,1216490013,Acceptable,122
363448003,Malignant tumor of prostate,482692013,Acceptable,122
363448003,NGP - New growth of prostate,1228574018,Acceptable,122
254841008,Cancer en cuirasse (disorder),645791012,Preferred,123
254841008,Cancer en cuirasse,379670018,Preferred,123
877621000000109,Family history of malignant neoplasm of urinary bladder (situation),2265041000000118,Preferred,124
877621000000109,FH: Malignant neoplasm of urinary bladder,2265051000000115,Preferred,124
877621000000109,FH: Bladder cancer,2265061000000117,Acceptable,124
267114006,FH: neoplasm of gastrointestinal tract (& [stomach]) (situation),2718920010,Preferred,125
267114006,FH: neoplasm of gastrointestinal tract (& [stomach]),398022014,Preferred,125
267114006,FH: * - gastrointestinal tract,398020018,Acceptable,125
267114006,FH: Stomach cancer,398021019,Acceptable,125
267114006,FH: stomach cancer,398019012,Acceptable,125
81341000000107,Cancer care review,121761000000110,Preferred,126
81341000000107,Cancer care review,121751000000112,Preferred,126
448668007,Malignant neoplasm of mandible (disorder),2898859013,Preferred,127
448668007,Malignant neoplasm of mandible,2901472014,Preferred,127
448668007,Cancer of mandible,2901471019,Acceptable,127
77031000000100,Cancer care review,116321000000118,Preferred,128
77031000000100,Cancer care review,116311000000112,Preferred,128
720006006,Cancer care review (procedure),3318840013,Preferred,129
720006006,Cancer care review,3318841012,Preferred,129
405843009,Widespread metastatic malignant neoplastic disease (disorder),2149673015,Preferred,130
405843009,Widespread metastatic malignant neoplastic disease,2157614015,Preferred,130
405843009,CA - Disseminated cancer,2163175014,Acceptable,130
405843009,Disseminated cancer,2163173019,Acceptable,130
405843009,Disseminated malignancy,2163172012,Acceptable,130
405843009,Generalised cancer,2161379019,Acceptable,130
405843009,Generalised malignancy,2161380016,Acceptable,130
405843009,Generalized cancer,2161522010,Acceptable,130
405843009,Generalized malignancy,2161521015,Acceptable,130
405843009,"Malignant neoplasm, disseminated",2163174013,Acceptable,130
103090006,Cancer antigen 549 (substance),548094011,Preferred,131
103090006,Cancer antigen 549,166588019,Preferred,131
103090006,CA 549 - Carbohydrate antigen 549,1218924014,Acceptable,131
103090006,Carbohydrate antigen 549,1218923015,Acceptable,131
371980003,Primary malignant neoplasm of clitoris (disorder),1197273015,Preferred,132
371980003,Primary malignant neoplasm of clitoris,1210567013,Preferred,132
371980003,Cancer of clitoris,3012592015,Acceptable,132
735995007,Exophiala cancerae (organism),3515991019,Preferred,133
735995007,Exophiala cancerae,3515992014,Preferred,133
399068003,Malignant tumor of prostate (disorder),1766988013,Preferred,134
399068003,Malignant tumour of prostate,1773293010,Preferred,134
399068003,CA - Cancer of prostate,1786664015,Acceptable,134
399068003,Cancer of prostate,1786665019,Acceptable,134
399068003,Malignant prostatic tumor,1784079012,Acceptable,134
399068003,Malignant prostatic tumour,1783694019,Acceptable,134
399068003,Malignant tumor of prostate,1774579013,Acceptable,134
103087000,Cancer antigen 242 (substance),548060014,Preferred,135
103087000,Cancer antigen 242,166585016,Preferred,135
103087000,CA 242 - Carbohydrate antigen 242,1218920017,Acceptable,135
103087000,Carbohydrate antigen 242,1218919011,Acceptable,135
300701000000100,Cancer counselling (procedure),534931000000113,Preferred,136
300701000000100,Cancer counselling,532741000000110,Preferred,136
160286008,FH: neoplasm of trachea &/or bronchus &/or lung (situation),2759216014,Preferred,137
160286008,FH: neoplasm of trachea &/or bronchus &/or lung,249759011,Preferred,137
160286008,FH: * - trachea/bronchus/lung,249762014,Acceptable,137
160286008,FH: Bronchus cancer,249760018,Acceptable,137
160286008,FH: bronchus cancer,249761019,Acceptable,137
422758009,Carcinoma of nasal meatus (disorder),2639514018,Preferred,138
422758009,Carcinoma of nasal meatus,2643509013,Preferred,138
422758009,Cancer of nasal meatus,3037106016,Acceptable,138
422758009,Carcinoma of meatus nasi,2647856019,Acceptable,138
422758009,Nasal meatus cancer,3037544019,Acceptable,138
275110002,Family history: Bronchus cancer (situation),2610300019,Preferred,139
275110002,FH: Bronchus cancer,411039013,Preferred,139
275110002,Family history of bronchial cancer,3037045012,Acceptable,139
275110002,Family history: Bronchus cancer,2670059018,Acceptable,139
372099007,Malignant neoplasm of exocervix (disorder),1197392016,Preferred,140
372099007,Malignant neoplasm of exocervix,1210677019,Preferred,140
372099007,Cancer of exocervix,3034718013,Acceptable,140
103086009,Cancer antigen 19-9 (substance),548049017,Preferred,141
103086009,Cancer antigen 19-9,166584017,Preferred,141
103086009,CA 19.9 - Carbohydrate antigen 19.9,1218918015,Acceptable,141
103086009,Carbohydrate antigen 19.9,1218917013,Acceptable,141
103091005,Cancer antigen 72-4 (substance),548106015,Preferred,142
103091005,Cancer antigen 72-4,166589010,Preferred,142
103091005,CA 72.4 - Carbohydrate antigen 72.4,1218926011,Acceptable,142
103091005,Carbohydrate antigen 72.4,1218925010,Acceptable,142
182974001,Cancer chemotherapy (regime/therapy),2719190014,Preferred,143
182974001,Cancer chemotherapy,282857017,Preferred,143
114451003,Enterobacter cancerogenus (organism),659164016,Preferred,144
114451003,Enterobacter cancerogenus,181551012,Preferred,144
114451003,Erwinia cancerogena,2618709017,Acceptable,144
51939009,Erwinia cancerogena (organism),789893011,Preferred,145
51939009,Erwinia cancerogena,86462012,Preferred,145
130656004,Cancer procoagulant (substance),734959010,Preferred,146
130656004,Cancer procoagulant,210014013,Preferred,146
103085008,Cancer antigen 19-5 (substance),548038011,Preferred,147
103085008,Cancer antigen 19-5,166583011,Preferred,147
103085008,CA 195 - Carbohydrate antigen 195,1218916016,Acceptable,147
103085008,Carbohydrate antigen 195,1218915017,Acceptable,147
69960004,Antineoplastic chemotherapy regimen (procedure),809962010,Preferred,148
69960004,Antineoplastic chemotherapy regimen,2160484015,Preferred,148
69960004,Cancer chemotherapy,501450016,Acceptable,148
69960004,Cancer chemotherapy regimen,501449016,Acceptable,148
69960004,Chemotherapy regimen,501448012,Acceptable,148
276810009,Late gastric cancer (disorder),669770018,Preferred,149
276810009,Late gastric cancer,413119019,Preferred,149
276810009,LGC - Late gastric cancer,413120013,Acceptable,149
103092003,Cancer antigen 15-3 (substance),548117019,Preferred,150
103092003,Cancer antigen 15-3,166590018,Preferred,150
103092003,CA 15.3 - Carbohydrate antigen 15.3,1218930014,Acceptable,150
103092003,Carbohydrate antigen 15.3,1218927019,Acceptable,150
103092003,Epithelial membrane antigen,2659281010,Acceptable,150
103092003,MCA - Mucin-like carcinoma-associated antigen,1218928012,Acceptable,150
103092003,Mucin-like carcinoma-associated antigen,1218929016,Acceptable,150
137689001,FH: neoplasm of trachea &/or bronchus &/or lung (situation),2711646019,Preferred,151
137689001,FH: neoplasm of trachea &/or bronchus &/or lung,218780017,Preferred,151
137689001,FH: * - trachea/bronchus/lung,218783015,Acceptable,151
137689001,FH: Bronchus cancer,218781018,Acceptable,151
137689001,FH: bronchus cancer,218782013,Acceptable,151
428262008,History of malignant neoplasm of prostate (situation),2691736017,Preferred,152
428262008,History of malignant neoplasm of prostate,2692217012,Preferred,152
428262008,H/O: prostate cancer,1717461000000112,Acceptable,152
10745291000119103,Malignant neoplastic disease in mother complicating childbirth (disorder),2995572018,Preferred,153
10745291000119103,Malignant neoplastic disease in mother complicating childbirth,2995725016,Preferred,153
10745291000119103,Cancer in childbirth,2995314011,Acceptable,153
363486007,Malignant tumor of vocal cord (disorder),755316010,Preferred,154
363486007,Malignant tumour of vocal cord,482760018,Preferred,154
363486007,CA - Cancer of vocal cord,1228598013,Acceptable,154
363486007,Cancer of vocal cord,1228599017,Acceptable,154
363486007,Malignant tumor of vocal cord,482759011,Acceptable,154
363486007,Malignant tumor of vocal fold,1217986012,Acceptable,154
363486007,Malignant tumour of vocal fold,1216496019,Acceptable,154
405150005,Risk control behavior: cancer (observable entity),2148980011,Preferred,155
405150005,Risk control behavior: cancer,2156982015,Preferred,155
405150005,Risk control: cancer,2162970011,Acceptable,155
778481000000106,H/O: prostate cancer,1744011000000116,Preferred,156
778481000000106,H/O: prostate cancer,1741321000000110,Preferred,156
449420002,Malignant neoplasm of cerebellum (disorder),2898824013,Preferred,157
449420002,Malignant neoplasm of cerebellum,2899889012,Preferred,157
449420002,Cancer of cerebellum,2899888016,Acceptable,157
276809004,Early gastric cancer (disorder),669769019,Preferred,158
276809004,Early gastric cancer,413118010,Preferred,158
276809004,EGC - Early gastric cancer,413117017,Acceptable,158
276821000,Malignant melanoma of anus (disorder),669783017,Preferred,159
276821000,Malignant melanoma of anus,413137018,Preferred,159
276821000,Cancer anal melanoma,3036582017,Acceptable,159
109378008,"Mesothelioma (malignant, clinical disorder) (disorder)",611321019,Preferred,160
109378008,"Mesothelioma (malignant, clinical disorder)",2660053016,Preferred,160
109378008,"Cancer, mesothelioma",3036244012,Acceptable,160
109378008,Malignant mesothelioma,3036103015,Acceptable,160
93779009,Primary malignant neoplasm of endocervix (disorder),837583019,Preferred,161
93779009,Primary malignant neoplasm of endocervix,510596012,Preferred,161
93779009,Cancer of endocervix,3012522013,Acceptable,161
397614000,Suspected central nervous system cancer (situation),2612987019,Preferred,162
397614000,Suspected central nervous system cancer,1777232019,Preferred,162
397614000,Suspected CNS cancer,1785877015,Acceptable,162
372064008,Malignant neoplasm of female breast (disorder),1197357012,Preferred,163
372064008,Malignant neoplasm of female breast,1210642019,Preferred,163
372064008,Cancer of female breast,3036344014,Acceptable,163
372064008,Female breast cancer,3036010011,Acceptable,163
15886004,Screening for cancer (procedure),742800016,Preferred,164
15886004,Screening for cancer,26911013,Preferred,164
15886004,Neoplasm screening,1221243012,Acceptable,164
94141000,Primary malignant neoplasm of vocal cord (disorder),838023011,Preferred,165
94141000,Primary malignant neoplasm of vocal cord,511200015,Preferred,165
94141000,CA - Cancer of vocal cord,511195012,Acceptable,165
94141000,Cancer of vocal cord,511196013,Acceptable,165
94141000,Carcinoma of vocal cord,511197016,Acceptable,165
94141000,Malignant tumor of vocal cord,511201016,Acceptable,165
94141000,Malignant tumor of vocal fold,511202011,Acceptable,165
94141000,Malignant tumour of vocal cord,511199018,Acceptable,165
94141000,Malignant tumour of vocal fold,511198014,Acceptable,165
64644003,Immunotherapy for cancer (procedure),1472477019,Preferred,166
64644003,Immunotherapy for cancer,107436014,Preferred,166
64644003,Biological agent therapy for malignant disease,1788105013,Acceptable,166
64644003,Cancer immunotherapy,499909010,Acceptable,166
103088005,Cancer antigen 27-29 (substance),548071010,Preferred,167
103088005,Cancer antigen 27-29,166586015,Preferred,167
877691000000107,No family history of malignant neoplasm of lung (situation),2265201000000112,Preferred,168
877691000000107,No FH of lung cancer,2265211000000114,Preferred,168
363352004,Malignant tumor of anal canal (disorder),755167019,Preferred,169
363352004,Malignant tumour of anal canal,482503016,Preferred,169
363352004,Cancer of anal canal,1228488016,Acceptable,169
363352004,Malignant tumor of anal canal,482504010,Acceptable,169
422985007,"Carcinoma of colon, stage IV (finding)",2639513012,Preferred,170
422985007,"Carcinoma of colon, stage IV",2643508017,Preferred,170
422985007,Colon cancer stage 4,3037442018,Acceptable,170
425213009,"Carcinoma of colon, stage I (finding)",2639510010,Preferred,171
425213009,"Carcinoma of colon, stage I",2643505019,Preferred,171
425213009,Colon cancer stage 1,3035992013,Acceptable,171
363410008,Malignant tumor of sigmoid colon (disorder),755231016,Preferred,172
363410008,Malignant tumour of sigmoid colon,482619017,Preferred,172
363410008,Malignant tumor of sigmoid colon,482620011,Acceptable,172
363410008,Sigmoid colon cancer,3288335015,Acceptable,172
877701000000107,No FH of lung cancer,2265221000000115,Preferred,173
877701000000107,No FH of lung cancer,2265231000000118,Preferred,173
363392002,Malignant tumor of oropharynx (disorder),755211015,Preferred,174
363392002,Malignant tumour of oropharynx,482583018,Preferred,174
363392002,CA - Cancer of oropharynx,1228527010,Acceptable,174
363392002,Cancer of oropharynx,1228526018,Acceptable,174
363392002,Malignant tumor of mesopharynx,2475225019,Acceptable,174
363392002,Malignant tumor of oropharynx,482584012,Acceptable,174
363392002,Malignant tumour of mesopharynx,2475015015,Acceptable,174
843531000000102,Management of cancer (procedure),2188231000000113,Preferred,175
843531000000102,Management of cancer,2188221000000111,Preferred,175
139841002,Suspected lung cancer (situation),2756946015,Preferred,176
139841002,Suspected lung cancer,221648017,Preferred,176
703135009,Anemia in malignant neoplastic disease (disorder),3007250012,Preferred,177
703135009,Anaemia in malignant neoplastic disease,3007260015,Preferred,177
703135009,Anemia in malignant neoplastic disease,3007262011,Acceptable,177
703135009,Cancer-related anaemia,3007186018,Acceptable,177
703135009,Cancer-related anemia,3007282010,Acceptable,177
92605003,Carcinoma in situ of gum (disorder),836164014,Preferred,178
92605003,Carcinoma in situ of gum,153183014,Preferred,178
92605003,Cancer in situ of gum,3036107019,Acceptable,178
92605003,Carcinoma in situ of gingiva,1235747011,Acceptable,178
724167008,Lung cancer screening (procedure),3431392014,Preferred,179
724167008,Lung cancer screening,3431393016,Preferred,179
422581008,"Carcinoma of colon, stage II (finding)",2639511014,Preferred,180
422581008,"Carcinoma of colon, stage II",2643506018,Preferred,180
422581008,"Cancer of the colon, stage 2",3036881018,Acceptable,180
422581008,"Colon cancer, stage 2",3036828014,Acceptable,180
422375001,"Carcinoma of colon, stage III (finding)",2639512019,Preferred,181
422375001,"Carcinoma of colon, stage III",2643507010,Preferred,181
422375001,"Cancer of colon, stage 3",3290094014,Acceptable,181
422375001,"Colon cancer, stage 3",3037656013,Acceptable,181
724451007,Fear of breast cancer (finding),3447274012,Preferred,182
724451007,Fear of breast cancer,3447275013,Preferred,182
162589009,Suspected skin cancer (situation),2735457019,Preferred,183
162589009,Suspected skin cancer,253486014,Preferred,183
516381000000106,Has cancer key worker,1149841000000116,Preferred,184
516381000000106,Has cancer key worker,1149851000000118,Preferred,184
516371000000109,Has cancer key worker (finding),1149821000000111,Preferred,185
516371000000109,Has cancer key worker,1149831000000113,Preferred,185
423349005,Carcinoma of tip of nose (disorder),2639585013,Preferred,186
423349005,Carcinoma of tip of nose,2643583012,Preferred,186
423349005,Cancer of tip of nose,3037508012,Acceptable,186
363451005,Malignant tumor of glans penis (disorder),755277013,Preferred,187
363451005,Malignant tumour of glans penis,482698012,Preferred,187
363451005,Cancer of glans penis,1228578015,Acceptable,187
363451005,Malignant tumor of glans penis,482699016,Acceptable,187
254908006,Malignant tumor of skin of penis (disorder),645867013,Preferred,188
254908006,Malignant tumour of skin of penis,379785017,Preferred,188
254908006,Cancer of penile skin,379783012,Acceptable,188
254908006,Malignant tumor of penile skin,379781014,Acceptable,188
254908006,Malignant tumor of skin of penis,379782019,Acceptable,188
254908006,Malignant tumour of penile skin,379784018,Acceptable,188
315276005,Suspected skin cancer (situation),2611957011,Preferred,189
315276005,Suspected skin cancer,459777014,Preferred,189
94143002,Primary malignant neoplasm of vulva (disorder),838025016,Preferred,190
94143002,Primary malignant neoplasm of vulva,511204012,Preferred,190
255072001,Malignant tumor of salivary gland (disorder),646054019,Preferred,191
255072001,Malignant tumour of salivary gland,380102011,Preferred,191
255072001,CA - Cancer of salivary gland,380101016,Acceptable,191
255072001,Cancer of salivary gland,380100015,Acceptable,191
255072001,Malignant tumor of salivary gland,380103018,Acceptable,191
255072001,Salivary gland cancer,3036890013,Acceptable,191
403889000,Verrucous carcinoma of oral cavity (disorder),1771815016,Preferred,192
403889000,Verrucous carcinoma of oral cavity,1782893015,Preferred,192
403889000,Snuff dipper's cancer,2912574018,Acceptable,192
93813005,Primary malignant neoplasm of glans penis (disorder),837626018,Preferred,193
93813005,Primary malignant neoplasm of glans penis,510664014,Preferred,193
93813005,Cancer of glans penis,510667019,Acceptable,193
93813005,Malignant tumor of glans penis,510665010,Acceptable,193
93813005,Malignant tumour of glans penis,510666011,Acceptable,193
162573006,Suspected lung cancer (situation),2607679019,Preferred,194
162573006,Suspected lung cancer,253467018,Preferred,194
275419009,Primary vulval cancer (disorder),668286017,Preferred,195
275419009,Primary vulval cancer,411399019,Preferred,195
1239431000000107,Cancer safety netting (regime/therapy),2800741000000116,Preferred,196
1239431000000107,Cancer safety netting,2800751000000118,Preferred,196
92590009,Carcinoma in situ of eye (disorder),836145015,Preferred,197
92590009,Carcinoma in situ of eye,153160011,Preferred,197
92590009,Cancer in situ of eye,3035945014,Acceptable,197
93781006,Primary malignant neoplasm of endometrium (disorder),837587018,Preferred,198
93781006,Primary malignant neoplasm of endometrium,510605012,Preferred,198
93781006,Cancer of endometrium,3012523015,Acceptable,198
93718007,Primary malignant neoplasm of body of uterus (disorder),837510011,Preferred,199
93718007,Primary malignant neoplasm of body of uterus,510496014,Preferred,199
93718007,Body of uterus Ca,510500011,Acceptable,199
93718007,CA - Cancer of uterus,510499019,Acceptable,199
93718007,Malignant neoplasm of corpus uteri,155137018,Acceptable,199
93718007,Malignant neoplasm of uterus,510501010,Acceptable,199
93718007,Malignant tumor of body of uterus,510497017,Acceptable,199
93718007,Malignant tumor of uterus,510498010,Acceptable,199
93718007,Malignant tumour of body of uterus,510502015,Acceptable,199
93718007,Malignant tumour of uterus,510503013,Acceptable,199
266884005,Family history of neoplasm of gastrointestinal tract (situation),2713159015,Preferred,200
266884005,Family history of neoplasm of gastrointestinal tract,397671018,Preferred,200
266884005,FH: * - gastrointestinal tract,397672013,Acceptable,200
266884005,FH: Intestinal cancer,397673015,Acceptable,200
187692001,Malignant tumor of nasopharynx (disorder),570893013,Preferred,201
187692001,Malignant tumour of nasopharynx,288526015,Preferred,201
187692001,CA - Cancer of nasopharynx,288523011,Acceptable,201
187692001,Cancer of nasopharynx,288521013,Acceptable,201
187692001,Malignant neoplasm of nasopharynx,288522018,Acceptable,201
187692001,Malignant tumor of epipharynx,288519015,Acceptable,201
187692001,Malignant tumor of nasopharynx,288527012,Acceptable,201
187692001,Malignant tumor of postnasal space,288520014,Acceptable,201
187692001,Malignant tumour of epipharynx,288524017,Acceptable,201
187692001,Malignant tumour of postnasal space,288525016,Acceptable,201
188214009,Malignant neoplasm of vulva: [unspecified] or [primary cancer] (disorder),2761268019,Preferred,202
188214009,Malignant neoplasm of vulva: [unspecified] or [primary cancer],289215019,Preferred,202
188214009,Malignant neoplasm of vulva unspecified,289214015,Acceptable,202
188214009,Primary vulval cancer,289213014,Acceptable,202
139857002,Suspected skin cancer (situation),2732916014,Preferred,203
139857002,Suspected skin cancer,221667018,Preferred,203
448674007,Malignant neoplasm of parametrium (disorder),2897595010,Preferred,204
448674007,Malignant neoplasm of parametrium,2901968015,Preferred,204
448674007,Cancer of parametrium,2901967013,Acceptable,204
737058005,Microsatellite instability-high colorectal cancer (disorder),3526500012,Preferred,205
737058005,Microsatellite instability-high colorectal cancer,3526497018,Preferred,205
737058005,MSI-H colorectal cancer,3526499015,Acceptable,205
737058005,Mismatch repair deficient colorectal cancer,3526496010,Acceptable,205
737058005,dMMR colorectal cancer,3526498011,Acceptable,205
36601000000100,Cancer care plan given,86601000000110,Preferred,206
36601000000100,Cancer care plan given,86591000000116,Preferred,206
411647008,Cancer pagurus diagnostic allergen extract (product),3082047010,Preferred,207
411647008,Cancer pagurus diagnostic allergen extract,3082048017,Preferred,207
411647008,Crab diagnostic allergen extract,3285823012,Acceptable,207
92649001,Carcinoma in situ of lung (disorder),836216013,Preferred,208
92649001,Carcinoma in situ of lung,153237011,Preferred,208
92649001,Cancer in situ of lung,3036367011,Acceptable,208
36591000000106,Cancer care plan given,86581000000118,Preferred,209
36591000000106,Cancer care plan given,86571000000115,Preferred,209
93735006,Primary malignant neoplasm of buccal mucosa (disorder),837531014,Preferred,210
93735006,Primary malignant neoplasm of buccal mucosa,510523014,Preferred,210
93735006,CA - Cancer of buccal mucosa,510527010,Acceptable,210
93735006,CA - Cancer of cheek mucosa,510529013,Acceptable,210
93735006,Cancer of buccal mucosa,510528017,Acceptable,210
93735006,Cancer of cheek mucosa,510531016,Acceptable,210
93735006,Malignant neoplasm of cheek mucosa,510530015,Acceptable,210
93735006,Malignant tumor of buccal mucosa,510524015,Acceptable,210
93735006,Malignant tumor of cheek mucosa,510525019,Acceptable,210
93735006,Malignant tumor of internal cheek,510526018,Acceptable,210
93735006,Malignant tumour of buccal mucosa,510533018,Acceptable,210
93735006,Malignant tumour of cheek mucosa,510534012,Acceptable,210
93735006,Malignant tumour of internal cheek,510532011,Acceptable,210
716749005,Fatigue associated with malignant neoplastic disease (finding),3307428011,Preferred,211
716749005,Cancer-related fatigue,3307427018,Preferred,211
716749005,Fatigue associated with malignant neoplastic disease,3307429015,Acceptable,211
724450008,Fear of genital cancer (finding),3438162018,Preferred,212
724450008,Fear of genital cancer,3438163011,Preferred,212
25031000000106,Cancer care plan given (finding),64091000000115,Preferred,213
25031000000106,Cancer care plan given,62561000000111,Preferred,213
449309003,Malignant neoplasm of skin of scrotum (disorder),2898180016,Preferred,214
449309003,Malignant neoplasm of skin of scrotum,2901118010,Preferred,214
449309003,Cancer of scrotal skin,2901117017,Acceptable,214
363386008,Malignant tumor of buccal mucosa (disorder),755205018,Preferred,215
363386008,Malignant tumour of buccal mucosa,482571015,Preferred,215
363386008,CA - Cancer of buccal mucosa,1228520012,Acceptable,215
363386008,CA - Cancer of cheek mucosa,1228519018,Acceptable,215
363386008,Cancer of buccal mucosa,1228522016,Acceptable,215
363386008,Cancer of cheek mucosa,1228521011,Acceptable,215
363386008,Malignant tumor of buccal mucosa,482572010,Acceptable,215
363386008,Malignant tumor of cheek mucosa,1217967016,Acceptable,215
363386008,Malignant tumor of internal cheek,1217966013,Acceptable,215
363386008,Malignant tumour of cheek mucosa,1216477018,Acceptable,215
363386008,Malignant tumour of internal cheek,1216476010,Acceptable,215
447883002,Malignant neoplasm of carotid body (disorder),2898929016,Preferred,216
447883002,Malignant neoplasm of carotid body,2900052019,Preferred,216
447883002,Cancer of carotid body,2900051014,Acceptable,216
94381002,Secondary malignant neoplasm of liver (disorder),838313010,Preferred,217
94381002,Secondary malignant neoplasm of liver,156291015,Preferred,217
94381002,Cancer metastatic to liver,3036079019,Acceptable,217
94381002,Hepatic metastasis,511278011,Acceptable,217
94381002,Liver secondaries,511276010,Acceptable,217
94381002,Liver secondary cancer,511274013,Acceptable,217
94381002,Metastasis to liver,511275014,Acceptable,217
94381002,Metastatic malignant neoplasm to liver,156294011,Acceptable,217
94381002,Secondary malignancy of liver,511277018,Acceptable,217
762999001,Suspected bowel cancer (situation),3637517019,Preferred,218
762999001,Suspected bowel cancer,3637516011,Preferred,218
373627005,Bronchioloalveolar carcinoma (disorder),1198927011,Preferred,219
373627005,Bronchioloalveolar carcinoma - disorder,1212091018,Preferred,219
373627005,Alveolar cell carcinoma,1229262012,Acceptable,219
373627005,Bronchiolar adenocarcinoma,1229260016,Acceptable,219
373627005,Bronchiolar carcinoma,1229261017,Acceptable,219
373627005,Bronchioloalveolar carcinoma,1229263019,Acceptable,219
373627005,Bronchoalveolar cancer,3036050014,Acceptable,219
423274005,"Carcinoma of ovary, stage 4 (finding)",2639573017,Preferred,220
423274005,"Carcinoma of ovary, stage 4",2643569010,Preferred,220
423274005,"Cancer of ovary, stage 4",3012589019,Acceptable,220
423274005,Ovarian cancer stage 4,3012633017,Acceptable,220
276822007,Malignant melanoma of rectum (disorder),669784011,Preferred,221
276822007,Malignant melanoma of rectum,413138011,Preferred,221
276822007,Cancer rectum melanoma,3036589014,Acceptable,221
94360002,Secondary malignant neoplasm of kidney (disorder),838287017,Preferred,222
94360002,Secondary malignant neoplasm of kidney,156237018,Preferred,222
94360002,Cancer metastatic to kidney,3036463011,Acceptable,222
94360002,Metastasis to renal parenchyma,1235832012,Acceptable,222
94360002,Metastatic malignant neoplasm to kidney,156240018,Acceptable,222
94360002,Metastatic tumor in kidney,1218776015,Acceptable,222
94360002,Metastatic tumour in kidney,1217288017,Acceptable,222
94360002,Renal metastasis,1235834013,Acceptable,222
94360002,Secondary cancer of kidney,1235835014,Acceptable,222
94360002,Secondary renal cancer,1235833019,Acceptable,222
423480004,"Carcinoma of ovary, stage 3 (finding)",2639572010,Preferred,223
423480004,"Carcinoma of ovary, stage 3",2643568019,Preferred,223
423480004,"Cancer of ovary, stage 3",3012583018,Acceptable,223
423480004,Ovarian cancer stage 3,3012567018,Acceptable,223
254632001,Small cell carcinoma of lung (disorder),645552017,Preferred,224
254632001,Small cell carcinoma of lung,379179016,Preferred,224
254632001,SCLC - Small cell lung cancer,379180018,Acceptable,224
254632001,Small cell lung cancer,379181019,Acceptable,224
363412000,Malignant tumor of ascending colon (disorder),755233018,Preferred,225
363412000,Malignant tumour of ascending colon,482623013,Preferred,225
363412000,Ascending colon cancer,3288993017,Acceptable,225
363412000,Malignant tumor of ascending colon,482624019,Acceptable,225
117961000000109,Fear of getting cancer,205321000000110,Preferred,226
117961000000109,Fear of getting cancer,194041000000117,Preferred,226
115491006,Cancer antigen DM /70K (substance),669054013,Preferred,227
115491006,Cancer antigen DM /70K,176291019,Preferred,227
424486004,"Carcinoma of ovary, stage 2 (finding)",2639571015,Preferred,228
424486004,"Carcinoma of ovary, stage 2",2643567012,Preferred,228
424486004,"Cancer of ovary, stage 2",3012630019,Acceptable,228
424486004,Ovarian cancer stage 2,3012586014,Acceptable,228
275978004,Screening for malignant neoplasm of colon (procedure),2821319019,Preferred,229
275978004,Screening for malignant neoplasm of colon,2821318010,Preferred,229
275978004,Colon cancer screening,3046881015,Acceptable,229
275978004,Colon neoplasm screening,411955015,Acceptable,229
275978004,Screening for colon cancer,3046880019,Acceptable,229
92749008,Carcinoma in situ of skin (disorder),836337019,Preferred,230
92749008,Carcinoma in situ of skin,153358015,Preferred,230
92749008,Cancer in situ of skin,3036084013,Acceptable,230
111511000000106,Fear of getting cancer,200831000000110,Preferred,231
111511000000106,Fear of getting cancer,188731000000117,Preferred,231
424600001,"Carcinoma of ovary, stage 1 (finding)",2639570019,Preferred,232
424600001,"Carcinoma of ovary, stage 1",2643566015,Preferred,232
424600001,"Cancer of ovary, stage 1",3012577016,Acceptable,232
424600001,Ovarian cancer stage 1,3012579018,Acceptable,232
762996008,Suspected vulva cancer (situation),3637510017,Preferred,233
762996008,Suspected vulva cancer,3637509010,Preferred,233
473063008,History of malignant neoplasm of oral cavity (situation),2956167019,Preferred,234
473063008,History of malignant neoplasm of oral cavity,2955930016,Preferred,234
473063008,History of cancer of oral cavity,2241951000000110,Acceptable,234
473063008,History of malignant tumor of oral cavity,2955886017,Acceptable,234
473063008,History of malignant tumour of oral cavity,2956168012,Acceptable,234
473063008,History of oral cancer,2241961000000113,Acceptable,234
511901000000108,History of malignant neoplasm of oral cavity (situation),1138391000000111,Preferred,235
511901000000108,History of malignant neoplasm of oral cavity,1138401000000114,Preferred,235
511901000000108,History of cancer of oral cavity,1138421000000117,Acceptable,235
511901000000108,History of oral cancer,1138411000000111,Acceptable,235
363459007,Malignant tumor of urethra (disorder),755286015,Preferred,236
363459007,Malignant tumour of urethra,482714015,Preferred,236
363459007,CA - Cancer of urethra,1228590018,Acceptable,236
363459007,Malignant tumor of urethra,482715019,Acceptable,236
363459007,Malignant urethral tumor,1217983016,Acceptable,236
363459007,Malignant urethral tumour,1216493010,Acceptable,236
363459007,Urethral Ca,1228589010,Acceptable,236
243591000000107,Symptoms due to cancer (finding),396891000000115,Preferred,237
243591000000107,Symptoms due to cancer,396901000000119,Preferred,237
162583005,Suspected kidney cancer (situation),2734295015,Preferred,238
162583005,Suspected kidney cancer,253479018,Preferred,238
315270004,Suspected kidney cancer (situation),2611951012,Preferred,239
315270004,Suspected kidney cancer,459770011,Preferred,239
425066001,"Carcinoma of urinary bladder, invasive (disorder)",2639579018,Preferred,240
425066001,"Carcinoma of urinary bladder, invasive",2643575018,Preferred,240
425066001,Invasive bladder cancer,3036487013,Acceptable,240
254986007,Malignant tumor of peripheral nerve (disorder),645955010,Preferred,241
254986007,Malignant tumour of peripheral nerve,379946015,Preferred,241
254986007,Cancer of peripheral nerve,3037889011,Acceptable,241
254986007,Malignant tumor of peripheral nerve,379947012,Acceptable,241
254986007,Peripheral nerve cancer,3036661017,Acceptable,241
255052006,Malignant neoplasm of unknown origin (disorder),3770440013,Preferred,242
255052006,Malignant tumour of unknown origin,380059013,Preferred,242
255052006,CA - Cancer of unknown origin,380062011,Acceptable,242
255052006,Cancer - unknown origin,380064012,Acceptable,242
255052006,Malignant neoplasm of unknown origin,3770439011,Acceptable,242
255052006,Malignant tumor - unknown primary,380057010,Acceptable,242
255052006,Malignant tumor of unknown origin,380056018,Acceptable,242
255052006,Malignant tumour - unknown primary,380060015,Acceptable,242
255052006,Metastasis - unknown primary,380063018,Acceptable,242
255052006,UKP - Malignant tumor - unknown primary,380058017,Acceptable,242
255052006,UKP - Malignant tumour - unknown primary,380061016,Acceptable,242
363409003,Malignant tumor of descending colon (disorder),755230015,Preferred,243
363409003,Malignant tumour of descending colon,482618013,Preferred,243
363409003,Descending colon cancer,3289030012,Acceptable,243
363409003,Malignant tumor of descending colon,482617015,Acceptable,243
363408006,Malignant tumor of transverse colon (disorder),755229013,Preferred,244
363408006,Malignant tumour of transverse colon,482615011,Preferred,244
363408006,Ca transverse colon,1228538010,Acceptable,244
363408006,Malignant tumor of transverse colon,482616012,Acceptable,244
363408006,Transverse colon cancer,3288737014,Acceptable,244
367205006,Suspected breast cancer (situation),2760180012,Preferred,245
367205006,Suspected breast cancer,490780011,Preferred,245
878431000000105,No FH of bladder cancer,2266721000000116,Preferred,246
878431000000105,No FH of bladder cancer,2266731000000119,Preferred,246
134405005,Suspected breast cancer (situation),2606608015,Preferred,247
134405005,Suspected breast cancer,216211016,Preferred,247
878421000000108,No family history of malignant tumour of urinary bladder (situation),2266701000000113,Preferred,248
878421000000108,No FH of bladder cancer,2266711000000110,Preferred,248
92679008,Carcinoma in situ of penis (disorder),836252012,Preferred,249
92679008,Carcinoma in situ of penis,153280019,Preferred,249
92679008,Cancer in situ of penis,3036323014,Acceptable,249
93949007,Primary malignant neoplasm of parotid gland (disorder),837789017,Preferred,250
93949007,Primary malignant neoplasm of parotid gland,510902013,Preferred,250
93949007,CA - Cancer of parotid gland,510904014,Acceptable,250
93949007,Cancer of parotid gland,510905010,Acceptable,250
93949007,Malignant tumor of parotid gland,510903015,Acceptable,250
93949007,Malignant tumour of parotid gland,510906011,Acceptable,250
448233000,Malignant neoplasm of urinary organ (disorder),2898158019,Preferred,251
448233000,Malignant neoplasm of urinary organ,2899410013,Preferred,251
448233000,Cancer of urinary organ,2899409015,Acceptable,251
698308008,Consultation for malignant neoplasm disease (procedure),2973835011,Preferred,252
698308008,Consultation for malignant neoplasm disease,2973834010,Preferred,252
698308008,Consultation for cancer,2339041000000117,Acceptable,252
92660005,Carcinoma in situ of mouth (disorder),836231016,Preferred,253
92660005,Carcinoma in situ of mouth,153252016,Preferred,253
92660005,Cancer in situ of mouth,3036137011,Acceptable,253
139851001,Suspected kidney cancer (situation),2717144013,Preferred,254
139851001,Suspected kidney cancer,221660016,Preferred,254
92802003,Carcinoma in situ of vulva (disorder),836403011,Preferred,255
92802003,Carcinoma in situ of vulva,153422014,Preferred,255
92802003,Cancer in situ of vulva,3035948011,Acceptable,255
188230001,Malignant tumor of body of penis (disorder),571495019,Preferred,256
188230001,Malignant tumour of body of penis,289244017,Preferred,256
188230001,Cancer of body of penis,289247012,Acceptable,256
188230001,Malignant neoplasm of body of penis,289246015,Acceptable,256
188230001,Malignant tumor of body of penis,289245016,Acceptable,256
188230001,Malignant tumor of shaft of penis,289248019,Acceptable,256
188230001,Malignant tumour of shaft of penis,289243011,Acceptable,256
363379000,Malignant tumor of parotid gland (disorder),755197010,Preferred,257
363379000,Malignant tumour of parotid gland,482554016,Preferred,257
363379000,CA - Cancer of parotid gland,1228512010,Acceptable,257
363379000,Cancer of parotid gland,1228511015,Acceptable,257
363379000,Malignant tumor of parotid gland,482555015,Acceptable,257
268547008,Screening for malignant neoplasm of breast (procedure),2821315013,Preferred,258
268547008,Screening for malignant neoplasm of breast,2821305019,Preferred,258
268547008,Breast cancer screening,3046856018,Acceptable,258
268547008,Breast neoplasm screening,401564012,Acceptable,258
268547008,Screening for breast cancer,3046875011,Acceptable,258
366980001,Suspected breast cancer (situation),2735237015,Preferred,259
366980001,Suspected breast cancer,490538014,Preferred,259
92613002,Carcinoma in situ of ileum (disorder),836174012,Preferred,260
92613002,Carcinoma in situ of ileum,153193019,Preferred,260
92613002,Cancer in situ of ileum,3035922015,Acceptable,260
363355002,Malignant tumor of adrenal gland (disorder),755171016,Preferred,261
363355002,Malignant tumour of adrenal gland,482510010,Preferred,261
363355002,Adrenal gland malignancy,2579393015,Acceptable,261
363355002,CA - Cancer of adrenal gland,1228494012,Acceptable,261
363355002,Cancer of adrenal gland,1228495013,Acceptable,261
363355002,Malignant tumor of adrenal gland,482509017,Acceptable,261
48989000,Pre-cancerous dysplasia (morphologic abnormality),786617010,Preferred,262
48989000,Pre-cancerous dysplasia,81613017,Preferred,262
92568009,Carcinoma in situ of colon (disorder),836118016,Preferred,263
92568009,Carcinoma in situ of colon,153133016,Preferred,263
92568009,Cancer in situ of colon,3036230018,Acceptable,263
423973006,"Carcinoma of uterine cervix, invasive (disorder)",2639569015,Preferred,264
423973006,"Carcinoma of uterine cervix, invasive",2643565016,Preferred,264
423973006,"Cancer of uterine cervix, invasive",3035963014,Acceptable,264
423973006,Invasive cervical cancer,3036130013,Acceptable,264
94391008,Secondary malignant neoplasm of lung (disorder),838325013,Preferred,265
94391008,Secondary malignant neoplasm of lung,156319016,Preferred,265
94391008,Cancer metastatic to lung,3036139014,Acceptable,265
94391008,Metastatic malignant neoplasm to lung,156322019,Acceptable,265
94391008,Pulmonary metastasis,1235838011,Acceptable,265
94391008,Secondary cancer of lung,1235839015,Acceptable,265
94391008,Secondary malignant tumor of lung,1218777012,Acceptable,265
94391008,Secondary malignant tumour of lung,1217289013,Acceptable,265
92696009,Carcinoma in situ of rectum (disorder),836273012,Preferred,266
92696009,Carcinoma in situ of rectum,153300015,Preferred,266
92696009,Cancer in situ of rectum,3036087018,Acceptable,266
188220005,Malignant tumor of ectopic testis (disorder),571484013,Preferred,267
188220005,Malignant tumour of ectopic testis,289227016,Preferred,267
188220005,Cancer of ectopic testis,289225012,Acceptable,267
188220005,Malignant neoplasm of ectopic testis,289224011,Acceptable,267
188220005,Malignant tumor of ectopic testis,289226013,Acceptable,267
394058005,Cancer treatment started (situation),2743268017,Preferred,268
394058005,Cancer treatment started,1487905017,Preferred,268
878401000000104,No family history of malignant tumour of prostate (situation),2266661000000119,Preferred,269
878401000000104,No FH of prostate cancer,2266671000000114,Preferred,269
93734005,Primary malignant neoplasm of bronchus (disorder),837530010,Preferred,270
93734005,Primary malignant neoplasm of bronchus,510522016,Preferred,270
93734005,Primary bronchial cancer,1235802016,Acceptable,270
878411000000102,No FH of prostate cancer,2266681000000111,Preferred,271
878411000000102,No FH of prostate cancer,2266691000000113,Preferred,271
705089007,At risk of breast cancer (finding),3023236014,Preferred,272
705089007,At risk of breast cancer,3023201010,Preferred,272
363385007,Malignant tumor of floor of mouth (disorder),755204019,Preferred,273
363385007,Malignant tumour of floor of mouth,482570019,Preferred,273
363385007,CA - Cancer of floor of mouth,1228518014,Acceptable,273
363385007,Cancer of floor of mouth,1228517016,Acceptable,273
363385007,FOM - Cancer of floor of mouth,1228516013,Acceptable,273
363385007,FOM - Malignant tumor of floor of mouth,1217965012,Acceptable,273
363385007,FOM - Malignant tumour of floor of mouth,1216475014,Acceptable,273
363385007,Malignant neoplasm of floor of mouth,2969212012,Acceptable,273
363385007,Malignant tumor of floor of mouth,482569015,Acceptable,273
848881000000108,QCancer lung cancer risk (observable entity),2257871000000118,Preferred,274
848881000000108,QCancer lung cancer risk,2257861000000113,Preferred,274
722712000,Occupational cancer of skin (disorder),3333138013,Preferred,275
722712000,Occupational cancer of skin,3333139017,Preferred,275
722712000,Occupational skin cancer,3333140015,Acceptable,275
92754004,Carcinoma in situ of spleen (disorder),836344011,Preferred,276
92754004,Carcinoma in situ of spleen,153365011,Preferred,276
92754004,Cancer in situ of spleen,3036256013,Acceptable,276
395073001,Cancer treatment started (situation),2612958015,Preferred,277
395073001,Cancer treatment started,1488772013,Preferred,277
61321005,Cancer-related substance (substance),800371016,Preferred,278
61321005,Cancer-related substance,101886019,Preferred,278
254622008,Squamous cell carcinoma of bronchus (disorder),645541011,Preferred,279
254622008,Squamous cell carcinoma of bronchus,379159012,Preferred,279
254622008,BC - Bronchogenic carcinoma,379164011,Acceptable,279
254622008,Bronchial carcinoma,379165012,Acceptable,279
254622008,Bronchogenic carcinoma,379166013,Acceptable,279
254622008,CA - Carcinoma of bronchus,379163017,Acceptable,279
254622008,Carcinoma of bronchus,379162010,Acceptable,279
254622008,SCC - Squamous cell carcinoma of bronchus,379160019,Acceptable,279
94222008,Secondary malignant neoplasm of bone (disorder),838121010,Preferred,280
94222008,Secondary malignant neoplasm of bone,155869012,Preferred,280
94222008,Bony metastasis,1235816014,Acceptable,280
94222008,Cancer metastatic to bone,3035791010,Acceptable,280
94222008,Metastatic malignant neoplasm to bone,155872017,Acceptable,280
94222008,Metastatic tumor of bone,1218771013,Acceptable,280
94222008,Metastatic tumour of bone,1217283014,Acceptable,280
94222008,Osseous metastasis,1235815013,Acceptable,280
94222008,Secondary cancer of bone,1235813018,Acceptable,280
94222008,Secondary malignant neoplasm of bone and bone marrow,1235814012,Acceptable,280
94222008,Tumor metastatic to bone,3035829013,Acceptable,280
94222008,Tumour metastatic to bone,3035821011,Acceptable,280
762997004,Suspected ovarian cancer (situation),3637511018,Preferred,281
762997004,Suspected ovarian cancer,3637512013,Preferred,281
92769003,Carcinoma in situ of tongue (disorder),836361014,Preferred,282
92769003,Carcinoma in situ of tongue,153382013,Preferred,282
92769003,Cancer in situ of tongue,3035939018,Acceptable,282
393107000,Cancer treatment started (situation),2755893015,Preferred,283
393107000,Cancer treatment started,1487076017,Preferred,283
139850000,Suspected bladder cancer (situation),2730636017,Preferred,284
139850000,Suspected bladder cancer,221659014,Preferred,284
199251000000107,Fast track cancer referral (procedure),301071000000117,Preferred,285
199251000000107,Fast track cancer referral,301081000000115,Preferred,285
199251000000107,Priority cancer referral,473311000000110,Acceptable,285
92788005,Carcinoma in situ of uterus (disorder),836384019,Preferred,286
92788005,Carcinoma in situ of uterus,153406013,Preferred,286
92788005,Cancer in situ of uterus,3036511019,Acceptable,286
715412008,Familial malignant neoplasm of prostate (disorder),3302509011,Preferred,287
715412008,Familial prostate cancer,3302511019,Preferred,287
715412008,Familial malignant neoplasm of prostate,3302510018,Acceptable,287
92634009,Carcinoma in situ of larynx (disorder),836199013,Preferred,288
92634009,Carcinoma in situ of larynx,153218019,Preferred,288
92634009,Cancer in situ of larynx,3036503012,Acceptable,288
92791005,Carcinoma in situ of vagina (disorder),836389012,Preferred,289
92791005,Carcinoma in situ of vagina,153410011,Preferred,289
92791005,Cancer in situ of vagina,3036401011,Acceptable,289
92791005,VAIN - Vaginal intraepithelial neoplasia 3,1235768012,Acceptable,289
92791005,VAIN III - Vaginal intraepithelial neoplasia grade III,1235769016,Acceptable,289
92791005,Vaginal intraepithelial neoplasia grade III,1235767019,Acceptable,289
94579000,Secondary malignant neoplasm of skin (disorder),838551011,Preferred,290
94579000,Secondary malignant neoplasm of skin,156777013,Preferred,290
94579000,Cancer metastatic to skin,3036599016,Acceptable,290
94579000,Cutaneous metastasis,511339010,Acceptable,290
94579000,Dermal metastasis,511338019,Acceptable,290
94579000,Malignant infiltration of skin,511340012,Acceptable,290
94579000,Metastasis to skin,511343014,Acceptable,290
94579000,Metastatic malignant neoplasm to skin,156780014,Acceptable,290
94579000,Secondary cancer of skin,511342016,Acceptable,290
94579000,Skin secondaries,511341011,Acceptable,290
152891000119106,History of malignant neoplasm of eye (situation),3038406012,Preferred,291
152891000119106,History of malignant neoplasm of eye,3038308014,Preferred,291
152891000119106,History of cancer of eye,3038043015,Acceptable,291
315269000,Suspected bladder cancer (situation),2611950013,Preferred,292
315269000,Suspected bladder cancer,459769010,Preferred,292
162582000,Suspected bladder cancer (situation),2731826017,Preferred,293
162582000,Suspected bladder cancer,253478014,Preferred,293
94602001,Secondary malignant neoplasm of vertebral column (disorder),838581015,Preferred,294
94602001,Secondary malignant neoplasm of vertebral column,156829016,Preferred,294
94602001,CA - Secondary cancer of spine,511356019,Acceptable,294
94602001,Metastasis to spine,511354016,Acceptable,294
94602001,Metastasis to vertebral column,511353010,Acceptable,294
94602001,Metastatic malignant neoplasm to spine,156835016,Acceptable,294
94602001,Metastatic malignant neoplasm to vertebral column,156836015,Acceptable,294
94602001,Secondary cancer of spine,511355015,Acceptable,294
94602001,Secondary malignant neoplasm of spine,156834017,Acceptable,294
94602001,Secondary tumor of spine,511352017,Acceptable,294
94602001,Secondary tumour of spine,511358018,Acceptable,294
94602001,Spinal metastases,511357011,Acceptable,294
162579005,Suspected cervical cancer (situation),2731182015,Preferred,295
162579005,Suspected cervical cancer,253475012,Preferred,295
373793006,Basis of cancer diagnosis (finding),1199093011,Preferred,296
373793006,Basis of cancer diagnosis,1212244017,Preferred,296
162581007,Suspected prostate cancer (situation),2758838013,Preferred,297
162581007,Suspected prostate cancer,253477016,Preferred,297
315268008,Suspected prostate cancer (situation),2611949013,Preferred,298
315268008,Suspected prostate cancer,459768019,Preferred,298
315266007,Suspected cervical cancer (situation),2611820016,Preferred,299
315266007,Suspected cervical cancer,459765016,Preferred,299
24971000000108,Basis of cancer diagnosis (finding),64041000000113,Preferred,300
24971000000108,Basis of cancer diagnosis,62501000000112,Preferred,300
848911000000108,QCancer renal cancer risk (observable entity),2257931000000112,Preferred,301
848911000000108,QCancer renal cancer risk,2257921000000110,Preferred,301
304717005,Cancer attitude inventory (assessment scale),701058015,Preferred,302
304717005,Cancer attitude inventory,447089018,Preferred,302
304717005,CAI - Cancer attitude inventory,447090010,Acceptable,302
449308006,Malignant neoplasm of visceral pleura (disorder),2898179019,Preferred,303
449308006,Malignant neoplasm of visceral pleura,2901116014,Preferred,303
449308006,Cancer of visceral pleura,2901115013,Acceptable,303
449067008,Malignant neoplasm of parietal pleura (disorder),2898349018,Preferred,304
449067008,Malignant neoplasm of parietal pleura,2901158012,Preferred,304
449067008,Cancer of parietal pleura,2901157019,Acceptable,304
254843006,Familial cancer of breast (disorder),645794016,Preferred,305
254843006,Familial cancer of breast,379672014,Preferred,305
139849000,Suspected prostate cancer (situation),2739302012,Preferred,306
139849000,Suspected prostate cancer,221658018,Preferred,306
92621008,Carcinoma in situ of jejunum (disorder),836184013,Preferred,307
92621008,Carcinoma in situ of jejunum,153203015,Preferred,307
92621008,Cancer in situ of jejunum,3036473013,Acceptable,307
139847003,Suspected cervical cancer (situation),2717141017,Preferred,308
139847003,Suspected cervical cancer,221656019,Preferred,308
92681005,Carcinoma in situ of pharynx (disorder),836256010,Preferred,309
92681005,Carcinoma in situ of pharynx,153283017,Preferred,309
92681005,Cancer in situ of pharynx,3036384017,Acceptable,309
92693001,Carcinoma in situ of pylorus (disorder),836270010,Preferred,310
92693001,Carcinoma in situ of pylorus,153297013,Preferred,310
92693001,Cancer in situ of pylorus,3036154015,Acceptable,310
92693001,Carcinoma in situ of pyloric canal,510074013,Acceptable,310
94455000,Secondary malignant neoplasm of ovary (disorder),838402011,Preferred,311
94455000,Secondary malignant neoplasm of ovary,156493015,Preferred,311
94455000,Cancer metastatic to ovary,3012511014,Acceptable,311
94455000,Krukenburg tumor,511302014,Acceptable,311
94455000,Krukenburg tumour,511308013,Acceptable,311
94455000,Metastasis to ovary,511305011,Acceptable,311
94455000,Metastatic malignant neoplasm to ovary,156494014,Acceptable,311
94455000,Ovarian metastasis,511304010,Acceptable,311
94455000,Secondary cancer of ovary,511306012,Acceptable,311
94455000,Secondary tumor to ovary,511303016,Acceptable,311
94455000,Secondary tumour to ovary,511307015,Acceptable,311
444638005,Screening for malignant neoplasm of skin (procedure),2869645019,Preferred,312
444638005,Screening for malignant neoplasm of skin,2872563014,Preferred,312
444638005,Screening for skin cancer,3077980019,Acceptable,312
363414004,Malignant tumor of rectosigmoid junction (disorder),755236014,Preferred,313
363414004,Malignant tumour of rectosigmoid junction,482627014,Preferred,313
363414004,Malignant tumor of rectosigmoid junction,482628016,Acceptable,313
363414004,Rectosigmoid colon cancer,3288987013,Acceptable,313
432519008,Increased cancer antigen 125 (finding),2761074010,Preferred,314
432519008,Increased cancer antigen 125,2767429015,Preferred,314
432519008,Elevated cancer antigen 125,2770619016,Acceptable,314
432519008,Raised cancer antigen 125,2767430013,Acceptable,314
92767001,Carcinoma in situ of thyroid gland (disorder),836359017,Preferred,315
92767001,Carcinoma in situ of thyroid gland,153380017,Preferred,315
92767001,Cancer in situ of thyroid,3036210017,Acceptable,315
92767001,Carcinoma in situ of thyroid,1235765010,Acceptable,315
874271000000104,QCancer blood cancer risk (observable entity),2257721000000112,Preferred,316
874271000000104,QCancer blood cancer risk,2257731000000114,Preferred,316
874281000000102,QCancer blood cancer risk,2257741000000117,Preferred,317
874281000000102,QCancer blood cancer risk,2257751000000119,Preferred,317
94225005,Secondary malignant neoplasm of brain (disorder),838124019,Preferred,318
94225005,Secondary malignant neoplasm of brain,155879014,Preferred,318
94225005,Cancer metastatic to brain,3035775012,Acceptable,318
94225005,Metastasis to brain,1235818010,Acceptable,318
94225005,Metastatic malignant neoplasm to brain,155882016,Acceptable,318
94225005,Secondary cancer of brain,1235817017,Acceptable,318
243296005,Enterobacter cancerogenus (organism),2759207010,Preferred,319
243296005,Enterobacter cancerogenus,363865016,Preferred,319
429635001,History of malignant neoplasm of vulva (situation),2688527010,Preferred,320
429635001,History of malignant neoplasm of vulva,2694039016,Preferred,320
429635001,History of cancer of vulva,2995244012,Acceptable,320
874291000000100,QCancer breast cancer risk (observable entity),2257761000000116,Preferred,321
874291000000100,QCancer breast cancer risk,2257771000000111,Preferred,321
314994000,Metastasis from malignant tumor of prostate (disorder),711840017,Preferred,322
314994000,Metastasis from malignant tumour of prostate,459437017,Preferred,322
314994000,Cancer of the prostate with metastasis,3036358011,Acceptable,322
314994000,Metastasis from malignant tumor of prostate,459438010,Acceptable,322
314994000,Metastatic prostate cancer,3036413018,Acceptable,322
255088001,Malignant tumor of exocrine pancreas (disorder),646072013,Preferred,323
255088001,Malignant tumour of exocrine pancreas,380143011,Preferred,323
255088001,Malignant tumor of exocrine pancreas,380141013,Acceptable,323
255088001,Pancreatic exocrine cancer,380142018,Acceptable,323
254637007,Non-small cell lung cancer (disorder),645558018,Preferred,324
254637007,Non-small cell lung cancer,379195016,Preferred,324
254637007,NSCLC - Non-small cell lung cancer,379196015,Acceptable,324
423463003,Basal cell carcinoma of back (disorder),2639553010,Preferred,325
423463003,Basal cell carcinoma of back,2643549017,Preferred,325
423463003,"Cancer of back, basal cell",3037219011,Acceptable,325
402508006,Basal cell carcinoma of chin (disorder),1770432018,Preferred,326
402508006,Basal cell carcinoma of chin,1781634010,Preferred,326
402508006,"Cancer of chin, basal cell",3038082018,Acceptable,326
425231005,"Carcinoma of urinary bladder, superficial (disorder)",2639578014,Preferred,327
425231005,"Carcinoma of urinary bladder, superficial",2643574019,Preferred,327
425231005,Superficial bladder cancer,3036329013,Acceptable,327
402520003,Basal cell carcinoma of hand (disorder),1770444015,Preferred,328
402520003,Basal cell carcinoma of hand,1781646014,Preferred,328
402520003,"Cancer of hand, basal cell",3037945010,Acceptable,328
402520003,"Carcinoma on hand, basal cell",3036557017,Acceptable,328
429090009,History of malignant neoplasm of ovary (situation),2688894017,Preferred,329
429090009,History of malignant neoplasm of ovary,2693378016,Preferred,329
429090009,History of cancer of ovary,3012568011,Acceptable,329
254701007,Basal cell carcinoma of skin (disorder),645632010,Preferred,330
254701007,Basal cell carcinoma of skin,379314010,Preferred,330
254701007,BCC - Basal cell carcinoma of skin,379317015,Acceptable,330
254701007,Basalioma,379316012,Acceptable,330
254701007,"Cancer of skin, basal cell",3038127012,Acceptable,330
254701007,RU - Rodent ulcer,379318013,Acceptable,330
254701007,Rodent ulcer,379315011,Acceptable,330
94327000,Secondary malignant neoplasm of heart (disorder),838247010,Preferred,331
94327000,Secondary malignant neoplasm of heart,156149010,Preferred,331
94327000,Cancer metastatic to heart,3036462018,Acceptable,331
94327000,Metastasis to heart,1235829014,Acceptable,331
94327000,Metastatic malignant neoplasm to heart,156152019,Acceptable,331
94327000,Secondary malignant tumor of heart,1218775016,Acceptable,331
94327000,Secondary malignant tumour of heart,1217287010,Acceptable,331
175661000000102,Cancer screening follow up,245981000000117,Preferred,332
175661000000102,Cancer screening follow up,234691000000113,Preferred,332
402818009,Basal cell carcinoma of nose (disorder),1770742015,Preferred,333
402818009,Basal cell carcinoma of nose,1781910019,Preferred,333
402818009,"Cancer of nose, basal cell",3038165017,Acceptable,333
395081000,Cancer diagnosis discussed (situation),2869016017,Preferred,334
395081000,Cancer diagnosis discussed,1488780018,Preferred,334
403593004,Phobic fear of skin cancer (disorder),1771519019,Preferred,335
403593004,Phobic fear of skin cancer,1782612011,Preferred,335
403593004,Phobic state due to fear of skin cancer,1787808011,Acceptable,335
762501000000109,History of prostate cancer (situation),1689351000000118,Preferred,336
762501000000109,History of prostate cancer,1689361000000115,Preferred,336
276111000000103,Patient on cancer register,472971000000112,Preferred,337
276111000000103,Patient on cancer register,472981000000114,Preferred,337
276121000000109,Patient on cancer register,472991000000111,Preferred,338
276121000000109,Patient on cancer register,473001000000110,Preferred,338
94681006,Secondary malignant neoplasm of vulva (disorder),838676019,Preferred,339
94681006,Secondary malignant neoplasm of vulva,157025019,Preferred,339
94681006,Cancer metastatic to vulva,3036261010,Acceptable,339
94681006,Metastatic malignant neoplasm to vulva,157028017,Acceptable,339
94681006,Secondary cancer of the vulva,511385013,Acceptable,339
394920009,Cancer information offered (situation),2612828013,Preferred,340
394920009,Cancer information offered,1488622016,Preferred,340
1103861000000107,Cancer information offered (situation),2763401000000115,Preferred,341
1103861000000107,Cancer information offered,2763391000000118,Preferred,341
874301000000101,QCancer breast cancer risk,2257781000000113,Preferred,342
874301000000101,QCancer breast cancer risk,2257791000000110,Preferred,342
214671000000104,Fast track cancer referral,323701000000117,Preferred,343
214671000000104,Fast track cancer referral,337431000000113,Preferred,343
394088001,Cancer diagnosis discussed (situation),2746750011,Preferred,344
394088001,Cancer diagnosis discussed,1487935012,Preferred,344
92577002,Carcinoma in situ of duodenum (disorder),836129017,Preferred,345
92577002,Carcinoma in situ of duodenum,153143018,Preferred,345
92577002,Cancer in situ of duodenum,3036205016,Acceptable,345
92734000,Carcinoma in situ of skin of lip (disorder),836320014,Preferred,346
92734000,Carcinoma in situ of skin of lip,153340014,Preferred,346
92734000,Cancer in situ skin of lip,3038205014,Acceptable,346
394009006,Cancer information offered (situation),2750965016,Preferred,347
394009006,Cancer information offered,1487858011,Preferred,347
214681000000102,Fast track cancer referral,323711000000115,Preferred,348
214681000000102,Fast track cancer referral,337441000000116,Preferred,348
448675008,Malignant neoplasm of digestive system (disorder),2897596011,Preferred,349
448675008,Malignant neoplasm of digestive system,2901970012,Preferred,349
448675008,Cancer of digestive system,2901969011,Acceptable,349
371440003,Cancer protocol observable (observable entity),1196738010,Preferred,350
371440003,Cancer protocol observable,1210098015,Preferred,350
92691004,Carcinoma in situ of prostate (disorder),836268018,Preferred,351
92691004,Carcinoma in situ of prostate,153295017,Preferred,351
92691004,Cancer in situ of prostate,3036016017,Acceptable,351
393053009,Cancer information offered (situation),2761054015,Preferred,352
393053009,Cancer information offered,1487024016,Preferred,352
363357005,Malignant neoplasm of ill-defined site (disorder),3770465010,Preferred,353
363357005,Malignant tumour of ill-defined site,482514018,Preferred,353
363357005,CA - Cancer of ill-defined site,1228497017,Acceptable,353
363357005,Cancer of ill-defined site,1228496014,Acceptable,353
363357005,Malignant neoplasm of ill-defined site,3770448018,Acceptable,353
363357005,Malignant tumor of ill-defined site,482513012,Acceptable,353
709606007,Cancer associated serum antigen (substance),3040576011,Preferred,354
709606007,Cancer associated serum antigen,3040616010,Preferred,354
709606007,Cancer associated serum Ag,3040565012,Acceptable,354
413744002,Cancer screening follow up (finding),2530217018,Preferred,355
413744002,Cancer screening follow up,2533653010,Preferred,355
393137009,Cancer diagnosis discussed (procedure),2734697015,Preferred,356
393137009,Cancer diagnosis discussed,1487106015,Preferred,356
288261000000100,Fast track cancer referral,509771000000116,Preferred,357
288261000000100,Fast track cancer referral,510791000000111,Preferred,357
292461000000104,Fast track cancer referral,510281000000116,Preferred,358
292461000000104,Fast track cancer referral,511301000000111,Preferred,358
92672004,Carcinoma in situ of pancreas (disorder),836245010,Preferred,359
92672004,Carcinoma in situ of pancreas,153272014,Preferred,359
92672004,Cancer in situ of pancreas,3036575016,Acceptable,359
171001000000109,Cancer screening follow up,242361000000118,Preferred,360
171001000000109,Cancer screening follow up,230501000000112,Preferred,360
449377002,Malignant neoplasm of pelvic peritoneum (disorder),2898318011,Preferred,361
449377002,Malignant neoplasm of pelvic peritoneum,2901085015,Preferred,361
449377002,Cancer of pelvic peritoneum,2901084016,Acceptable,361
395100000,No evidence of cancer found (situation),2612832019,Preferred,362
395100000,No evidence of cancer found,1488799010,Preferred,362
397657005,Suspected urological cancer (situation),2613087011,Preferred,363
397657005,Suspected urological cancer,1777272011,Preferred,363
403915004,Basal cell carcinoma of scalp (disorder),1771841010,Preferred,364
403915004,Basal cell carcinoma of scalp,1782919016,Preferred,364
403915004,"Cancer of scalp, basal cell",3037915012,Acceptable,364
429484003,History of malignant neoplasm of cervix (situation),2688285015,Preferred,365
429484003,History of malignant neoplasm of cervix,2694573016,Preferred,365
429484003,History of cancer of cervix,3012605017,Acceptable,365
449260004,Malignant neoplasm of alveolus dentalis (disorder),2898053013,Preferred,366
449260004,Malignant neoplasm of alveolus dentalis,2902302012,Preferred,366
449260004,Cancer of alveolus dentalis,2902301017,Acceptable,366
94603006,Secondary malignant neoplasm of spleen (disorder),838582010,Preferred,367
94603006,Secondary malignant neoplasm of spleen,156837012,Preferred,367
94603006,Cancer metastatic to spleen,3036077017,Acceptable,367
94603006,Metastasis to spleen,1235866015,Acceptable,367
94603006,Metastatic malignant neoplasm to spleen,156838019,Acceptable,367
94603006,Secondary malignant deposit to spleen,1235867012,Acceptable,367
392734002,No evidence of cancer found (situation),2746820010,Preferred,368
392734002,No evidence of cancer found,1486710015,Preferred,368
162585003,Suspected testicular cancer (situation),2735458012,Preferred,369
162585003,Suspected testicular cancer,253481016,Preferred,369
92736003,Carcinoma in situ of skin of neck (disorder),836322018,Preferred,370
92736003,Carcinoma in situ of skin of neck,153343011,Preferred,370
92736003,Cancer in situ skin of neck,3038133015,Acceptable,370
885411000000103,No history of malignant tumour of breast (situation),2282141000000113,Preferred,371
885411000000103,No history of breast cancer,2282151000000111,Preferred,371
427844008,History of malignant neoplasm of vagina (situation),2691590011,Preferred,372
427844008,History of malignant neoplasm of vagina,2693414013,Preferred,372
427844008,History of cancer of vagina,3012639018,Acceptable,372
188469005,Secondary malignant neoplasm of cervix uteri (disorder),571766010,Preferred,373
188469005,Secondary malignant neoplasm of cervix uteri,289553011,Preferred,373
188469005,Cancer metastatic to cervix,3036537016,Acceptable,373
188469005,Metastatic malignant neoplasm to cervix uteri,1784809012,Acceptable,373
188469005,Metastatic malignant neoplasm to uterine cervix,1784808016,Acceptable,373
188469005,Secondary cancer of the cervix,289554017,Acceptable,373
188469005,Secondary malignant neoplasm of uterine cervix,1784810019,Acceptable,373
252171000000109,Suspected pancreatic cancer,414571000000115,Preferred,374
252171000000109,Suspected pancreatic cancer,414581000000118,Preferred,374
94513006,Secondary malignant neoplasm of rectum (disorder),838473019,Preferred,375
94513006,Secondary malignant neoplasm of rectum,156627017,Preferred,375
94513006,Cancer metastatic to rectum,3036574017,Acceptable,375
94513006,Metastatic malignant neoplasm to rectum,156628010,Acceptable,375
94493005,Secondary malignant neoplasm of pleura (disorder),838448019,Preferred,376
94493005,Secondary malignant neoplasm of pleura,156585018,Preferred,376
94493005,Cancer metastatic to pleura,3036489011,Acceptable,376
94493005,Metastasis to pleura,1235856011,Acceptable,376
94493005,Metastatic malignant neoplasm to pleura,156588016,Acceptable,376
94493005,Pleural seedling,1235855010,Acceptable,376
94493005,Secondary malignant tumor of pleura,1218782017,Acceptable,376
94493005,Secondary malignant tumour of pleura,1217294013,Acceptable,376
187821000000109,Cancer home care pack given,275621000000111,Preferred,377
187821000000109,Cancer home care pack given,282901000000112,Preferred,377
249541000000100,Suspected pancreatic cancer,409141000000119,Preferred,378
249541000000100,Suspected pancreatic cancer,409151000000116,Preferred,378
92585006,Carcinoma in situ of esophagus (disorder),836139011,Preferred,379
92585006,Carcinoma in situ of oesophagus,201640017,Preferred,379
92585006,Cancer in situ of esophagus,3036354013,Acceptable,379
92585006,Cancer in situ of oesophagus,3036455010,Acceptable,379
92585006,Carcinoma in situ of esophagus,153153017,Acceptable,379
315272007,Suspected testicular cancer (situation),2611953010,Preferred,380
315272007,Suspected testicular cancer,459772015,Preferred,380
406100007,Seen by breast cancer nurse (finding),2149930010,Preferred,381
406100007,Seen by breast cancer nurse,2157808012,Preferred,381
247591000000101,Suspected pancreatic cancer (situation),467171000000117,Preferred,382
247591000000101,Suspected pancreatic cancer,405201000000111,Preferred,382
191261000000109,Cancer home care pack given,279061000000113,Preferred,383
191261000000109,Cancer home care pack given,286341000000113,Preferred,383
347111000000107,Advice on testicular cancer,652051000000119,Preferred,384
347111000000107,Advice on testicular cancer,655931000000116,Preferred,384
347111000000107,Advice on testicular cancer (InPS+developmental),725531000000117,Acceptable,384
397715008,Suspected children's cancer (situation),2613011019,Preferred,385
397715008,Suspected children's cancer,1777326010,Preferred,385
962751000000106,Prostate cancer care review,2453211000000115,Preferred,386
962751000000106,Prostate cancer care review,2453221000000114,Preferred,386
139853003,Suspected testicular cancer (situation),2762145018,Preferred,387
139853003,Suspected testicular cancer,221662012,Preferred,387
139852008,Suspected urothelial cancer (situation),2753082015,Preferred,388
139852008,Suspected urothelial cancer,221661017,Preferred,388
735935009,Chronic pain due to malignant neoplastic disease (finding),3515748018,Preferred,389
735935009,Chronic pain due to malignant neoplastic disease,3515749014,Preferred,389
735935009,Chronic cancer related pain,3515750014,Acceptable,389
735935009,Chronic pain due to malignancy,3760166016,Acceptable,389
720007002,Prostate cancer care review (procedure),3318842017,Preferred,390
720007002,Prostate cancer care review,3318843010,Preferred,390
417680009,Cancer home care pack given (situation),2613212016,Preferred,391
417680009,Cancer home care pack given,2549900011,Preferred,391
315271000,Suspected urothelial cancer (situation),2611952017,Preferred,392
315271000,Suspected urothelial cancer,459771010,Preferred,392
962741000000108,Prostate cancer care review (regime/therapy),2453191000000119,Preferred,393
962741000000108,Prostate cancer care review,2453201000000117,Preferred,393
393689000,No evidence of cancer found (situation),2750875019,Preferred,394
393689000,No evidence of cancer found,1487543012,Preferred,394
286481000119102,Carrier of heritable cancer (finding),3433012012,Preferred,395
286481000119102,Carrier of heritable cancer,3433013019,Preferred,395
162584004,Suspected urothelial cancer (situation),2761829016,Preferred,396
162584004,Suspected urothelial cancer,253480015,Preferred,396
848891000000105,QCancer ovarian cancer risk (observable entity),2257891000000119,Preferred,397
848891000000105,QCancer ovarian cancer risk,2257881000000116,Preferred,397
885421000000109,No history of breast cancer,2282161000000114,Preferred,398
885421000000109,No history of breast cancer,2282171000000119,Preferred,398
94668004,Secondary malignant neoplasm of vagina (disorder),838659018,Preferred,399
94668004,Secondary malignant neoplasm of vagina,156997010,Preferred,399
94668004,Cancer metastatic to vagina,3012556019,Acceptable,399
94668004,Metastasis to vagina,1235883012,Acceptable,399
94668004,Metastatic malignant neoplasm to vagina,157000011,Acceptable,399
94668004,Secondary tumor to vagina,1218790017,Acceptable,399
94668004,Secondary tumour to vagina,1217302015,Acceptable,399
94665001,Secondary malignant neoplasm of uterus (disorder),838656013,Preferred,400
94665001,Secondary malignant neoplasm of uterus,156989015,Preferred,400
94665001,Cancer metastatic to uterus,3036108012,Acceptable,400
94665001,Metastasis to uterus,1235882019,Acceptable,400
94665001,Metastatic malignant neoplasm to uterus,156992016,Acceptable,400
94392001,Secondary malignant neoplasm of lymph node (disorder),838326014,Preferred,401
94392001,Secondary malignant neoplasm of lymph node,156323012,Preferred,401
94392001,Cancer metastatic to lymph nodes,3036034018,Acceptable,401
94392001,Metastatic malignant neoplasm to lymph node,156326016,Acceptable,401
94392001,Secondary lymph node cancer,1235840018,Acceptable,401
254898001,Paget's disease of vulva (disorder),645856012,Preferred,402
254898001,Paget's disease of vulva,379764017,Preferred,402
254898001,Paget disease of vulva,2839270018,Acceptable,402
254898001,Paget disease vulvar cancer,3036849010,Acceptable,402
254898001,Pagets disease of vulva,3012815014,Acceptable,402
92668003,Carcinoma in situ of oropharynx (disorder),836239019,Preferred,403
92668003,Carcinoma in situ of oropharynx,153265013,Preferred,403
92668003,Cancer in situ of oropharynx,3036227013,Acceptable,403
92668003,Carcinoma in situ of mesopharynx,1235757012,Acceptable,403
92668003,Carcinoma situ of oropharynx,1235756015,Acceptable,403
413739009,Cancer monitoring invitation (procedure),2529988010,Preferred,404
413739009,Cancer monitoring invitation,2533424016,Preferred,404
139848008,Suspected endometrial cancer (situation),2732912011,Preferred,405
139848008,Suspected endometrial cancer,221657011,Preferred,405
445553001,Residual cancer burden score (observable entity),2869814015,Preferred,406
445553001,Residual cancer burden score,2870768011,Preferred,406
445050009,Residual cancer burden index (assessment scale),2868918013,Preferred,407
445050009,Residual cancer burden index,2872184011,Preferred,407
444782009,Residual cancer burden index (observable entity),2869986012,Preferred,408
444782009,Residual cancer burden index,2872831010,Preferred,408
363407001,Malignant tumor of hepatic flexure (disorder),755228017,Preferred,409
363407001,Malignant tumour of hepatic flexure,482614010,Preferred,409
363407001,Ca hepatic flexure - colon,1228537017,Acceptable,409
363407001,Hepatic flexure colon cancer,3288712016,Acceptable,409
363407001,Malignant tumor of hepatic flexure,482613016,Acceptable,409
363413005,Malignant tumor of splenic flexure (disorder),755234012,Preferred,410
363413005,Malignant tumour of splenic flexure,482626017,Preferred,410
363413005,Ca splenic flexure - colon,1228542013,Acceptable,410
363413005,Malignant tumor of splenic flexure,482625018,Acceptable,410
363413005,Splenic flexure colon cancer,3288598016,Acceptable,410
449096009,Malignant neoplasm of respiratory system (disorder),2898692017,Preferred,411
449096009,Malignant neoplasm of respiratory system,2899758015,Preferred,411
449096009,Cancer of respiratory system,2899757013,Acceptable,411
403917007,Basal cell carcinoma of temple (disorder),1771843013,Preferred,412
403917007,Basal cell carcinoma of temple,1782921014,Preferred,412
403917007,"Cancer of temple, basal cell",3038164018,Acceptable,412
874211000000109,QCancer prostate cancer risk (observable entity),2257601000000110,Preferred,413
874211000000109,QCancer prostate cancer risk,2257611000000112,Preferred,413
449223003,Malignant neoplasm of alveolus of maxilla (disorder),2897433019,Preferred,414
449223003,Malignant neoplasm of alveolus of maxilla,2901918011,Preferred,414
449223003,Cancer of maxillary alveolus,2901917018,Acceptable,414
94606003,Secondary malignant neoplasm of stomach (disorder),838585012,Preferred,415
94606003,Secondary malignant neoplasm of stomach,156843014,Preferred,415
94606003,Cancer metastatic to stomach,3036572018,Acceptable,415
94606003,Metastatic malignant neoplasm to stomach,156846018,Acceptable,415
702455009,Screening for malignant neoplasm of vagina (procedure),2995570014,Preferred,416
702455009,Screening for malignant neoplasm of vagina,2995255012,Preferred,416
702455009,Screening for malignant tumor of vagina,2995251015,Acceptable,416
702455009,Screening for malignant tumour of vagina,2995795013,Acceptable,416
702455009,Screening for vaginal cancer,2995537016,Acceptable,416
92745002,Carcinoma in situ of skin of trunk (disorder),836333015,Preferred,417
92745002,Carcinoma in situ of skin of trunk,153352019,Preferred,417
92745002,Cancer in situ skin of trunk,3038004019,Acceptable,417
94626004,Secondary malignant neoplasm of omentum (disorder),3038141015,Preferred,418
94626004,Secondary malignant neoplasm of omentum,3037929013,Preferred,418
94626004,Cancer metastatic to omentum,3036428018,Acceptable,418
94626004,Metastasis to omentum,1235871010,Acceptable,418
94626004,Metastatic malignant neoplasm to omentum,3038009012,Acceptable,418
94626004,Omental metastasis,1235869010,Acceptable,418
94626004,Omental seedling,1235870011,Acceptable,418
94634005,Secondary malignant neoplasm of thyroid gland (disorder),838619016,Preferred,419
94634005,Secondary malignant neoplasm of thyroid gland,156911010,Preferred,419
94634005,Cancer metastatic to thyroid,3036030010,Acceptable,419
94634005,Metastasis to thyroid,511370019,Acceptable,419
94634005,Metastatic malignant neoplasm to thyroid gland,156912015,Acceptable,419
94641004,Secondary malignant neoplasm of trachea (disorder),838628015,Preferred,420
94641004,Secondary malignant neoplasm of trachea,156927015,Preferred,420
94641004,Cancer metastatic to trachea,3036481014,Acceptable,420
94641004,Metastasis to trachea,1235878016,Acceptable,420
94641004,Metastatic malignant neoplasm to trachea,156930010,Acceptable,420
94641004,Secondary malignant tumor of trachea,1218787011,Acceptable,420
94641004,Secondary malignant tumour of trachea,1217299015,Acceptable,420
87171000000105,Did not attend cancer clinic,171521000000111,Preferred,421
87171000000105,Did not attend cancer clinic,136681000000118,Preferred,421
94365007,Secondary malignant neoplasm of large intestine (disorder),838293013,Preferred,422
94365007,Secondary malignant neoplasm of large intestine,156249017,Preferred,422
94365007,Cancer metastatic to large intestine,3036520011,Acceptable,422
94365007,Metastasis to large intestine,1235836010,Acceptable,422
94365007,Metastatic malignant neoplasm to large intestine,156252013,Acceptable,422
94365007,Metastatic colorectal cancer,3688532010,Acceptable,422
86151000000104,Did not attend cancer clinic,186681000000110,Preferred,423
86151000000104,Did not attend cancer clinic,157571000000117,Preferred,423
402661009,Paraneoplastic vasculitis (disorder),1770585010,Preferred,424
402661009,Paraneoplastic vasculitis,1781768012,Preferred,424
402661009,Cancer-associated vasculitis,2511911000000110,Acceptable,424
92531006,Carcinoma in situ of anal canal (disorder),836075010,Preferred,425
92531006,Carcinoma in situ of anal canal,153089011,Preferred,425
92531006,Cancer in situ of anal canal,3036407010,Acceptable,425
93391000000102,Did not attend cancer clinic (finding),161831000000118,Preferred,426
93391000000102,Did not attend cancer clinic,142211000000111,Preferred,426
93391000000102,DNA (did not attend) cancer clinic,1681851000000114,Acceptable,426
73801000119102,History of cancer of urethra (situation),3038089010,Preferred,427
73801000119102,History of cancer of urethra,3038152014,Preferred,427
874261000000106,QCancer cervical cancer risk,2257701000000115,Preferred,428
874261000000106,QCancer cervical cancer risk,2257711000000118,Preferred,428
269544008,Carcinoma of the rectosigmoid junction (disorder),662419012,Preferred,429
269544008,Carcinoma of the rectosigmoid junction,403829018,Preferred,429
269544008,Cancer of the rectosigmoid junction,3036985011,Acceptable,429
269544008,Rectosigmoid junction cancer,3037113016,Acceptable,429
94254004,Secondary malignant neoplasm of choroid (disorder),838159019,Preferred,430
94254004,Secondary malignant neoplasm of choroid,155955011,Preferred,430
94254004,Cancer metastatic to choroid,3036102013,Acceptable,430
94254004,Metastasis to choroid,1235821012,Acceptable,430
94254004,Metastatic malignant neoplasm to choroid,155956012,Acceptable,430
94254004,Secondary choroidal tumor,1218773011,Acceptable,430
94254004,Secondary choroidal tumour,1217285019,Acceptable,430
188219004,Malignant tumor of undescended testis (disorder),571483019,Preferred,431
188219004,Malignant tumour of undescended testis,289220019,Preferred,431
188219004,Cancer of undescended testis,289222010,Acceptable,431
188219004,Malignant neoplasm of undescended testis,289223017,Acceptable,431
188219004,Malignant tumor of retained testis,2475173018,Acceptable,431
188219004,Malignant tumor of undescended testis,289221015,Acceptable,431
188219004,Malignant tumour of retained testis,2474968017,Acceptable,431
1035531000000101,Lymphoedema following cancer,2613961000000115,Preferred,432
1035531000000101,Lymphoedema following cancer,2613971000000110,Preferred,432
1035521000000103,Lymphoedema following cancer (disorder),2613941000000116,Preferred,433
1035521000000103,Lymphoedema following cancer,2613951000000118,Preferred,433
723121004,Fear of hematological cancer (finding),3334655015,Preferred,434
723121004,Fear of haematological cancer,3334657011,Preferred,434
723121004,Fear of hematological cancer,3334656019,Acceptable,434
422782004,"Primary malignant neoplasm of ovary, with widespread metastatic disease (disorder)",2639599012,Preferred,435
422782004,"Ovarian cancer, disseminated",2643597016,Preferred,435
422782004,"Primary malignant neoplasm of ovary, with widespread metastatic disease",2647879018,Acceptable,435
874251000000108,QCancer cervical cancer risk (observable entity),2257681000000117,Preferred,436
874251000000108,QCancer cervical cancer risk,2257691000000115,Preferred,436
781076008,Secondary malignant neoplasm of colon and/or rectum (disorder),3744742016,Preferred,437
781076008,Secondary malignant neoplasm of colon and/or rectum,3744741011,Preferred,437
781076008,Metastasis to colon and/or rectum,3744743014,Acceptable,437
781076008,Metastatic colorectal cancer,3744744015,Acceptable,437
874221000000103,QCancer prostate cancer risk,2257621000000118,Preferred,438
874221000000103,QCancer prostate cancer risk,2257631000000116,Preferred,438
315267003,Suspected endometrial cancer (situation),2611821017,Preferred,439
315267003,Suspected endometrial cancer,459766015,Preferred,439
162580008,Suspected endometrial cancer (situation),2753653017,Preferred,440
162580008,Suspected endometrial cancer,253476013,Preferred,440
444987009,Residual cancer burden class (observable entity),2869703010,Preferred,441
444987009,Residual cancer burden class,2873065015,Preferred,441
94275007,Secondary malignant neoplasm of duodenum (disorder),838184016,Preferred,442
94275007,Secondary malignant neoplasm of duodenum,156007019,Preferred,442
94275007,Cancer metastatic to duodenum,3036061018,Acceptable,442
94275007,Metastatic malignant neoplasm to duodenum,156008012,Acceptable,442
128331000119100,High risk for cervical cancer (finding),3513189011,Preferred,443
128331000119100,High risk for cervical cancer,3513190019,Preferred,443
448509007,Transglottic malignant neoplasm of larynx (disorder),2898167019,Preferred,444
448509007,Transglottic malignant neoplasm of larynx,2901093015,Preferred,444
448509007,Transglottic cancer of larynx,2901092013,Acceptable,444
449578008,Malignant neoplasm of alveolus of mandible (disorder),2897919014,Preferred,445
449578008,Malignant neoplasm of alveolus of mandible,2902239010,Preferred,445
92612007,Carcinoma in situ of hypopharynx (disorder),836173018,Preferred,446
92612007,Carcinoma in situ of hypopharynx,153191017,Preferred,446
92612007,Cancer in situ of hypopharynx,3036240015,Acceptable,446
92612007,Carcinoma in situ of laryngopharynx,1235749014,Acceptable,446
706970001,Triple negative malignant neoplasm of breast (disorder),3028004011,Preferred,447
706970001,Triple-negative breast cancer,3028054017,Preferred,447
706970001,TNBC - Triple-negative breast cancer,3028040013,Acceptable,447
706970001,Triple negative malignant neoplasm of breast,3027973018,Acceptable,447
706970001,"The absence of staining for oestrogen receptor, progesterone receptor, and hormone epidermal growth factor receptor 2 (HER2/neu).",3776291019,Preferred,447
276291000000102,Urgent cancer referral - skin,473341000000111,Preferred,448
276291000000102,Urgent cancer referral - skin,473351000000114,Preferred,448
468976001,Electro cancer therapy system (physical object),2948212010,Preferred,449
468976001,Electro cancer therapy system,2936028016,Preferred,449
429247002,History of malignant neoplasm of bone (situation),2690730017,Preferred,450
429247002,History of malignant neoplasm of bone,2692258017,Preferred,450
429247002,History of cancer of the bone,3035723015,Acceptable,450
401113000,Cancer supportive care worker (occupation),1769034017,Preferred,451
401113000,Cancer supportive care worker,1780314010,Preferred,451
276301000000103,Urgent cancer referral - skin,473361000000112,Preferred,452
276301000000103,Urgent cancer referral - skin,473371000000117,Preferred,452
187777008,Malignant neoplasm of intrahepatic gall duct (disorder),570989015,Preferred,453
187777008,Malignant neoplasm of intrahepatic gall duct,288698019,Preferred,453
187777008,Ca intrahepatic bile ducts,1222171014,Acceptable,453
187777008,Intrahepatic bile duct cancer,3036505017,Acceptable,453
187777008,Malignant neoplasm of intrahepatic biliary passages,2619456011,Acceptable,453
94503003,Secondary malignant neoplasm of prostate (disorder),838461019,Preferred,454
94503003,Secondary malignant neoplasm of prostate,156607018,Preferred,454
94503003,Cancer metastatic to prostate,3036018016,Acceptable,454
94503003,Metastasis to prostate,1235857019,Acceptable,454
94503003,Metastatic malignant neoplasm to prostate,156608011,Acceptable,454
94503003,Metastatic tumor to prostate,1218783010,Acceptable,454
94503003,Metastatic tumour to prostate,1217295014,Acceptable,454
434193002,History of malignant neoplasm of neck (situation),2745992016,Preferred,455
434193002,History of malignant neoplasm of neck,2771386019,Preferred,455
434193002,History of cancer of the neck,3035722013,Acceptable,455
429405004,Family history of malignant neoplasm of skin (situation),2689365012,Preferred,456
429405004,Family history of malignant neoplasm of skin,2694335019,Preferred,456
429405004,Family history of skin cancer,2769174011,Acceptable,456
423987006,"Primary malignant neoplasm of vulva, with widespread metastatic disease (disorder)",2639600010,Preferred,457
423987006,"Cancer of vulva, disseminated",2643598014,Preferred,457
423987006,"Primary malignant neoplasm of vulva, with widespread metastatic disease",2647880015,Acceptable,457
844371000000105,Cancer survivorship care plan (record artifact),2190561000000116,Preferred,458
844371000000105,Cancer survivorship care plan,2190551000000119,Preferred,458
81971000000102,Cancer supportive care worker,122101000000119,Preferred,459
81971000000102,Cancer supportive care worker,122091000000110,Preferred,459
312940006,Carcinoma-associated retinopathy (disorder),2529027017,Preferred,460
312940006,Carcinoma-associated retinopathy,2532533013,Preferred,460
312940006,Cancer associated retinopathy,3644837018,Acceptable,460
363416002,Malignant tumor of extrahepatic bile duct (disorder),755238010,Preferred,461
363416002,Malignant tumour of extrahepatic bile duct,482631015,Preferred,461
363416002,Ca extrahepatic bile ducts,1490770018,Acceptable,461
363416002,Extrahepatic bile duct cancer,3036201013,Acceptable,461
363416002,Malignant tumor of extrahepatic bile duct,482632010,Acceptable,461
294291000000102,Bowel cancer screening status (finding),517391000000114,Preferred,462
294291000000102,Bowel cancer screening status,517401000000112,Preferred,462
276501000000107,Urgent cancer referral - lung,473761000000111,Preferred,463
276501000000107,Urgent cancer referral - lung,473771000000116,Preferred,463
188470006,Secondary malignant neoplasm of vulva (disorder),2719333017,Preferred,464
188470006,Secondary malignant neoplasm of vulva,289556015,Preferred,464
188470006,Secondary cancer of the vulva,289555016,Acceptable,464
772992009,Primary differentiated carcinoma of thyroid gland (disorder),3722223010,Preferred,465
772992009,Primary differentiated carcinoma of thyroid gland,3722224016,Preferred,465
772992009,DTC - differentiated thyroid cancer,3720063014,Acceptable,465
772992009,Differentiated thyroid cancer,3720066018,Acceptable,465
77571000000108,Cancer supportive care worker,116621000000111,Preferred,466
77571000000108,Cancer supportive care worker,116611000000117,Preferred,466
276511000000109,Urgent cancer referral - lung,473781000000119,Preferred,467
276511000000109,Urgent cancer referral - lung,473791000000117,Preferred,467
92574009,Carcinoma in situ of cystic duct (disorder),836126012,Preferred,468
92574009,Carcinoma in situ of cystic duct,153140015,Preferred,468
92574009,Cancer in situ of cystic duct,3036292012,Acceptable,468
94459006,Secondary malignant neoplasm of pancreas (disorder),838406014,Preferred,469
94459006,Secondary malignant neoplasm of pancreas,156505015,Preferred,469
94459006,Cancer metastatic to pancreas,3036468019,Acceptable,469
94459006,Metastasis to pancreas,1235848013,Acceptable,469
94459006,Metastatic malignant neoplasm to pancreas,156508018,Acceptable,469
94459006,Pancreatic metastasis,1235850017,Acceptable,469
94459006,Secondary malignant deposit in pancreas,1235849017,Acceptable,469
429011007,Family history of malignant neoplasm of lung (situation),2691308012,Preferred,470
429011007,Family history of malignant neoplasm of lung,2693157011,Preferred,470
429011007,Family history of lung cancer,2768684015,Acceptable,470
92719006,Carcinoma in situ of skin of ear (disorder),836301012,Preferred,471
92719006,Carcinoma in situ of skin of ear,153324011,Preferred,471
92719006,Cancer in situ of skin of ear,3038199019,Acceptable,471
874201000000107,QCancer testicular cancer risk,2257581000000118,Preferred,472
874201000000107,QCancer testicular cancer risk,2257591000000116,Preferred,472
315275009,Suspected hematological malignancy (situation),2611956019,Preferred,473
315275009,Suspected haematological malignancy,459775018,Preferred,473
315275009,Suspected haemotological cancer,1783527014,Acceptable,473
315275009,Suspected hematological cancer,1783908011,Acceptable,473
315275009,Suspected hematological malignancy,459776017,Acceptable,473
916751000000109,Cancer supportive drugs Band 1,2354701000000115,Preferred,474
916751000000109,Cancer supportive drugs Band 1,2357351000000110,Preferred,474
848861000000104,QCancer colorectal cancer risk (observable entity),2257831000000115,Preferred,475
848861000000104,QCancer colorectal cancer risk,2258201000000112,Preferred,475
315277001,Suspected head and neck cancer (situation),2611816015,Preferred,476
315277001,Suspected head and neck cancer,459778016,Preferred,476
848901000000106,QCancer pancreatic cancer risk (observable entity),2257911000000116,Preferred,477
848901000000106,QCancer pancreatic cancer risk,2257901000000118,Preferred,477
897691000000104,Cancer supportive drugs Band 1 (procedure),2309381000000118,Preferred,478
897691000000104,Cancer supportive drugs Band 1,2309391000000116,Preferred,478
162590000,Suspected head and neck cancer (situation),2731822015,Preferred,479
162590000,Suspected head and neck cancer,253487017,Preferred,479
874191000000105,QCancer testicular cancer risk (observable entity),2257561000000110,Preferred,480
874191000000105,QCancer testicular cancer risk,2257571000000115,Preferred,480
164901000000102,Cancer monitoring third letter,247191000000112,Preferred,481
164901000000102,Cancer monitoring third letter,236041000000117,Preferred,481
165551000000109,Cancer monitoring first letter,238341000000115,Preferred,482
165551000000109,Cancer monitoring first letter,225851000000115,Preferred,482
353741000119106,Secondary malignant neoplasm of left lung (disorder),3046870018,Preferred,483
353741000119106,Secondary malignant neoplasm of left lung,3046874010,Preferred,483
353741000119106,Cancer metastatic to left lung,3046863018,Acceptable,483
723118001,Fear of musculoskeletal cancer (finding),3334648017,Preferred,484
723118001,Fear of musculoskeletal cancer,3334649013,Preferred,484
449224009,Malignant neoplasm of anterior mediastinum (disorder),2897918018,Preferred,485
449224009,Malignant neoplasm of anterior mediastinum,2901920014,Preferred,485
449224009,Cancer of anterior mediastinum,2901919015,Acceptable,485
413741005,Cancer monitoring third letter (procedure),2529980015,Preferred,486
413741005,Cancer monitoring third letter,2533416014,Preferred,486
139858007,Suspected head and neck cancer (situation),2753996012,Preferred,487
139858007,Suspected head and neck cancer,221668011,Preferred,487
170921000000107,Cancer monitoring first letter,249521000000111,Preferred,488
170921000000107,Cancer monitoring first letter,230421000000116,Preferred,488
413738001,Cancer monitoring first letter (procedure),2529982011,Preferred,489
413738001,Cancer monitoring first letter,2533418010,Preferred,489
448882009,Malignant neoplasm of intraabdominal organ (disorder),2899002018,Preferred,490
448882009,Malignant neoplasm of intraabdominal organ,2901459013,Preferred,490
448882009,Cancer of intraabdominal organ,2901458017,Acceptable,490
243877001,Cancer cervix screening status (finding),3043174015,Preferred,491
243877001,Cancer cervix screening status,3043212017,Preferred,491
243877001,Ca cervix screening status,364713015,Acceptable,491
448669004,Malignant neoplasm of soft tissue of orbit (disorder),2898860015,Preferred,492
448669004,Malignant neoplasm of soft tissue of orbit,2901474010,Preferred,492
448669004,Cancer of soft tissue of orbit,2901473016,Acceptable,492
208001000000106,Cancer screening leaflet given,318621000000119,Preferred,493
208001000000106,Cancer screening leaflet given,332351000000111,Preferred,493
395685008,Cancer information offered to patient (procedure),1469625018,Preferred,494
395685008,Cancer information offered to patient,1489341016,Preferred,494
395685008,Cancer info offered to patient,1494686012,Acceptable,494
13015001000119105,Lung cancer screening declined (situation),3432733017,Preferred,495
13015001000119105,Lung cancer screening declined,3432734011,Preferred,495
276601000000106,Urgent cancer referral - brain,473961000000113,Preferred,496
276601000000106,Urgent cancer referral - brain,473971000000118,Preferred,496
276591000000100,Urgent cancer referral - brain,473941000000112,Preferred,497
276591000000100,Urgent cancer referral - brain,473951000000110,Preferred,497
207991000000102,Cancer screening leaflet given,328671000000110,Preferred,498
207991000000102,Cancer screening leaflet given,342401000000116,Preferred,498
92724009,Carcinoma in situ of skin of face (disorder),836308018,Preferred,499
92724009,Carcinoma in situ of skin of face,153329018,Preferred,499
92724009,Cancer in situ of skin of face,3038128019,Acceptable,499
403916003,Basal cell carcinoma of forehead (disorder),1771842015,Preferred,500
403916003,Basal cell carcinoma of forehead,1782920010,Preferred,500
403916003,"Cancer of forehead, basal cell",3038058011,Acceptable,500
202201000000100,Cancer screening leaflet given (situation),598951000000117,Preferred,501
202201000000100,Cancer screening leaflet given,308191000000110,Preferred,501
397682005,Suspected gynecological cancer (situation),2613051016,Preferred,502
397682005,Suspected gynaecological cancer,1773144010,Preferred,502
397682005,Suspected gynecological cancer,1774430019,Acceptable,502
198791000000101,Suspected gynaecological cancer (situation),466171000000119,Preferred,503
198791000000101,Suspected gynaecological cancer,299881000000115,Preferred,503
198791000000101,Suspected gynaecologica cancer,299891000000118,Acceptable,503
429410000,History of malignant neoplasm of esophagus (situation),2688798011,Preferred,504
429410000,History of malignant neoplasm of oesophagus,2691902016,Preferred,504
429410000,History of cancer of esophagus,3035701019,Acceptable,504
429410000,History of cancer of oesophagus,3038207018,Acceptable,504
429410000,History of malignant neoplasm of esophagus,2695368016,Acceptable,504
175591000000107,Cancer monitoring third letter,245931000000116,Preferred,505
175591000000107,Cancer monitoring third letter,234631000000112,Preferred,505
429236009,Family history of malignant neoplasm of liver (situation),2690956017,Preferred,506
429236009,Family history of malignant neoplasm of liver,2695999013,Preferred,506
429236009,Family history of cancer of the liver,3035778014,Acceptable,506
429236009,Family history of liver cancer,2767572011,Acceptable,506
428880006,History of malignant neoplasm of penis (situation),2691441014,Preferred,507
428880006,History of malignant neoplasm of penis,2693139010,Preferred,507
428880006,History of cancer of the penis,3036394010,Acceptable,507
94286009,Secondary malignant neoplasm of esophagus (disorder),838197019,Preferred,508
94286009,Secondary malignant neoplasm of oesophagus,201714016,Preferred,508
94286009,Cancer metastatic to esophagus,3036360013,Acceptable,508
94286009,Metastatic malignant neoplasm to esophagus,156036019,Acceptable,508
94286009,Metastatic malignant neoplasm to oesophagus,511247012,Acceptable,508
94286009,Secondary malignant neoplasm of esophagus,156033010,Acceptable,508
105121000119102,Squamous cell carcinoma of vagina (disorder),3287691015,Preferred,509
105121000119102,Squamous cell carcinoma of vagina,3287664017,Preferred,509
105121000119102,Squamous cell cancer of vagina,3287670011,Acceptable,509
268543007,Cancer cervix - screening done (finding),3043314019,Preferred,510
268543007,Cancer cervix - screening done,3043250011,Preferred,510
268543007,Ca cervix - screening done,401560015,Acceptable,510
276361000000104,Urgent cancer referral - breast,473481000000113,Preferred,511
276361000000104,Urgent cancer referral - breast,473491000000110,Preferred,511
353561000119103,Secondary malignant neoplasm of right lung (disorder),3046865013,Preferred,512
353561000119103,Secondary malignant neoplasm of right lung,3046864012,Preferred,512
353561000119103,Cancer metastatic to right lung,3046858017,Acceptable,512
444764006,Cancer antigen 27-29 above reference range (finding),2868825019,Preferred,513
444764006,Cancer antigen 27-29 above reference range,2870958010,Preferred,513
444764006,High cancer antigen 27-29 level,2870959019,Acceptable,513
170931000000109,Cancer monitoring second letter,242301000000117,Preferred,514
170931000000109,Cancer monitoring second letter,230431000000119,Preferred,514
448670003,Malignant neoplasm of posterior mediastinum (disorder),2898489013,Preferred,515
448670003,Malignant neoplasm of posterior mediastinum,2901476012,Preferred,515
448670003,Cancer of posterior mediastinum,2901475011,Acceptable,515
113058009,Cancer antigen 15-3 measurement (procedure),2989812013,Preferred,516
113058009,CA 15-3 measurement,185954017,Preferred,516
113058009,CA 153 measurement,2989926015,Acceptable,516
113058009,Cancer antigen 15-3 measurement,2989975019,Acceptable,516
294221000000100,Declined bowel cancer screening,517251000000114,Preferred,517
294221000000100,Declined bowel cancer screening,517261000000112,Preferred,517
92740007,Carcinoma in situ of skin of scalp (disorder),836327012,Preferred,518
92740007,Carcinoma in situ of skin of scalp,153347012,Preferred,518
92740007,Cancer in situ of skin of scalp,3037928017,Acceptable,518
254856004,Undifferentiated carcinoma of ovary (disorder),645808018,Preferred,519
254856004,Undifferentiated carcinoma of ovary,379696016,Preferred,519
254856004,Undifferentiated ovarian cancer,3012796019,Acceptable,519
294211000000106,Declined bowel cancer screening,517231000000119,Preferred,520
294211000000106,Declined bowel cancer screening,517241000000111,Preferred,520
874241000000105,QCancer endometrial cancer risk,2257661000000114,Preferred,521
874241000000105,QCancer endometrial cancer risk,2257671000000119,Preferred,521
276351000000102,Urgent cancer referral - breast,473461000000116,Preferred,522
276351000000102,Urgent cancer referral - breast,473471000000111,Preferred,522
294201000000109,Bowel cancer screening declined (situation),517211000000110,Preferred,523
294201000000109,Bowel cancer screening declined,517221000000116,Preferred,523
92547008,Carcinoma in situ of body of pancreas (disorder),836093011,Preferred,524
92547008,Carcinoma in situ of body of pancreas,153109010,Preferred,524
92547008,Cancer in situ of pancreas body,3038138012,Acceptable,524
94627008,Secondary malignant neoplasm of peritoneum (disorder),3038095011,Preferred,525
94627008,Secondary malignant neoplasm of peritoneum,1235875018,Preferred,525
94627008,Cancer metastatic to peritoneum,3036037013,Acceptable,525
94627008,Metastasis to peritoneum,1235872015,Acceptable,525
94627008,Metastatic malignant neoplasm to peritoneum,3038118011,Acceptable,525
94627008,Peritoneal seedling,1235873013,Acceptable,525
94627008,Secondary malignant peritoneal deposit,1235874019,Acceptable,525
175581000000105,Cancer monitoring second letter,248601000000110,Preferred,526
175581000000105,Cancer monitoring second letter,237521000000119,Preferred,526
214221000000101,Suspected gynaecological cancer,323391000000111,Preferred,527
214221000000101,Suspected gynaecological cancer,337121000000118,Preferred,527
363474009,Malignant neoplasm of cerebral meninges (disorder),755303010,Preferred,528
363474009,Malignant neoplasm of cerebral meninges,482737014,Preferred,528
363474009,Cancer of the cerebral meninges,3035959019,Acceptable,528
716859000,Hereditary diffuse carcinoma of stomach (disorder),3307807012,Preferred,529
716859000,Hereditary diffuse carcinoma of stomach,3307808019,Preferred,529
716859000,E-cadherin-associated hereditary gastric cancer,3529911013,Acceptable,529
716859000,Familial diffuse gastric cancer,3529910014,Acceptable,529
716859000,Hereditary diffuse gastric cancer,3307809010,Acceptable,529
214211000000107,Suspected gynaecological cancer,323381000000114,Preferred,530
214211000000107,Suspected gynaecological cancer,337111000000112,Preferred,530
429409005,History of malignant neoplasm of tongue (situation),2690840014,Preferred,531
429409005,History of malignant neoplasm of tongue,2694432015,Preferred,531
429409005,History of cancer of the tongue,3035831016,Acceptable,531
413740006,Cancer monitoring second letter (procedure),2529981016,Preferred,532
413740006,Cancer monitoring second letter,2533417017,Preferred,532
40939009,Cancer antigen 19-9 measurement (procedure),2989915014,Preferred,533
40939009,CA 19-9 measurement,68283018,Preferred,533
40939009,CA 199 measurement,2990049011,Acceptable,533
40939009,Cancer antigen 19-9 measurement,2989802018,Acceptable,533
369523007,Secondary malignant neoplasm of left ovary (disorder),774237012,Preferred,534
369523007,Secondary malignant neoplasm of left ovary,491069012,Preferred,534
369523007,Cancer metastatic to left ovary,3036027015,Acceptable,534
874231000000101,QCancer endometrial cancer risk (observable entity),2257641000000113,Preferred,535
874231000000101,QCancer endometrial cancer risk,2257651000000111,Preferred,535
425148008,Squamous cell carcinoma of temple (disorder),2639550013,Preferred,536
425148008,Squamous cell carcinoma of temple,2643546012,Preferred,536
425148008,"Cancer of temple, squamous cell",3036149012,Acceptable,536
94253005,Secondary malignant neoplasm of chest wall (disorder),838158010,Preferred,537
94253005,Secondary malignant neoplasm of chest wall,155951019,Preferred,537
94253005,Cancer metastatic to chest wall,3035973011,Acceptable,537
94253005,Metastatic malignant neoplasm to chest wall,155954010,Acceptable,537
429740004,Family history of malignant neoplasm of breast (situation),2689041015,Preferred,538
429740004,Family history of breast cancer,3671080015,Preferred,538
429740004,Family history of malignant neoplasm of breast,2694878016,Acceptable,538
423158009,Hurthle cell carcinoma of thyroid (disorder),2639584012,Preferred,539
423158009,Hurthle cell carcinoma of thyroid,2643582019,Preferred,539
423158009,"Cancer of thyroid, Hurthle cell",3037210010,Acceptable,539
188325002,Malignant neoplasm of peripheral nerve of thorax (disorder),571603010,Preferred,540
188325002,Malignant neoplasm of peripheral nerve of thorax,289388010,Preferred,540
188325002,"Peripheral nerve cancer, thorax",3036419019,Acceptable,540
31001000119109,Colon cancer screening declined (situation),3320498013,Preferred,541
31001000119109,Colon cancer screening declined,3320499017,Preferred,541
448218008,Malignant neoplasm of cerebellopontine angle (disorder),2897768015,Preferred,542
448218008,Malignant neoplasm of cerebellopontine angle,2900745013,Preferred,542
448218008,Cancer of cerebellopontine angle,2900744012,Acceptable,542
188221009,Malignant tumor of retained testis (disorder),571485014,Preferred,543
188221009,Malignant tumour of retained testis,289228014,Preferred,543
188221009,Cancer of intra-abdominal testis,289231010,Acceptable,543
188221009,Malignant neoplasm of retained testis,289230011,Acceptable,543
188221009,Malignant tumor of retained testis,289229018,Acceptable,543
94312000,Secondary malignant neoplasm of gallbladder (disorder),838230014,Preferred,544
94312000,Secondary malignant neoplasm of gallbladder,156109019,Preferred,544
94312000,Cancer metastatic to gallbladder,3036483012,Acceptable,544
94312000,Metastatic malignant neoplasm to gallbladder,156110012,Acceptable,544
92786009,Carcinoma in situ of urinary system (disorder),836382015,Preferred,545
92786009,Carcinoma in situ of urinary system,153402010,Preferred,545
92786009,Cancer in situ of urinary system,3036550015,Acceptable,545
94217008,Secondary malignant neoplasm of bone marrow (disorder),838114010,Preferred,546
94217008,Secondary malignant neoplasm of bone marrow,155849019,Preferred,546
94217008,Cancer metastatic to bone marrow,3035739010,Acceptable,546
94217008,Metastasis to bone marrow,511230011,Acceptable,546
94217008,Metastatic malignant neoplasm to bone marrow,155852010,Acceptable,546
762594002,Chronic pain following surgical procedure for cancer (disorder),3636900010,Preferred,547
762594002,Chronic pain following surgical procedure for cancer,3636901014,Preferred,547
762594002,Chronic post cancer surgery pain,3636899017,Acceptable,547
175571000000108,Cancer monitoring administration,245921000000118,Preferred,548
175571000000108,Cancer monitoring administration,234621000000110,Preferred,548
78080008,Hyperthermia treatment of cancer (procedure),818980016,Preferred,549
78080008,Hyperthermia treatment of cancer,129583014,Preferred,549
276441000000106,Urgent cancer referral - urology,473641000000119,Preferred,550
276441000000106,Urgent cancer referral - urology,473651000000116,Preferred,550
276451000000109,Urgent cancer referral - urology,473661000000118,Preferred,551
276451000000109,Urgent cancer referral - urology,473671000000113,Preferred,551
92723003,Carcinoma in situ of skin of eyelid (disorder),836307011,Preferred,552
92723003,Carcinoma in situ of skin of eyelid,153328014,Preferred,552
92723003,Cancer in situ of skin of eyelid,3037940017,Acceptable,552
276531000000101,Urgent cancer referral - sarcoma,473821000000110,Preferred,553
276531000000101,Urgent cancer referral - sarcoma,473831000000112,Preferred,553
12275351000119103,Breast cancer screening declined (situation),3320486015,Preferred,554
12275351000119103,Breast cancer screening declined,3320487012,Preferred,554
276541000000105,Urgent cancer referral - sarcoma,473841000000115,Preferred,555
276541000000105,Urgent cancer referral - sarcoma,473851000000117,Preferred,555
720008007,Prostate cancer care review done (situation),3318844016,Preferred,556
720008007,Prostate cancer care review done,3318845015,Preferred,556
369530001,Secondary malignant neoplasm of right ovary (disorder),774245019,Preferred,557
369530001,Secondary malignant neoplasm of right ovary,491076019,Preferred,557
369530001,Cancer metastatic to right ovary,3036577012,Acceptable,557
719864002,Monitoring following treatment for cancer (regime/therapy),3318186012,Preferred,558
719864002,Monitoring following treatment for cancer,3318187015,Preferred,558
719864002,Post-cancer treatment monitoring,3318188013,Acceptable,558
423535002,Basal cell carcinoma of chest wall (disorder),2639586014,Preferred,559
423535002,Basal cell carcinoma of chest wall,2643584018,Preferred,559
423535002,"Cancer of chest wall, basal cell",3037020014,Acceptable,559
171153008,Cancer cervix screening - wanted (finding),3043097015,Preferred,560
171153008,Cancer cervix screening - wanted,3043248015,Preferred,560
171153008,Ca cervix screening - wanted,265198011,Acceptable,560
286901000000107,Bowel cancer screening programme (procedure),495721000000112,Preferred,561
286901000000107,Bowel cancer screening programme,495731000000114,Preferred,561
713751000000109,Cancer monitoring administration (record artifact),1557801000000116,Preferred,562
713751000000109,Cancer monitoring administration,1564991000000119,Preferred,562
92598002,Carcinoma in situ of fundus of stomach (disorder),836154017,Preferred,563
92598002,Carcinoma in situ of fundus of stomach,153174016,Preferred,563
92598002,Cancer in situ fundus of stomach,3038122018,Acceptable,563
94409002,Secondary malignant neoplasm of mediastinum (disorder),838346016,Preferred,564
94409002,Secondary malignant neoplasm of mediastinum,156375015,Preferred,564
94409002,Cancer metastatic to mediastinum,3036056015,Acceptable,564
94409002,Mediastinal metastasis,1235844010,Acceptable,564
94409002,Metastasis to mediastinum,1235843016,Acceptable,564
94409002,Metastatic malignant neoplasm to mediastinum,156378018,Acceptable,564
94409002,Secondary malignant tumor of mediastinum,1218778019,Acceptable,564
94409002,Secondary malignant tumour of mediastinum,1217290016,Acceptable,564
170911000000101,Cancer monitoring administration,242291000000116,Preferred,565
170911000000101,Cancer monitoring administration,230411000000110,Preferred,565
165741000000102,Cancer monitoring administration (administrative concept),238441000000114,Preferred,566
165741000000102,Cancer monitoring administration,225981000000119,Preferred,566
67771000119102,Grade 2 astrocytoma of brain (disorder),3718072018,Preferred,567
67771000119102,Grade 2 astrocytoma of brain,3718074017,Preferred,567
67771000119102,Diffuse astrocytoma of brain,3718089014,Acceptable,567
67771000119102,Grade 2 astrocytoma brain cancer,3718090017,Acceptable,567
85121000119109,Genetic susceptibility to cancer (finding),3427495014,Preferred,568
85121000119109,Genetic susceptibility to cancer,3427496010,Preferred,568
399427004,Monitoring of patient with cancer (regime/therapy),1767347013,Preferred,569
399427004,Monitoring of patient with cancer,1778856010,Preferred,569
312824007,Family history of cancer of colon (situation),2610795017,Preferred,570
312824007,Family history of cancer of colon,456612019,Preferred,570
449066004,Malignant neoplasm of upper respiratory tract (disorder),2898348014,Preferred,571
449066004,Malignant neoplasm of upper respiratory tract,2901156011,Preferred,571
449066004,Cancer of upper respiratory tract,2901155010,Acceptable,571
92750008,Carcinoma in situ of small intestine (disorder),836339016,Preferred,572
92750008,Carcinoma in situ of small intestine,153360018,Preferred,572
92750008,Cancer in situ of small intestine,3035961011,Acceptable,572
171151005,Cancer cervix screening - offered (finding),3043251010,Preferred,573
171151005,Cancer cervix screening - offered,3043278012,Preferred,573
171151005,Ca cervix screening - offered,265196010,Acceptable,573
92546004,Carcinoma in situ of bladder (disorder),836092018,Preferred,574
92546004,Cancer in situ of urinary bladder,3036308016,Preferred,574
92546004,Carcinoma in situ of bladder,153107012,Acceptable,574
831061000000100,No family history of bowel cancer,2162321000000116,Preferred,575
831061000000100,No family history of bowel cancer,2160771000000117,Preferred,575
402820007,Basal cell carcinoma of ear (disorder),1770744019,Preferred,576
402820007,Basal cell carcinoma of ear,1781912010,Preferred,576
402820007,"Cancer of skin of ear, basal cell",3038096012,Acceptable,576
402819001,Basal cell carcinoma of skin of lip (disorder),1770743013,Preferred,577
402819001,Basal cell carcinoma of skin of lip,1781911015,Preferred,577
402819001,"Cancer of skin of lip, basal cell",3038130017,Acceptable,577
146861000119102,Screening for malignant neoplasm of vagina done (situation),2995377013,Preferred,578
146861000119102,Screening for malignant neoplasm of vagina done,2995917011,Preferred,578
146861000119102,Screening for vaginal cancer done,2995206015,Acceptable,578
92549006,Carcinoma in situ of body of stomach (disorder),836095016,Preferred,579
92549006,Carcinoma in situ of body of stomach,153111018,Preferred,579
92549006,Cancer in situ of body of stomach,3038039019,Acceptable,579
92549006,Carcinoma in situ of gastric body,3038125016,Acceptable,579
276391000000105,Urgent cancer referral - children,473541000000118,Preferred,580
276391000000105,Urgent cancer referral - children,473551000000115,Preferred,580
164201000000109,Family history of prostate cancer,250241000000111,Preferred,581
164201000000109,Family history of prostate cancer,235791000000117,Preferred,581
428941002,History of malignant neoplasm of uterine body (situation),2689196011,Preferred,582
428941002,History of malignant neoplasm of uterine body,2692362014,Preferred,582
428941002,History of cancer of uterine body,3012632010,Acceptable,582
978821000000103,Discussion about suspected cancer (procedure),2489331000000111,Preferred,583
978821000000103,Discussion about suspected cancer,2489341000000119,Preferred,583
276381000000108,Urgent cancer referral - children,473521000000113,Preferred,584
276381000000108,Urgent cancer referral - children,473531000000110,Preferred,584
428269004,Family history of malignant neoplasm of trachea (situation),2690170018,Preferred,585
428269004,Family history of malignant neoplasm of trachea,2694624018,Preferred,585
428269004,Family history of tracheal cancer,3037830016,Acceptable,585
171511000000101,Family history of prostate cancer,242791000000113,Preferred,586
171511000000101,Family history of prostate cancer,230981000000112,Preferred,586
909291000000100,Se CA (cancer antigen) 15-3 level,2337271000000110,Preferred,587
909291000000100,Se CA (cancer antigen) 15-3 level,2337281000000112,Preferred,587
424887002,"Primary malignant neoplasm of thyroid gland, metastatic to bone (disorder)",2639598016,Preferred,588
424887002,Thyroid cancer metastatic to bone,2643596013,Preferred,588
424887002,"Primary malignant neoplasm of thyroid gland, metastatic to bone",2647878014,Acceptable,588
424887002,Primary thyroid malignancy metastatic to bone,2647877016,Acceptable,588
758811000000100,No family history of bowel cancer (situation),1673191000000119,Preferred,589
758811000000100,No family history of bowel cancer,1673201000000117,Preferred,589
1027511000000100,Cancer antigen 125 level (observable entity),2592431000000117,Preferred,591
1027511000000100,CA 125 (cancer antigen 125) level,2595641000000116,Preferred,591
1027511000000100,CA 125 level,2595661000000115,Acceptable,591
1104621000000103,Cervical cancer screening offered (situation),2765071000000115,Preferred,592
1104621000000103,Cervical cancer screening offered,2765061000000110,Preferred,592
73751000119108,History of cancer of gall bladder (situation),3038112012,Preferred,593
73751000119108,History of cancer of gall bladder,3037956010,Preferred,593
990821000000107,Discussion about suspected cancer,2517181000000110,Preferred,594
990821000000107,Discussion about suspected cancer,2518001000000117,Preferred,594
92581002,Carcinoma in situ of endocrine gland (disorder),836135017,Preferred,595
92581002,Carcinoma in situ of endocrine gland,153147017,Preferred,595
92581002,Cancer in situ of endocrine gland,3036585015,Acceptable,595
722103009,Hormone sensitive prostate cancer (disorder),3330227019,Preferred,596
722103009,Hormone sensitive prostate cancer,3330697018,Preferred,596
722103009,Castrate-sensitive prostate cancer,3330698011,Acceptable,596
722103009,Castration-sensitive prostate cancer,3330699015,Acceptable,596
422599000,Squamous cell carcinoma of back (disorder),2639564013,Preferred,597
422599000,Squamous cell carcinoma of back,2643560014,Preferred,597
422599000,"Cancer of the back, squamous cell",3036080016,Acceptable,597
736595007,Screening for malignant neoplasm of cervix declined (situation),3518221017,Preferred,598
736595007,Screening for malignant neoplasm of cervix declined,3518222012,Preferred,598
736595007,Cervical cancer screening refused,3518223019,Acceptable,598
408647009,Adenocarcinoma of stomach (disorder),2152479019,Preferred,599
408647009,Adenocarcinoma of stomach,2160194015,Preferred,599
408647009,"Cancer of stomach, adenocarcinoma",3040651019,Acceptable,599
304745004,Mental adjustment to cancer scale (assessment scale),701088012,Preferred,600
304745004,Mental adjustment to cancer scale,447126013,Preferred,600
304745004,MAC - Mental adjustment to cancer scale,447127016,Acceptable,600
373817002,No anti-cancer treatment available (finding),1199117014,Preferred,601
373817002,No anti-cancer treatment available,1212267015,Preferred,601
191581000000103,Cancer shared care medication card,279381000000119,Preferred,602
191581000000103,Cancer shared care medication card,286661000000115,Preferred,602
403891008,Squamous cell carcinoma of scalp (disorder),1771817012,Preferred,603
403891008,Squamous cell carcinoma of scalp,1782895010,Preferred,603
403891008,"Cancer of the scalp, squamous cell",3036049014,Acceptable,603
25051000000104,No anti-cancer treatment available (finding),64111000000113,Preferred,604
25051000000104,No anti-cancer treatment available,62581000000119,Preferred,604
427492003,Hormone refractory prostate cancer (disorder),2662504019,Preferred,605
427492003,Hormone refractory prostate cancer,2674075014,Preferred,605
427492003,Castrate-resistant prostate cancer,3330702010,Acceptable,605
427492003,Castration-resistant prostate cancer,3330700019,Acceptable,605
25111000000102,Cancer treatment related morbidity (finding),64161000000110,Preferred,606
25111000000102,Cancer treatment related morbidity,62651000000112,Preferred,606
717130009,Breast Cancer Risk Assessment Tool (assessment scale),3308478011,Preferred,607
717130009,Breast Cancer Risk Assessment Tool,3308480017,Preferred,607
717130009,BCRAT - Breast Cancer Risk Assessment Tool,3308482013,Acceptable,607
717130009,Gail Model,3308481018,Acceptable,607
258235000,International Union Against Cancer (tumor staging),2914036016,Preferred,608
258235000,UICC,384314019,Preferred,608
258235000,International Union Against Cancer,2913958010,Acceptable,608
258235000,International Union Against Cancer (UICC),2619955018,Acceptable,608
258235000,International Union Against Cancer staging system,3035511012,Acceptable,608
94663008,Secondary malignant neoplasm of urinary system (disorder),838654011,Preferred,609
94663008,Secondary malignant neoplasm of urinary system,156981017,Preferred,609
94663008,Cancer metastatic to urinary tract,3036500010,Acceptable,609
94663008,Metastasis to urinary tract,1235881014,Acceptable,609
94663008,Metastatic malignant neoplasm to urinary system,156984013,Acceptable,609
449259009,Malignant neoplasm of broad ligament of uterus (disorder),2898052015,Preferred,610
449259009,Malignant neoplasm of broad ligament of uterus,2902300016,Preferred,610
449259009,Cancer of broad ligament of uterus,2902299012,Acceptable,610
31011000119107,Prostate cancer screening declined (situation),3320384016,Preferred,611
31011000119107,Prostate cancer screening declined,3320385015,Preferred,611
429637009,Family history of malignant neoplasm of uterus (situation),2690201013,Preferred,612
429637009,Family history of malignant neoplasm of uterus,2693580014,Preferred,612
429637009,Family history of cancer of uterus,3035770019,Acceptable,612
394038009,Administration of cancer treatment (procedure),2735714013,Preferred,613
394038009,Administration of cancer treatment,1487886015,Preferred,613
258236004,American Joint Committee on Cancer (tumor staging),2982701018,Preferred,614
258236004,AJCC,384315018,Preferred,614
258236004,American Joint Committee on Cancer,2982623010,Acceptable,614
258236004,American Joint Committee on Cancer (AJCC),2619956017,Acceptable,614
393087004,Administration of cancer treatment (finding),2751772016,Preferred,615
393087004,Administration of cancer treatment,1487057019,Preferred,615
443773007,Measurement of cancer antigen 72-4 (procedure),2834829010,Preferred,616
443773007,Measurement of cancer antigen 72-4,2842235019,Preferred,616
175621000000105,Cancer pain and symptom management,245951000000111,Preferred,617
175621000000105,Cancer pain and symptom management,234661000000119,Preferred,617
403468003,Squamous cell carcinoma of penis (disorder),1771394012,Preferred,618
403468003,Squamous cell carcinoma of penis,1782505013,Preferred,618
403468003,"Cancer of the penis, squamous cell",3035949015,Acceptable,618
403468003,Penile squamous cell carcinoma,1787763013,Acceptable,618
413742003,Cancer pain and symptom management (procedure),2530650012,Preferred,619
413742003,Cancer pain and symptom management,2534102018,Preferred,619
170961000000104,Cancer pain and symptom management,242331000000111,Preferred,620
170961000000104,Cancer pain and symptom management,230461000000112,Preferred,620
188081000000100,Cancer shared care medication card,275881000000113,Preferred,621
188081000000100,Cancer shared care medication card,283161000000118,Preferred,621
394930000,Gleason grading of prostate cancer (tumor staging),1468870018,Preferred,622
394930000,Gleason grading of prostate cancer,1488632011,Preferred,622
392991003,Gleason grading of prostate cancer (staging scale),2760758018,Preferred,623
392991003,Gleason grading of prostate cancer,1486967015,Preferred,623
171159007,Cancer cervix screen-no result yet (finding),3043262010,Preferred,624
171159007,Cancer cervix screen-no result yet,3043246016,Preferred,624
171159007,Ca cervix screen-no result yet,265208012,Acceptable,624
100731000119107,Low grade astrocytoma of brain (disorder),3717932010,Preferred,625
100731000119107,Low grade astrocytoma of brain,3717933017,Preferred,625
100731000119107,Low grade astrocytoma brain cancer,3718071013,Acceptable,625
712849003,Primary malignant neoplasm of prostate metastatic to bone (disorder),3286039014,Preferred,626
712849003,Prostate cancer metastatic to bone,3286034016,Preferred,626
712849003,Carcinoma of prostate with bony metastases,3286018019,Acceptable,626
712849003,Primary malignant neoplasm of prostate metastatic to bone,3286024013,Acceptable,626
393947006,Gleason grading of prostate cancer (staging scale),2743352013,Preferred,627
393947006,Gleason grading of prostate cancer,1487801010,Preferred,627
723115003,Fear of cancer of endocrine system (finding),3334642016,Preferred,628
723115003,Fear of cancer of endocrine system,3334643014,Preferred,628
416358008,Cancer shared care medication card (record artifact),2573125019,Preferred,629
416358008,Cancer shared care medication card,2548867016,Preferred,629
402519009,Basal cell carcinoma of face (disorder),1770443014,Preferred,630
402519009,Basal cell carcinoma of face,1781645013,Preferred,630
402519009,"Cancer of skin of face, basal cell",3038190015,Acceptable,630
81651000119109,Family history of heritable malignancy (situation),3513475011,Preferred,631
81651000119109,Family history of heritable malignancy,3513476012,Preferred,631
81651000119109,Family history of heritable cancer,3513477015,Acceptable,631
92570000,Carcinoma in situ of common bile duct (disorder),836121019,Preferred,632
92570000,Carcinoma in situ of common bile duct,153136012,Preferred,632
92570000,Cancer in situ of common bile duct,3036078010,Acceptable,632
92570000,Carcinoma in situ of distal extra hepatic duct,3004779014,Acceptable,632
430703009,Family history of malignant neoplasm of kidney (situation),2708452010,Preferred,633
430703009,Family history of malignant neoplasm of kidney,2764624013,Preferred,633
430703009,Family history of cancer of kidney,3038154010,Acceptable,633
403919005,Basal cell carcinoma of upper eyelid (disorder),1771845018,Preferred,634
403919005,Basal cell carcinoma of upper eyelid,1782923012,Preferred,634
403919005,"Cancer of upper eyelid, basal cell",3038080014,Acceptable,634
424334007,"Malignant tumor of spinal cord, intramedullary (disorder)",2639582011,Preferred,635
424334007,"Malignant tumour of spinal cord, intramedullary",2643579012,Preferred,635
424334007,"Cancer of spinal cord, intramedullary",3036091011,Acceptable,635
424334007,"Malignant tumor of spinal cord, intramedullary",2643578016,Acceptable,635
424334007,"Spinal cord cancer, intramedullary",3036021019,Acceptable,635
394900008,Administration of cancer treatment (procedure),1468840011,Preferred,636
394900008,Administration of cancer treatment,1488604019,Preferred,636
402509003,Basal cell carcinoma of neck (disorder),1770433011,Preferred,637
402509003,Basal cell carcinoma of neck,1781635011,Preferred,637
402509003,"Cancer of skin of neck, basal cell",3038044014,Acceptable,637
94161006,Secondary malignant neoplasm of adrenal gland (disorder),838047016,Preferred,638
94161006,Secondary malignant neoplasm of adrenal gland,155711012,Preferred,638
94161006,Cancer metastatic to adrenal gland,3035882018,Acceptable,638
94161006,Metastasis to adrenal gland,1235809013,Acceptable,638
94161006,Metastatic malignant neoplasm to adrenal gland,155712017,Acceptable,638
94161006,Suprarenal metastasis,1235808017,Acceptable,638
4461000175108,Cervical cancer screening not done (situation),3305804016,Preferred,639
4461000175108,Cervical cancer screening not done,3305805015,Preferred,639
4461000175108,Screening for malignant neoplasm of cervix not done,3306241018,Acceptable,639
109875002,Overlapping malignant neoplasm of penis (disorder),616663012,Preferred,640
109875002,Overlapping malignant neoplasm of penis,174561010,Preferred,640
109875002,"Cancer of penis, overlapping sites",3036073018,Acceptable,640
109875002,"Malignant neoplasm, overlapping lesion of penis",1219540012,Acceptable,640
254656002,Squamous cell carcinoma in situ of skin (disorder),645579018,Preferred,641
254656002,Squamous cell carcinoma in situ of skin,379241015,Preferred,641
254656002,Bowen's disease of skin,379237019,Acceptable,641
254656002,"Cancer in situ skin, squamous cell",3036544013,Acceptable,641
254656002,IEC - Intraepidermal carcinoma of skin,379238012,Acceptable,641
254656002,Intraepidermal carcinoma of skin,379240019,Acceptable,641
254656002,SCC - Squamous cell carcinoma in situ of skin,379239016,Acceptable,641
373865001,Cancer treatment related morbidity (disorder),2545849010,Preferred,642
373865001,Cancer treatment related morbidity,1212308013,Preferred,642
169931000000107,Cancer hospital treatment completed,241541000000117,Preferred,643
169931000000107,Cancer hospital treatment completed,229551000000115,Preferred,643
276421000000104,Urgent cancer referral - colorectal,473601000000117,Preferred,644
276421000000104,Urgent cancer referral - colorectal,473611000000115,Preferred,644
100721000119109,High grade astrocytoma of brain (disorder),3717937016,Preferred,645
100721000119109,High grade astrocytoma of brain,3717935012,Preferred,645
100721000119109,High grade astrocytoma brain cancer,3718070014,Acceptable,645
1026931000000103,Cancer antigen 15-3 level (observable entity),2591911000000111,Preferred,646
1026931000000103,CA 15-3 (cancer antigen 15-3) level,2616061000000111,Preferred,646
1026931000000103,CA 15-3 level,2602111000000113,Acceptable,646
88831000119109,History of cancer of floor of mouth (situation),3038204013,Preferred,647
88831000119109,History of cancer of floor of mouth,3038008016,Preferred,647
413737006,Cancer hospital treatment completed (situation),2639070013,Preferred,648
413737006,Cancer hospital treatment completed,2533540016,Preferred,648
413745001,Cancer short term health assessment (procedure),2835888011,Preferred,649
413745001,Cancer short term health assessment,2534079012,Preferred,649
414861001,No evidence of recurrence of cancer (situation),2613291012,Preferred,650
414861001,No evidence of recurrence of cancer,2533969018,Preferred,650
1030691000000107,Cancer antigen 19-9 level (observable entity),2590681000000115,Preferred,651
1030691000000107,CA 19-9 (cancer antigen 19-9) level,2602121000000119,Preferred,651
1030691000000107,CA 19-9 level,2616071000000116,Acceptable,651
1030691000000107,Carbohydrate antigen 19-9 level,2642601000000111,Acceptable,651
417084004,Cancer monitoring verbal invitation (procedure),2547294012,Preferred,652
417084004,Cancer monitoring verbal invitation,2549634010,Preferred,652
170971000000106,Cancer short term health assessment,242341000000119,Preferred,653
170971000000106,Cancer short term health assessment,230471000000117,Preferred,653
405822008,Squamous cell carcinoma of larynx (disorder),2149652015,Preferred,654
405822008,Squamous cell carcinoma of larynx,2157596013,Preferred,654
405822008,"Cancer of the larynx, squamous cell",3036241016,Acceptable,654
171751000000107,No evidence of recurrence of cancer,249611000000118,Preferred,655
171751000000107,No evidence of recurrence of cancer,231171000000118,Preferred,655
174581000000106,Cancer hospital treatment completed,249971000000116,Preferred,656
174581000000106,Cancer hospital treatment completed,233691000000111,Preferred,656
1035841000000108,Lymphoedema following breast cancer (disorder),2614611000000111,Preferred,657
1035841000000108,Lymphoedema following breast cancer,2614621000000117,Preferred,657
1035851000000106,Lymphoedema following breast cancer,2614631000000115,Preferred,658
1035851000000106,Lymphoedema following breast cancer,2614641000000112,Preferred,658
710121000000106,Cancer chemotherapy management plan,1551701000000115,Preferred,659
710121000000106,Cancer chemotherapy management plan,1551711000000118,Preferred,659
403894000,Squamous cell carcinoma of skin of ear (disorder),1771820016,Preferred,660
403894000,Squamous cell carcinoma of skin of ear,1782898012,Preferred,660
403894000,Squamous cell cancer of skin of ear,3083648012,Acceptable,660
710111000000100,Cancer chemotherapy management plan (qualifier value),1551681000000117,Preferred,661
710111000000100,Cancer chemotherapy management plan,1551691000000115,Preferred,661
423464009,Squamous cell carcinoma of oropharynx (disorder),2639827012,Preferred,662
423464009,Squamous cell carcinoma of oropharynx,2643843013,Preferred,662
423464009,"Cancer of oropharynx, squamous cell",3037596016,Acceptable,662
1064281000000106,Cancer chemotherapy management plan (record artifact),2673691000000111,Preferred,663
1064281000000106,Cancer chemotherapy management plan,2673681000000114,Preferred,663
175631000000107,Cancer short term health assessment,248611000000112,Preferred,664
175631000000107,Cancer short term health assessment,237531000000117,Preferred,664
848681000000107,QCancer lung cancer risk calculator (assessment scale),2199771000000114,Preferred,665
848681000000107,QCancer lung cancer risk calculator,2199781000000111,Preferred,665
402523001,Basal cell carcinoma of truncal skin (disorder),1770447010,Preferred,666
402523001,Basal cell carcinoma of truncal skin,1781649019,Preferred,666
402523001,"Cancer of skin of trunk, basal cell",3037981013,Acceptable,666
373785006,Cancer dataset administrative items (finding),1199085011,Preferred,667
373785006,Cancer dataset administrative items,1212236017,Preferred,667
909131000000109,Serum CA (cancer antigen) 125 level,2336871000000111,Preferred,668
909131000000109,Serum CA (cancer antigen) 125 level,2336881000000113,Preferred,668
188971000000101,Cancer monitoring verbal invitation,276771000000111,Preferred,669
188971000000101,Cancer monitoring verbal invitation,284051000000115,Preferred,669
831101000000103,No family history of ovarian cancer,2162361000000112,Preferred,670
831101000000103,No family history of ovarian cancer,2160811000000117,Preferred,670
192471000000109,Cancer monitoring verbal invitation,274351000000112,Preferred,671
192471000000109,Cancer monitoring verbal invitation,281631000000118,Preferred,671
164471000000100,No evidence of recurrence of cancer,237801000000114,Preferred,672
164471000000100,No evidence of recurrence of cancer,225161000000113,Preferred,672
24961000000101,Cancer dataset administrative items (finding),65041000000112,Preferred,673
24961000000101,Cancer dataset administrative items,62491000000118,Preferred,673
428944005,History of malignant neoplasm of uterine adnexa (situation),2689652010,Preferred,674
428944005,History of malignant neoplasm of uterine adnexa,2694371018,Preferred,674
428944005,History of cancer of uterine adnexa,3012595018,Acceptable,674
723301009,Squamous non-small cell lung cancer (disorder),3398697017,Preferred,675
723301009,Squamous non-small cell lung cancer,3398698010,Preferred,675
723301009,Squamous NSCLC (non-small cell lung cancer),3398701019,Acceptable,675
92560002,Carcinoma in situ of cardia of stomach (disorder),836109018,Preferred,676
92560002,Carcinoma in situ of cardia of stomach,153124018,Preferred,676
92560002,Cancer in situ of cardia of stomach,3038181010,Acceptable,676
92560002,Carcinoma in situ of cardia,1235740013,Acceptable,676
92560002,Carcinoma in situ of gastric cardia,3037930015,Acceptable,676
94402006,Secondary malignant neoplasm of male genital organ (disorder),838339013,Preferred,677
94402006,Secondary malignant neoplasm of male genital organ,156359018,Preferred,677
94402006,Cancer metastatic to male genital organ,3036031014,Acceptable,677
94402006,Cancer metastatic to male genitalia,3036535012,Acceptable,677
94402006,Metastasis to male genital organ,1235842014,Acceptable,677
94402006,Metastatic malignant neoplasm to male genital organ,156362015,Acceptable,677
1421000119104,Family history of colorectal cancer (situation),11291000119115,Preferred,678
1421000119104,Family history of colorectal cancer,2966873019,Preferred,678
758821000000106,No family history of ovarian cancer (situation),1673211000000115,Preferred,679
758821000000106,No family history of ovarian cancer,1673221000000114,Preferred,679
429000004,Family history of malignant neoplasm of pancreas (situation),2691380019,Preferred,680
429000004,Family history of malignant neoplasm of pancreas,2694512018,Preferred,680
429000004,Family history of cancer of the pancreas,3036142015,Acceptable,680
429000004,Family history of pancreatic cancer,2768110018,Acceptable,680
94442001,Secondary malignant neoplasm of nervous system (disorder),838387015,Preferred,681
94442001,Secondary malignant neoplasm of nervous system,156461011,Preferred,681
94442001,Cancer metastatic to nervous system,3036573011,Acceptable,681
94442001,Metastasis to nervous system,1235845011,Acceptable,681
94442001,Metastatic malignant neoplasm to nervous system,156464015,Acceptable,681
445430004,Measurement of cancer antigen 27-29 (procedure),2869532010,Preferred,682
445430004,Measurement of cancer antigen 27-29,2872376016,Preferred,682
276101000000100,Patient on regional cancer register (finding),472951000000115,Preferred,683
276101000000100,Patient on regional cancer register,472961000000117,Preferred,683
276411000000105,Urgent cancer referral - colorectal,473581000000114,Preferred,684
276411000000105,Urgent cancer referral - colorectal,473591000000111,Preferred,684
276321000000107,Urgent cancer referral - gynaecology,473401000000115,Preferred,685
276321000000107,Urgent cancer referral - gynaecology,473411000000118,Preferred,685
171154002,Cancer cervix screening - not needed (finding),3043256017,Preferred,686
171154002,Cancer cervix screening - not needed,3043207018,Preferred,686
171154002,Ca cervix screening - not needed,265199015,Acceptable,686
94186002,Secondary malignant neoplasm of bladder (disorder),838076018,Preferred,687
94186002,Secondary malignant neoplasm of bladder,155773015,Preferred,687
94186002,Cancer metastatic to urinary bladder,3035799012,Acceptable,687
94186002,Metastasis to bladder,511221015,Acceptable,687
94186002,Metastatic malignant neoplasm to bladder,155776011,Acceptable,687
94186002,Metastatic tumor to bladder,511223017,Acceptable,687
94186002,Metastatic tumour to bladder,511222010,Acceptable,687
408649007,Squamous cell carcinoma of pharynx (disorder),2152481017,Preferred,688
408649007,Squamous cell carcinoma of pharynx,2160196018,Preferred,688
408649007,"Cancer of the pharynx, squamous cell",3036495012,Acceptable,688
413743008,Cancer rehabilitation and readaption (regime/therapy),2530628011,Preferred,689
413743008,Cancer rehabilitation and readaption,2534080010,Preferred,689
909311000000104,Serum CA (cancer antigen) 19-9 level,2337321000000116,Preferred,690
909311000000104,Serum CA (cancer antigen) 19-9 level,2337331000000119,Preferred,690
428748002,Family history of malignant neoplasm of male breast (situation),2691726013,Preferred,691
428748002,Family history of malignant neoplasm of male breast,2691954014,Preferred,691
428748002,Family history of male breast cancer,3035668015,Acceptable,691
423896007,Squamous cell carcinoma of tip of nose (disorder),2639551012,Preferred,692
423896007,Squamous cell carcinoma of tip of nose,2643547015,Preferred,692
423896007,"Cancer of tip of nose, squamous cell",3035952011,Acceptable,692
848721000000100,QCancer renal cancer risk calculator (assessment scale),2199851000000113,Preferred,693
848721000000100,QCancer renal cancer risk calculator,2199861000000111,Preferred,693
1098941000119106,History of cancer metastatic to skin (situation),3038045010,Preferred,694
1098941000119106,History of cancer metastatic to skin,3038156012,Preferred,694
171155001,Cancer cervix screening - up-to-date (finding),3043130017,Preferred,695
171155001,Cancer cervix screening - up-to-date,3043209015,Preferred,695
171155001,Ca cervix screening - up-to-date,265200017,Acceptable,695
723093008,Fear of cancer of respiratory system (finding),3334586019,Preferred,696
723093008,Fear of cancer of respiratory system,3334587011,Preferred,696
716593008,Carcinoma of salivary gland type of breast (disorder),3306789014,Preferred,697
716593008,Carcinoma of salivary gland type of breast,3306795010,Preferred,697
716593008,Salivary gland type cancer of breast,3306796011,Acceptable,697
315058005,Hereditary nonpolyposis colon cancer (disorder),711910018,Preferred,698
315058005,HNPCC - hereditary nonpolyposis colon cancer,459528015,Preferred,698
315058005,HNPCC - hereditary nonpolyposis colorectal cancer,2971230015,Acceptable,698
315058005,Hereditary nonpolyposis colon cancer,459527013,Acceptable,698
175641000000103,Cancer rehabilitation and readaption,245961000000114,Preferred,699
175641000000103,Cancer rehabilitation and readaption,234671000000114,Preferred,699
1098961000119105,History of cancer metastatic to lung (situation),3038159017,Preferred,700
1098961000119105,History of cancer metastatic to lung,3038002015,Preferred,700
424666005,Basal cell carcinoma of auricle of ear (disorder),2639542016,Preferred,701
424666005,Basal cell carcinoma of auricle of ear,2643538011,Preferred,701
424666005,Basal cell carcinoma of pinna,2647871015,Acceptable,701
424666005,"Cancer of auricle of ear, basal cell",3036187016,Acceptable,701
170981000000108,Cancer rehabilitation and readaption,242351000000116,Preferred,702
170981000000108,Cancer rehabilitation and readaption,230481000000115,Preferred,702
448868009,Malignant neoplasm of lateral wall of oropharynx (disorder),2899130015,Preferred,703
448868009,Malignant neoplasm of lateral wall of oropharynx,2901613017,Preferred,703
448868009,Cancer of lateral wall of oropharynx,2901612010,Acceptable,703
757351000000109,Hereditary nonpolyposis colon cancer,1670761000000116,Preferred,704
757351000000109,Hereditary nonpolyposis colon cancer,1668911000000112,Preferred,704
18412003,Laparotomy for staging of ovarian cancer (procedure),745835011,Preferred,705
18412003,Laparotomy for staging of ovarian cancer,31067011,Preferred,705
18412003,Staging celiotomy for ovarian cancer,31068018,Acceptable,705
18412003,Staging coeliotomy for ovarian cancer,478582012,Acceptable,705
1051141000000100,Hereditary nonpolyposis colon cancer,2645291000000113,Preferred,706
1051141000000100,Hereditary nonpolyposis colon cancer,2644361000000112,Preferred,706
762391000000107,Cancer multidisciplinary team report (record artifact),1688901000000112,Preferred,707
762391000000107,Cancer multidisciplinary team report,1688911000000114,Preferred,707
1099291000119102,History of cancer metastatic to bone (situation),3038174015,Preferred,708
1099291000119102,History of cancer metastatic to bone,3038091019,Preferred,708
4471000175100,Colorectal cancer screening not done (situation),3305806019,Preferred,709
4471000175100,Colorectal cancer screening not done,3305807011,Preferred,709
4471000175100,Screening for malignant neoplasm of large intestine not done,3306239019,Acceptable,709
429252007,Family history of malignant neoplasm of bone (situation),2691349012,Preferred,710
429252007,Family history of malignant neoplasm of bone,2694089012,Preferred,710
429252007,Family history of cancer of the bone,3035784012,Acceptable,710
92747005,Carcinoma in situ of skin of upper limb (disorder),836335010,Preferred,711
92747005,Carcinoma in situ of skin of upper limb,153355017,Preferred,711
92747005,Cancer in situ of skin of upper limb,3038014011,Acceptable,711
94491007,Secondary malignant neoplasm of pituitary gland (disorder),838446015,Preferred,712
94491007,Secondary malignant neoplasm of pituitary gland,156581010,Preferred,712
94491007,Cancer metastatic to pituitary gland,3036441019,Acceptable,712
94491007,Metastasis to pituitary,1235854014,Acceptable,712
94491007,Metastatic malignant neoplasm to pituitary gland,156582015,Acceptable,712
106241006,Gleason grading system for prostatic cancer (staging scale),1475331016,Preferred,713
106241006,Gleason grading system for prostatic cancer,1490031016,Preferred,713
106241006,Gleason grading for prostatic cancer,170671011,Acceptable,713
106241006,Gleason's microscopic prostatic carcinoma grading system,1219220018,Acceptable,713
403892001,Squamous cell carcinoma of skin of face (disorder),1771818019,Preferred,714
403892001,Squamous cell carcinoma of skin of face,1782896011,Preferred,714
403892001,Squamous cell cancer of skin of face,3083731011,Acceptable,714
94601008,Secondary malignant neoplasm of spinal meninges (disorder),838580019,Preferred,715
94601008,Secondary malignant neoplasm of spinal meninges,156827019,Preferred,715
94601008,Cancer metastatic to spinal meninges,3036337017,Acceptable,715
94601008,Metastatic malignant neoplasm to spinal meninges,156828012,Acceptable,715
430527008,Family history of malignant neoplasm of testis (situation),2749767017,Preferred,716
430527008,Family history of malignant neoplasm of testis,2774287010,Preferred,716
430527008,Family history of cancer of testicle,3038180011,Acceptable,716
276331000000109,Urgent cancer referral - gynaecology,473421000000112,Preferred,717
276331000000109,Urgent cancer referral - gynaecology,473431000000114,Preferred,717
94580002,Secondary malignant neoplasm of small intestine (disorder),838553014,Preferred,718
94580002,Secondary malignant neoplasm of small intestine,156781013,Preferred,718
94580002,Cancer metastatic to small intestine,3036373012,Acceptable,718
94580002,Metastasis to small intestine,1235863011,Acceptable,718
94580002,Metastatic malignant neoplasm to small intestine,156784017,Acceptable,718
432327003,History of malignant neoplasm of spinal cord (situation),2746086019,Preferred,719
432327003,History of malignant neoplasm of spinal cord,2766264016,Preferred,719
432327003,History of cancer of the spinal cord,3035895011,Acceptable,719
276481000000103,Urgent cancer referral - haematology,473721000000115,Preferred,720
276481000000103,Urgent cancer referral - haematology,473731000000118,Preferred,720
276471000000100,Urgent cancer referral - haematology,473701000000112,Preferred,721
276471000000100,Urgent cancer referral - haematology,473711000000114,Preferred,721
171157009,Cancer cervix screening - not reached (finding),3043307016,Preferred,722
171157009,Cancer cervix screening - not reached,3043112012,Preferred,722
171157009,Ca cervix screening - not reached,265204014,Acceptable,722
171152003,Screening for malignant neoplasm of cervix not wanted (situation),3285581017,Preferred,723
171152003,Screening for malignant neoplasm of cervix not wanted,3285604019,Preferred,723
171152003,Cancer of cervix screening not wanted,3285597010,Acceptable,723
171150006,Cancer cervix screening - not offered (finding),3043222011,Preferred,724
171150006,Cancer cervix screening - not offered,3043147016,Preferred,724
171150006,Ca cervix screening - not offered,265195014,Acceptable,724
857411000000104,Education about risk of breast cancer,2215651000000114,Preferred,725
857411000000104,Education about risk of breast cancer,2218261000000119,Preferred,725
1104671000000104,Cervical cancer screening not offered (situation),2765171000000116,Preferred,726
1104671000000104,Cervical cancer screening not offered,2765161000000111,Preferred,726
171162005,Cancer cervix screening and fee claim (finding),3043249011,Preferred,727
171162005,Cancer cervix screening and fee claim,3043252015,Preferred,727
171162005,Ca cervix screening and fee claim,265211013,Acceptable,727
403893006,Squamous cell carcinoma of forehead (disorder),1771819010,Preferred,728
403893006,Squamous cell carcinoma of forehead,1782897019,Preferred,728
403893006,"Cancer of the forehead, squamous cell",3035957017,Acceptable,728
423284006,Squamous cell carcinoma of skin of neck (disorder),2639552017,Preferred,729
423284006,Squamous cell carcinoma of skin of neck,2643548013,Preferred,729
423284006,"Cancer of skin of neck, squamous cell",3037307018,Acceptable,729
424549003,"Malignant tumor of spinal cord, extramedullary (disorder)",2639583018,Preferred,730
424549003,"Malignant tumour of spinal cord, extramedullary",2643580010,Preferred,730
424549003,"Cancer of spinal cord, extramedullary",3036088011,Acceptable,730
424549003,"Malignant tumor of spinal cord, extramedullary",2643581014,Acceptable,730
109827007,Carcinoma in situ of salivary gland duct (disorder),616154011,Preferred,731
109827007,Carcinoma in situ of salivary gland duct,174504017,Preferred,731
109827007,Cancer in situ of salivary gland duct,3036583010,Acceptable,731
109827007,Carcinoma in situ of salivary duct,174505016,Acceptable,731
94298004,Secondary malignant neoplasm of female genital organ (disorder),838211014,Preferred,732
94298004,Secondary malignant neoplasm of female genital organ,156069019,Preferred,732
94298004,Cancer metastatic to female genital organ,3036238013,Acceptable,732
94298004,Cancer metastatic to female genitalia,3036220010,Acceptable,732
94298004,Metastasis to female genital organ,1235827011,Acceptable,732
94298004,Metastatic malignant neoplasm to female genital organ,156072014,Acceptable,732
425225007,Malignant mixed tumor of salivary gland (disorder),2639824017,Preferred,733
425225007,Malignant mixed tumour of salivary gland,2643839014,Preferred,733
425225007,"Cancer of salivary gland, mixed tumor",3036032019,Acceptable,733
425225007,"Cancer of salivary gland, mixed tumour",3036204017,Acceptable,733
425225007,Malignant mixed tumor of salivary gland,2643840011,Acceptable,733
275266006,Metastasis to digestive organs (disorder),668115015,Preferred,734
275266006,Metastasis to digestive organs,411226018,Preferred,734
275266006,Cancer metastatic to digestive organs,3037621014,Acceptable,734
429251000,Family history of malignant neoplasm of brain (situation),2689705012,Preferred,735
429251000,Family history of malignant neoplasm of brain,2693977015,Preferred,735
429251000,Family history of cancer of the brain,3035699019,Acceptable,735
94348003,Secondary malignant neoplasm of intra-abdominal organs (disorder),838272010,Preferred,736
94348003,Secondary malignant neoplasm of intra-abdominal organs,156203014,Preferred,736
94348003,Cancer metastatic to abdominal organs,3035964015,Acceptable,736
94348003,Cancer metastatic to intra-abdominal organs,3083555016,Acceptable,736
94348003,Metastatic malignant neoplasm to intra-abdominal organs,156206018,Acceptable,736
838351000000107,Education about risk of breast cancer (procedure),2175971000000119,Preferred,737
838351000000107,Education about risk of breast cancer,2175981000000117,Preferred,737
428037003,Family history of malignant neoplasm of ileum (situation),2691561017,Preferred,738
428037003,Family history of malignant neoplasm of ileum,2695900019,Preferred,738
428037003,Family history of cancer of the ileum,3035686017,Acceptable,738
395580008,Cancer information offered to patient (procedure),2761403012,Preferred,739
395580008,Cancer information offered to patient,1489237018,Preferred,739
294261000000108,Did not attend bowel cancer screening (finding),517331000000113,Preferred,740
294261000000108,Did not attend bowel cancer screening,517341000000116,Preferred,740
294271000000101,Did not attend bowel cancer screening,517351000000118,Preferred,741
294271000000101,Did not attend bowel cancer screening,517361000000115,Preferred,741
1098951000119108,History of cancer metastatic to liver (situation),3037953019,Preferred,742
1098951000119108,History of cancer metastatic to liver,3037961012,Preferred,742
1098971000119104,History of cancer metastatic to brain (situation),3038052012,Preferred,743
1098971000119104,History of cancer metastatic to brain,3038158013,Preferred,743
255124004,Metastasis to peripheral nerve (disorder),646115018,Preferred,744
255124004,Metastasis to peripheral nerve,380203014,Preferred,744
255124004,Cancer metastatic to peripheral nerve,3037348015,Acceptable,744
94397007,Secondary malignant neoplasm of lymph nodes of neck (disorder),838331011,Preferred,745
94397007,Secondary malignant neoplasm of lymph nodes of neck,156341016,Preferred,745
94397007,Cancer metastatic to neck lymph nodes,3036233016,Acceptable,745
94397007,Metastasis to cervical lymph nodes,2900906011,Acceptable,745
94397007,Metastatic malignant neoplasm to lymph nodes of neck,156344012,Acceptable,745
294281000000104,Did not attend bowel cancer screening,517371000000110,Preferred,746
294281000000104,Did not attend bowel cancer screening,517381000000112,Preferred,746
395627002,Cancer information offered to patient (situation),2745280010,Preferred,747
395627002,Cancer information offered to patient,1489284018,Preferred,747
268542002,Cancer cervix screening - not attended (finding),3043094010,Preferred,748
268542002,Cancer cervix screening - not attended,3043176018,Preferred,748
268542002,Ca cervix screening - not attended,401559013,Acceptable,748
25481000000102,Patient declined anti-cancer treatment (finding),65121000000118,Preferred,749
25481000000102,Patient declined anti-cancer treatment,63171000000118,Preferred,749
251611000000101,Cancer monitoring telephone invitation,413421000000117,Preferred,750
251611000000101,Cancer monitoring telephone invitation,413431000000115,Preferred,750
916741000000106,Cancer hormonal treatment drugs Band 1,2356191000000119,Preferred,751
916741000000106,Cancer hormonal treatment drugs Band 1,2353541000000111,Preferred,751
248331000000109,Cancer monitoring telephone invitation (procedure),406691000000112,Preferred,752
248331000000109,Cancer monitoring telephone invitation,406701000000112,Preferred,752
274591000000105,Cancer monitoring telephone invitation,464521000000115,Preferred,753
274591000000105,Cancer monitoring telephone invitation,464531000000118,Preferred,753
109912006,Overlapping malignant neoplasm of brain (disorder),617054016,Preferred,754
109912006,Overlapping malignant neoplasm of brain,174605010,Preferred,754
109912006,"Cancer of the brain, overlapping sites",3036184011,Acceptable,754
428276009,Family history of malignant neoplasm of vagina (situation),2690384017,Preferred,755
428276009,Family history of malignant neoplasm of vagina,2693318010,Preferred,755
428276009,Family history of cancer of the vagina,3035692011,Acceptable,755
94246001,Secondary malignant neoplasm of cerebral meninges (disorder),838149015,Preferred,756
94246001,Secondary malignant neoplasm of cerebral meninges,155931018,Preferred,756
94246001,Cancer metastatic to cerebral meninges,3035737012,Acceptable,756
94246001,Metastatic malignant neoplasm to cerebral meninges,155932013,Acceptable,756
966321000000101,Active Surveillance of Prostate Cancer,2460991000000116,Preferred,757
966321000000101,Active Surveillance of Prostate Cancer,2461001000000117,Preferred,757
109853004,Malignant mesothelioma of peritoneum (disorder),616424010,Preferred,758
109853004,Mesothelioma of peritoneum,174532014,Preferred,758
109853004,"Cancer of the peritoneum, mesothelioma",3035968017,Acceptable,758
109853004,Malignant mesothelioma of peritoneum,2765130015,Acceptable,758
109838007,Overlapping malignant neoplasm of colon (disorder),616270018,Preferred,759
109838007,Overlapping malignant neoplasm of colon,174516011,Preferred,759
109838007,"Cancer of the colon, overlapping sites",3036249019,Acceptable,759
966311000000107,Active surveillance of prostate cancer (regime/therapy),2460971000000115,Preferred,760
966311000000107,Active surveillance of prostate cancer,2460981000000118,Preferred,760
848741000000107,QCancer ovarian cancer risk calculator (assessment scale),2199891000000117,Preferred,761
848741000000107,QCancer ovarian cancer risk calculator,2199901000000116,Preferred,761
94336001,Secondary malignant neoplasm of iliac lymph nodes (disorder),838258018,Preferred,762
94336001,Secondary malignant neoplasm of iliac lymph nodes,156171017,Preferred,762
94336001,Cancer metastatic to iliac lymph nodes,3036414012,Acceptable,762
94336001,Metastatic malignant neoplasm to iliac lymph nodes,156172012,Acceptable,762
848871000000106,QCancer gastro-oesophageal cancer risk (observable entity),2257851000000110,Preferred,763
848871000000106,QCancer gastro-oesophageal cancer risk,2257841000000112,Preferred,763
712837004,Active surveillance of prostate cancer (regime/therapy),3285847017,Preferred,764
712837004,Active surveillance of prostate cancer,3285961014,Preferred,764
897671000000103,Cancer hormonal treatment drugs Band 1 (procedure),2309341000000114,Preferred,765
897671000000103,Cancer hormonal treatment drugs Band 1,2309351000000112,Preferred,765
94515004,Secondary malignant neoplasm of respiratory tract (disorder),838475014,Preferred,766
94515004,Secondary malignant neoplasm of respiratory tract,156631011,Preferred,766
94515004,Cancer metastatic to respiratory tract,3036381013,Acceptable,766
94515004,Metastatic malignant neoplasm to respiratory tract,156634015,Acceptable,766
373812008,Patient declined anti-cancer treatment (finding),1199112015,Preferred,767
373812008,Patient declined anti-cancer treatment,1212262014,Preferred,767
139855005,Suspected lower gastrointestinal cancer (situation),2717142012,Preferred,768
139855005,Suspected lower gastrointestinal cancer,221664013,Preferred,768
294411000000105,Patient given advice about bowel cancer (situation),517651000000111,Preferred,769
294411000000105,Patient given advice about bowel cancer,517661000000114,Preferred,769
139854009,Suspected upper gastrointestinal cancer (situation),2762193012,Preferred,770
139854009,Suspected upper gastrointestinal cancer,221663019,Preferred,770
294421000000104,Patient given advice about bowel cancer,517671000000119,Preferred,771
294421000000104,Patient given advice about bowel cancer,517681000000117,Preferred,771
395672005,Cancer diagnosis discussed with patient (situation),2869017014,Preferred,772
395672005,Cancer diagnosis discussed with patient,1489329011,Preferred,772
10987871000119109,History of malignant neoplasm of rectosigmoid junction (situation),3039530018,Preferred,773
10987871000119109,History of rectosigmoid junction cancer,3040270018,Preferred,773
10987871000119109,History of malignant neoplasm of rectosigmoid junction,3040048013,Acceptable,773
699346009,Hereditary cancer-predisposing syndrome (disorder),2988939011,Preferred,774
699346009,Hereditary cancer-predisposing syndrome,2988878014,Preferred,774
699346009,Hereditary neoplastic syndrome,2983926014,Acceptable,774
315274008,Suspected lower gastrointestinal cancer (situation),2611955015,Preferred,775
315274008,Suspected lower gastrointestinal cancer,459774019,Preferred,775
395673000,Cancer care plan discussed with patient (situation),2869696017,Preferred,776
395673000,Cancer care plan discussed with patient,1489330018,Preferred,776
395673000,Ca care plan discussed with pt,1494680018,Acceptable,776
700064004,Familial nonpolyposis colorectal cancer (disorder),2988824014,Preferred,777
700064004,Familial nonpolyposis colorectal cancer,2988833011,Preferred,777
315273002,Suspected upper gastrointestinal cancer (situation),2611954016,Preferred,778
315273002,Suspected upper gastrointestinal cancer,459773013,Preferred,778
294431000000102,Patient given advice about bowel cancer,517691000000115,Preferred,779
294431000000102,Patient given advice about bowel cancer,517701000000115,Preferred,779
395635004,Cancer diagnosis discussed with patient (situation),2761470014,Preferred,780
395635004,Cancer diagnosis discussed with patient,1489292010,Preferred,780
395594009,Cancer care plan discussed with patient (procedure),2745105013,Preferred,781
395594009,Cancer care plan discussed with patient,1489251018,Preferred,781
109831001,Overlapping malignant neoplasm of palate (disorder),616195014,Preferred,782
109831001,Overlapping malignant neoplasm of palate,174509010,Preferred,782
109831001,"Cancer of the palate, overlapping sites",3036515011,Acceptable,782
709285002,Secondary malignant neoplasm of lumbosacral plexus (disorder),3039368017,Preferred,783
709285002,Secondary malignant neoplasm of lumbosacral plexus,3039373011,Preferred,783
709285002,Cancer metastatic to lumbosacral plexus,3039415012,Acceptable,783
709285002,Metastatic malignant neoplasm to lumbosacral plexus,3039383010,Acceptable,783
109824000,Overlapping malignant neoplasm of major salivary gland (disorder),616122019,Preferred,784
109824000,Overlapping malignant neoplasm of major salivary gland,174501013,Preferred,784
109824000,Cancer major salivary glands contiguous,3036482019,Acceptable,784
109824000,"Malignant neoplasm, overlapping lesion of major salivary glands",1219532018,Acceptable,784
395590000,Cancer diagnosis discussed with patient (procedure),2745104012,Preferred,785
395590000,Cancer diagnosis discussed with patient,1489247015,Preferred,785
423793008,Mucoepidermoid carcinoma of parotid gland (disorder),2639819015,Preferred,786
423793008,Mucoepidermoid carcinoma of parotid gland,2643834016,Preferred,786
423793008,"Cancer of parotid gland, mucoepidermoid",3037235016,Acceptable,786
106242004,Walter Reed staging of prostatic cancer (tumor staging),579246019,Preferred,787
106242004,Walter Reed staging of prostatic cancer,170672016,Preferred,787
94636007,Secondary malignant neoplasm of tibial lymph nodes (disorder),838621014,Preferred,788
94636007,Secondary malignant neoplasm of tibial lymph nodes,156915018,Preferred,788
94636007,Cancer metastatic to tibial lymph nodes,3036193012,Acceptable,788
94636007,Metastatic malignant neoplasm to tibial lymph nodes,156916017,Acceptable,788
909121000000107,Measurement of cancer antigen 125 in serum specimen (procedure),2336851000000119,Preferred,789
909121000000107,Serum CA 125 (cancer antigen 125) measurement,2336861000000116,Preferred,789
909121000000107,Serum CA 125 (cancer antigen 125) level,2336891000000110,Acceptable,789
1053701000000101,Signposting to Macmillan Cancer Support (procedure),2652101000000115,Preferred,790
1053701000000101,Signposting to Macmillan Cancer Support,2652091000000111,Preferred,790
162586002,Suspected upper gastrointestinal cancer (situation),2735463011,Preferred,791
162586002,Suspected upper gastrointestinal cancer,253482011,Preferred,791
395639005,Cancer care plan discussed with patient (procedure),2747132019,Preferred,792
395639005,Cancer care plan discussed with patient,1489296013,Preferred,792
440388004,Knowledge level about cancer management (observable entity),2788461013,Preferred,793
440388004,Knowledge level about cancer management,2791668016,Preferred,793
162587006,Suspected lower gastrointestinal cancer (situation),2748432011,Preferred,794
162587006,Suspected lower gastrointestinal cancer,253483018,Preferred,794
431572009,History of malignant neoplasm of endocrine gland (situation),2746250010,Preferred,795
431572009,History of malignant neoplasm of endocrine gland,2772170019,Preferred,795
431572009,History of cancer of an endocrine gland,3035803013,Acceptable,795
431691000,History of malignant neoplasm of nervous system (situation),2746179012,Preferred,796
431691000,History of malignant neoplasm of nervous system,2766358013,Preferred,796
431691000,History of cancer of the nervous system,3035908015,Acceptable,796
1000461000000109,Serum cancer antigen 125 level (observable entity),2529921000000113,Preferred,797
1000461000000109,Serum CA 125 (cancer antigen 125) level,2607171000000117,Preferred,797
1000461000000109,Serum CA 125 level,2560241000000112,Acceptable,797
384171000000104,Bowel cancer screening programme finding (finding),758031000000116,Preferred,798
384171000000104,Bowel cancer screening programme finding,758021000000118,Preferred,798
424260006,Squamous cell carcinoma of nasolabial fold (disorder),2639549013,Preferred,799
424260006,Squamous cell carcinoma of nasolabial fold,2643545011,Preferred,799
424260006,"Cancer of nasolabial fold, squamous cell",3036053011,Acceptable,799
426964009,"Non-small cell lung cancer, positive for epidermal growth factor receptor expression (disorder)",2662916015,Preferred,800
426964009,Epidermal growth factor receptor positive non-small cell lung cancer,3006049013,Preferred,800
426964009,EGF-R positive non-small cell lung cancer,2674755012,Acceptable,800
426964009,EGFR positive non-small cell lung cancer,2674756013,Acceptable,800
426964009,"Non-small cell lung cancer, positive for epidermal growth factor receptor expression",2674754011,Acceptable,800
94394000,Secondary malignant neoplasm of lymph nodes of head (disorder),838328010,Preferred,801
94394000,Secondary malignant neoplasm of lymph nodes of head,156331019,Preferred,801
94394000,Cancer metastatic to lymph nodes of head,3036327010,Acceptable,801
94394000,Metastatic malignant neoplasm to lymph nodes of head,156334010,Acceptable,801
427038005,"Non-small cell lung cancer, negative for epidermal growth factor receptor expression (disorder)",2662585016,Preferred,802
427038005,Epidermal growth factor receptor negative non-small cell lung cancer,3005998011,Preferred,802
427038005,EGF-R negative non-small cell lung cancer,2674436011,Acceptable,802
427038005,EGFR negative non-small cell lung cancer,2674435010,Acceptable,802
427038005,"Non-small cell lung cancer, negative for epidermal growth factor receptor expression",2674433015,Acceptable,802
609102007,Educated about screening for malignant neoplasm of prostate (situation),2958534016,Preferred,803
609102007,Educated about screening for malignant neoplasm of prostate,2959059011,Preferred,803
609102007,Educated about prostate cancer screening,2958453012,Acceptable,803
842911000000105,Multidisciplinary cancer case management (procedure),2186381000000116,Preferred,804
842911000000105,Multidisciplinary cancer case management,2186371000000118,Preferred,804
109836006,Overlapping malignant neoplasm of stomach (disorder),616250012,Preferred,805
109836006,Overlapping malignant neoplasm of stomach,174514014,Preferred,805
109836006,"Cancer of the stomach, overlapping sites",3036074012,Acceptable,805
109836006,"Malignant neoplasm, overlapping lesion of stomach",1219534017,Acceptable,805
402522006,Basal cell carcinoma of lower extremity (disorder),1770446018,Preferred,806
402522006,Basal cell carcinoma of lower extremity,1781648010,Preferred,806
402522006,"Cancer of skin of lower limb, basal cell",3038042013,Acceptable,806
94393006,Secondary malignant neoplasm of lymph nodes of face (disorder),838327017,Preferred,807
94393006,Secondary malignant neoplasm of lymph nodes of face,156327013,Preferred,807
94393006,Cancer metastatic to lymph nodes of face,3035931015,Acceptable,807
94393006,Metastatic malignant neoplasm to lymph nodes of face,156330018,Acceptable,807
73771000119104,History of cancer of ampulla of duodenum (situation),3037999017,Preferred,808
73771000119104,History of cancer of ampulla of duodenum,3038166016,Preferred,808
402521004,Basal cell carcinoma of upper extremity (disorder),1770445019,Preferred,809
402521004,Basal cell carcinoma of upper extremity,1781647017,Preferred,809
402521004,Basal cell carcinoma of arm,1787586015,Acceptable,809
402521004,"Cancer of skin of upper limb, basal cell",3037922016,Acceptable,809
92600008,Carcinoma in situ of gastrointestinal tract (disorder),836157012,Preferred,810
92600008,Carcinoma in situ of gastrointestinal tract,153176019,Preferred,810
92600008,Cancer in situ of gastrointestinal tract,3036558010,Acceptable,810
387983000,Cancer pagurus specific immunoglobulin E (substance),1462161013,Preferred,811
387983000,Crab specific immunoglobulin E,1482053013,Preferred,811
387983000,Cancer pagurus specific immunoglobulin E,2672500012,Acceptable,811
387983000,Crab specific IgE,1492441018,Acceptable,811
109848009,Overlapping malignant neoplasm of pancreas (disorder),616367015,Preferred,812
109848009,Overlapping malignant neoplasm of pancreas,174527013,Preferred,812
109848009,"Cancer of the pancreas, overlapping sites",3036579010,Acceptable,812
109848009,"Malignant neoplasm, overlapping lesion of pancreas",1219538019,Acceptable,812
73891000119108,History of cancer of unknown primary site (situation),3038034012,Preferred,813
73891000119108,History of cancer of unknown primary site,3037946011,Preferred,813
373815005,Patient died before anti-cancer treatment (finding),1199115018,Preferred,814
373815005,Patient died before anti-cancer treatment,1212265011,Preferred,814
94339008,Secondary malignant neoplasm of inguinal lymph nodes (disorder),838261017,Preferred,815
94339008,Secondary malignant neoplasm of inguinal lymph nodes,156177018,Preferred,815
94339008,Cancer metastatic to inguinal lymph nodes,3036147014,Acceptable,815
94339008,Metastatic malignant neoplasm to inguinal lymph nodes,156178011,Acceptable,815
90671000119109,Carrier of high risk cancer mutation gene (finding),3433007011,Preferred,816
90671000119109,Carrier of high risk cancer mutation gene,3433008018,Preferred,816
848761000000108,QCancer pancreatic cancer risk calculator (assessment scale),2199931000000110,Preferred,817
848761000000108,QCancer pancreatic cancer risk calculator,2199941000000118,Preferred,817
848691000000109,QCancer lung cancer risk assessment score,2199791000000113,Preferred,818
848691000000109,QCancer lung cancer risk assessment score,2199801000000112,Preferred,818
848661000000103,QCancer colorectal cancer risk calculator (assessment scale),2199731000000112,Preferred,819
848661000000103,QCancer colorectal cancer risk calculator,2199741000000115,Preferred,819
722843001,Fear of having cancer of digestive system (finding),3333743014,Preferred,820
722843001,Fear of having cancer of digestive system,3333744015,Preferred,820
1000451000000106,Serum cancer antigen 19-9 level (observable entity),2529911000000119,Preferred,821
1000451000000106,Serum CA 19-9 (cancer antigen 19-9) level,2607191000000118,Preferred,821
1000451000000106,Serum CA 19-9 level,2560841000000113,Acceptable,821
1000451000000106,Serum carbohydrate antigen 19-9 level,2642641000000114,Acceptable,821
25041000000102,Patient died before anti-cancer treatment (finding),64101000000111,Preferred,822
25041000000102,Patient died before anti-cancer treatment,62571000000116,Preferred,822
909281000000102,Measurement of cancer antigen 15-3 in serum specimen (procedure),2337251000000118,Preferred,823
909281000000102,Serum CA 15-3 (cancer antigen 15-3) measurement,2337261000000115,Preferred,823
909281000000102,Serum CA 15-3 (cancer antigen 15-3) level,2337291000000114,Acceptable,823
909301000000101,Measurement of cancer antigen 19-9 in serum specimen (procedure),2337301000000113,Preferred,824
909301000000101,Serum CA 19-9 (cancer antigen 19-9) measurement,2337311000000110,Preferred,824
909301000000101,Serum CA 19-9 (cancer antigen 19-9) level,2337341000000111,Acceptable,824
16227531000119109,Cancer antigen 19-9 above reference range (finding),3433087014,Preferred,825
16227531000119109,Cancer antigen 19-9 above reference range,3433088016,Preferred,825
430331003,Family history of cancer of the esophagus (situation),2708643011,Preferred,826
430331003,Family history of cancer of the oesophagus,2765718017,Preferred,826
430331003,Family history of cancer of the esophagus,2771675011,Acceptable,826
1000441000000108,Serum cancer antigen 15-3 level (observable entity),2529901000000116,Preferred,827
1000441000000108,Serum CA 15-3 (cancer antigen 15-3) level,2607181000000115,Preferred,827
1000441000000108,Serum CA 15-3 level,2584311000000114,Acceptable,827
382761000000101,Seen in fast track suspected cancer clinic (finding),754431000000116,Preferred,828
382761000000101,Seen in fast track suspected cancer clinic,754441000000113,Preferred,828
382771000000108,Seen in fast track suspected cancer clinic,754451000000111,Preferred,829
382771000000108,Seen in fast track suspected cancer clinic,754461000000114,Preferred,829
403898002,Squamous cell carcinoma of skin of lower extremity (disorder),1771824013,Preferred,830
403898002,Squamous cell carcinoma of skin of lower extremity,1782902018,Preferred,830
403898002,Squamous cell cancer of skin of lower limb,3083697015,Acceptable,830
382781000000105,Seen in fast track suspected cancer clinic,754471000000119,Preferred,831
382781000000105,Seen in fast track suspected cancer clinic,754481000000117,Preferred,831
385377005,Gleason grade finding for prostatic cancer (finding),1459556017,Preferred,832
385377005,Gleason grade finding for prostatic cancer,1479600014,Preferred,832
848731000000103,QCancer renal cancer risk assessment score,2199871000000116,Preferred,833
848731000000103,QCancer renal cancer risk assessment score,2199881000000119,Preferred,833
430954001,Family history of malignant neoplasm of genital structure (situation),2750260017,Preferred,834
430954001,Family history of malignant neoplasm of genital structure,2764440017,Preferred,834
430954001,Family history of cancer of genital system,3038055014,Acceptable,834
94509004,Secondary malignant neoplasm of rectosigmoid junction (disorder),838467015,Preferred,835
94509004,Secondary malignant neoplasm of rectosigmoid junction,156619014,Preferred,835
94509004,Cancer metastatic to rectosigmoid junction,3036192019,Acceptable,835
94509004,Metastatic malignant neoplasm to rectosigmoid junction,156620015,Acceptable,835
94494004,Secondary malignant neoplasm of popliteal lymph nodes (disorder),838449010,Preferred,836
94494004,Secondary malignant neoplasm of popliteal lymph nodes,156589012,Preferred,836
94494004,Cancer metastatic to popliteal lymph nodes,3036436010,Acceptable,836
94494004,Metastatic malignant neoplasm to popliteal lymph nodes,156590015,Acceptable,836
94446003,Secondary malignant neoplasm of obturator lymph nodes (disorder),838391013,Preferred,837
94446003,Secondary malignant neoplasm of obturator lymph nodes,156473011,Preferred,837
94446003,Cancer metastatic to obturator lymph nodes,3036988013,Acceptable,837
94446003,Metastatic malignant neoplasm to obturator lymph nodes,156474017,Acceptable,837
430542006,Family history of malignant neoplasm of urinary bladder (situation),2759038018,Preferred,838
430542006,Family history of malignant neoplasm of urinary bladder,2774216011,Preferred,838
430542006,Family history of cancer of urinary bladder,3038078015,Acceptable,838
405827002,Breast cancer type 1 susceptibility protein (substance),2149657014,Preferred,839
405827002,Breast cancer type 1 susceptibility protein,2157601016,Preferred,839
405827002,BRCA1 gene product,2163158015,Acceptable,839
1098931000119102,History of cancer metastatic to lymph nodes (situation),3038027010,Preferred,840
1098931000119102,History of cancer metastatic to lymph nodes,3038029013,Preferred,840
286921000000103,Patient on bowel cancer screening programme,495761000000116,Preferred,841
286921000000103,Patient on bowel cancer screening programme,495771000000111,Preferred,841
286911000000109,Patient on bowel cancer screening programme,495741000000117,Preferred,842
286911000000109,Patient on bowel cancer screening programme,495751000000119,Preferred,842
405828007,Breast cancer type 2 susceptibility protein (substance),2149658016,Preferred,843
405828007,Breast cancer type 2 susceptibility protein,2157602011,Preferred,843
405828007,BRCA2 gene product,2163159011,Acceptable,843
94330007,Secondary malignant neoplasm of hypogastric lymph nodes (disorder),838251012,Preferred,844
94330007,Secondary malignant neoplasm of hypogastric lymph nodes,156157013,Preferred,844
94330007,Cancer metastatic to hypogastric lymph node,3036214014,Acceptable,844
94330007,Metastatic malignant neoplasm to hypogastric lymph nodes,156158015,Acceptable,844
25451000000108,Cancer diagnosis based on clinical evidence (finding),64421000000112,Preferred,845
25451000000108,Cancer diagnosis based on clinical evidence,63141000000112,Preferred,845
25491000000100,No anti-cancer treatment - watchful waiting (finding),64451000000119,Preferred,846
25491000000100,No anti-cancer treatment - watchful waiting,63181000000116,Preferred,846
94591009,Secondary malignant neoplasm of soft tissues of pelvis (disorder),838567017,Preferred,847
94591009,Secondary malignant neoplasm of soft tissues of pelvis,156805011,Preferred,847
94591009,Cancer metastatic to soft tissues of pelvis,3036444010,Acceptable,847
94591009,Metastatic malignant neoplasm to soft tissues of pelvis,156806012,Acceptable,847
373818007,No anti-cancer treatment - watchful waiting (finding),1199118016,Preferred,848
373818007,No anti-cancer treatment - watchful waiting,1212268013,Preferred,848
373794000,Cancer diagnosis based on death certificate (finding),1199094017,Preferred,849
373794000,Cancer diagnosis based on death certificate,1212245016,Preferred,849
94345000,Secondary malignant neoplasm of intestinal lymph nodes (disorder),838269015,Preferred,850
94345000,Secondary malignant neoplasm of intestinal lymph nodes,156193010,Preferred,850
94345000,Cancer metastatic to intestinal lymph nodes,3036601019,Acceptable,850
94345000,Metastatic malignant neoplasm to intestinal lymph nodes,156194016,Acceptable,850
422378004,Squamous cell carcinoma of bridge of nose (disorder),2639546018,Preferred,851
422378004,Squamous cell carcinoma of bridge of nose,2643542014,Preferred,851
422378004,"Cancer of the bridge of nose, squamous cell",3036539018,Acceptable,851
94410007,Secondary malignant neoplasm of mesenteric lymph nodes (disorder),838348015,Preferred,852
94410007,Secondary malignant neoplasm of mesenteric lymph nodes,156379014,Preferred,852
94410007,Cancer metastatic to mesenteric lymph nodes,3036335013,Acceptable,852
94410007,Metastatic malignant neoplasm to mesenteric lymph nodes,156380012,Acceptable,852
94466007,Secondary malignant neoplasm of pararectal lymph nodes (disorder),838415019,Preferred,853
94466007,Secondary malignant neoplasm of pararectal lymph nodes,156523011,Preferred,853
94466007,Cancer metastatic to pararectal lymph nodes,3036590017,Acceptable,853
94466007,Metastatic malignant neoplasm to pararectal lymph nodes,156524017,Acceptable,853
24981000000105,Cancer diagnosis based on death certificate (finding),64051000000111,Preferred,854
24981000000105,Cancer diagnosis based on death certificate,62511000000114,Preferred,854
373795004,Cancer diagnosis based on clinical evidence (finding),1199095016,Preferred,855
373795004,Cancer diagnosis based on clinical evidence,1212246015,Preferred,855
762401000000105,Cancer multidisciplinary team meeting report,1688921000000115,Preferred,856
762401000000105,Cancer multidisciplinary team meeting report,1688931000000118,Preferred,856
94344001,Secondary malignant neoplasm of intercostal lymph nodes (disorder),838268011,Preferred,857
94344001,Secondary malignant neoplasm of intercostal lymph nodes,156191012,Preferred,857
94344001,Cancer metastatic to intercostal lymph nodes,3035927014,Acceptable,857
94344001,Metastatic malignant neoplasm to intercostal lymph nodes,156192017,Acceptable,857
848751000000105,QCancer ovarian cancer risk assessment score,2199911000000119,Preferred,858
848751000000105,QCancer ovarian cancer risk assessment score,2199921000000113,Preferred,858
752371000000103,Advice given about prostate cancer screening,1655271000000111,Preferred,859
752371000000103,Advice given about prostate cancer screening,1655281000000113,Preferred,859
698470001,Patient advised about prostate cancer screening (situation),2974535010,Preferred,860
698470001,Patient advised about prostate cancer screening,2974472018,Preferred,860
698470001,Advice given about prostate cancer screening,2974456014,Acceptable,860
752361000000105,Advice given about prostate cancer screening (situation),1655251000000119,Preferred,861
752361000000105,Advice given about prostate cancer screening,1655261000000116,Preferred,861
94350006,Secondary malignant neoplasm of intrapelvic lymph nodes (disorder),838275012,Preferred,862
94350006,Secondary malignant neoplasm of intrapelvic lymph nodes,156209013,Preferred,862
94350006,Cancer metastatic to intrapelvic lymph nodes,3035941017,Acceptable,862
94350006,Metastatic malignant neoplasm to intrapelvic lymph nodes,156212011,Acceptable,862
373811001,Reason for no specific anti-cancer treatment (finding),1199111010,Preferred,863
373811001,Reason for no specific anti-cancer treatment,1212261019,Preferred,863
980001000000106,Discharge from secondary care cancer service,2492171000000119,Preferred,864
980001000000106,Discharge from secondary care cancer service,2492181000000117,Preferred,864
979991000000103,Discharge from secondary care cancer service (finding),2492151000000111,Preferred,865
979991000000103,Discharge from secondary care cancer service,2492161000000114,Preferred,865
280531000000105,Fast track referral for head and neck cancer,482201000000116,Preferred,866
280531000000105,Fast track referral for head and neck cancer,482211000000119,Preferred,866
25441000000105,Reason for no specific anti-cancer treatment (finding),64411000000118,Preferred,867
25441000000105,Reason for no specific anti-cancer treatment,63131000000115,Preferred,867
280541000000101,Fast track referral for head and neck cancer,482221000000113,Preferred,868
280541000000101,Fast track referral for head and neck cancer,482231000000110,Preferred,868
429226001,History of non-small cell malignant neoplasm of lung (situation),2690734014,Preferred,869
429226001,History of non-small cell malignant neoplasm of lung,2694818010,Preferred,869
429226001,History of non-small cell cancer of the lung,3035246017,Acceptable,869
276491000000101,Fast track referral for suspected lung cancer (procedure),473741000000110,Preferred,870
276491000000101,Fast track referral for suspected lung cancer,473751000000113,Preferred,870
449034009,Malignant neoplasm of anterior and lateral floor of mouth (disorder),2898029019,Preferred,871
449034009,Malignant neoplasm of anterior and lateral floor of mouth,2902175016,Preferred,871
449034009,Cancer of anterior and lateral floor of mouth,2902174017,Acceptable,871
276281000000104,Fast track referral for suspected skin cancer (procedure),473321000000116,Preferred,872
276281000000104,Fast track referral for suspected skin cancer,473331000000119,Preferred,872
423189008,Adenoid cystic carcinoma of submandibular gland (disorder),2639820014,Preferred,873
423189008,Adenoid cystic carcinoma of submandibular gland,2643835015,Preferred,873
423189008,"Cancer of submandibular gland, adenoid cystic",3037301017,Acceptable,873
1090561000000106,Mental Adjustment to Cancer Scale score (observable entity),2732001000000112,Preferred,874
1090561000000106,MAC (Mental Adjustment to Cancer) Scale score,2731991000000114,Preferred,874
988781000000100,Provision of written information about cancer (procedure),2513261000000115,Preferred,875
988781000000100,Provision of written information about cancer,2513271000000110,Preferred,875
722089009,Obstructive nephropathy due to bladder cancer (disorder),3330637015,Preferred,876
722089009,Obstructive nephropathy due to bladder cancer,3330638013,Preferred,876
988791000000103,Provision of written information about cancer,2513281000000112,Preferred,877
988791000000103,Provision of written information about cancer,2513291000000114,Preferred,877
718220008,Hereditary breast and ovarian cancer syndrome (disorder),3310356010,Preferred,878
718220008,Hereditary breast and ovarian cancer syndrome,3311566010,Preferred,878
423424005,Mucoepidermoid carcinoma of submandibular gland (disorder),2639821013,Preferred,879
423424005,Mucoepidermoid carcinoma of submandibular gland,2643836019,Preferred,879
423424005,"Cancer of submandibular gland, mucoepidermoid",3037671012,Acceptable,879
175601000000101,Date cancer diagnosis received in primary care,250101000000116,Preferred,880
175601000000101,Date cancer diagnosis received in primary care,234641000000115,Preferred,880
383351000000108,Application for Macmillan cancer support grant (procedure),756191000000117,Preferred,881
383351000000108,Application for Macmillan cancer support grant,756201000000115,Preferred,881
25001000000100,Cancer diagnosis based on cytological evidence (finding),64071000000119,Preferred,882
25001000000100,Cancer diagnosis based on cytological evidence,62531000000118,Preferred,882
103071000000107,Exception reporting: cancer quality indicators,178501000000110,Preferred,883
103071000000107,Exception reporting: cancer quality indicators,150401000000110,Preferred,883
170941000000100,Date cancer diagnosis received in primary care,242311000000115,Preferred,884
170941000000100,Date cancer diagnosis received in primary care,230441000000111,Preferred,884
94351005,Secondary malignant neoplasm of intrathoracic lymph nodes (disorder),838277016,Preferred,885
94351005,Secondary malignant neoplasm of intrathoracic lymph nodes,156213018,Preferred,885
94351005,Cancer metastatic to intrathoracic lymph nodes,3036295014,Acceptable,885
94351005,Metastatic malignant neoplasm to intrathoracic lymph nodes,156216014,Acceptable,885
52166007,Pleurodesis with cancer chemotherapy substance (procedure),790145010,Preferred,886
52166007,Pleurodesis with cancer chemotherapy substance,86822015,Preferred,886
94398002,Secondary malignant neoplasm of lymph nodes of upper limb (disorder),838332016,Preferred,887
94398002,Secondary malignant neoplasm of lymph nodes of upper limb,156345013,Preferred,887
94398002,Cancer metastatic to lymph nodes of upper limb,3036058019,Acceptable,887
94398002,Metastasis to upper limb lymph node,511282013,Acceptable,887
94398002,Metastatic malignant neoplasm to lymph nodes of upper limb,156348010,Acceptable,887
722081007,Obstructive nephropathy due to carcinoma of prostate (disorder),3330513011,Preferred,888
722081007,Obstructive nephropathy due to prostate cancer,3330499014,Preferred,888
722081007,Obstructive nephropathy due to carcinoma of prostate,3330514017,Acceptable,888
98161000000101,Exception reporting: cancer quality indicators,174871000000110,Preferred,889
98161000000101,Exception reporting: cancer quality indicators,146251000000111,Preferred,889
94395004,Secondary malignant neoplasm of lymph nodes of lower limb (disorder),838329019,Preferred,890
94395004,Secondary malignant neoplasm of lymph nodes of lower limb,156335011,Preferred,890
94395004,Cancer metastatic to lymph nodes of lower limb,3036223012,Acceptable,890
94395004,Metastasis to lower limb lymph node,1235841019,Acceptable,890
94395004,Metastatic malignant neoplasm to lymph nodes of lower limb,156338013,Acceptable,890
89881000000106,Exception reporting: cancer quality indicators (finding),1555001000000115,Preferred,891
89881000000106,Exception reporting: cancer quality indicators,158091000000113,Preferred,891
773345007,Oligodontia and cancer predisposition syndrome (disorder),3723248018,Preferred,892
773345007,Oligodontia and cancer predisposition syndrome,3723247011,Preferred,892
773345007,"A rare genetic odontologic disease with characteristics of the congenital absence of six or more permanent teeth (excluding the third molars) in association with an increased risk for malignancies, ranging from gastrointestinal polyposis to early-onset colorectal cancer and/or breast cancer. Ectodermal dysplasia (manifesting with sparse hair and/or eyebrows) may also be associated.",3723249014,Preferred,892
166851000000104,Date cancer diagnosis received in primary care (observable entity),469561000000110,Preferred,893
166851000000104,Date cancer diagnosis received in primary care,226911000000117,Preferred,893
428047000,Family history of malignant neoplasm of cervix uteri (situation),2691677012,Preferred,894
428047000,Family history of malignant neoplasm of cervix uteri,2694362010,Preferred,894
428047000,Family history of cancer of the uterine cervix,3035679013,Acceptable,894
428047000,Family history of malignant neoplasm of uterine cervix,2691891016,Acceptable,894
373798002,Cancer diagnosis based on cytological evidence (finding),1199098019,Preferred,895
373798002,Cancer diagnosis based on cytological evidence,1212248019,Preferred,895
293221000000102,Bowel cancer screening programme administration (administrative concept),514931000000116,Preferred,896
293221000000102,Bowel cancer screening programme administration,514941000000113,Preferred,896
399626004,No anti-cancer treatment due to unknown primary (finding),1767546017,Preferred,897
399626004,No anti-cancer treatment due to unknown primary,1778976015,Preferred,897
848671000000105,QCancer colorectal cancer risk assessment score,2199751000000117,Preferred,898
848671000000105,QCancer colorectal cancer risk assessment score,2199761000000119,Preferred,898
382681000000102,Seen in fast track suspected lung cancer clinic (finding),754271000000115,Preferred,899
382681000000102,Seen in fast track suspected lung cancer clinic,754281000000118,Preferred,899
382711000000103,Seen in fast track suspected skin cancer clinic (finding),754331000000111,Preferred,900
382711000000103,Seen in fast track suspected skin cancer clinic,754341000000119,Preferred,900
109830000,Overlapping malignant neoplasm of floor of mouth (disorder),616185019,Preferred,901
109830000,Overlapping malignant neoplasm of floor of mouth,174508019,Preferred,901
109830000,"Cancer of the floor of mouth, overlapping sites",3036141010,Acceptable,901
109830000,"Malignant neoplasm, overlapping lesion of floor of mouth",1219533011,Acceptable,901
491061000000104,Seen in fast track suspected skin cancer clinic,1055781000000114,Preferred,902
491061000000104,Seen in fast track suspected skin cancer clinic,1055791000000111,Preferred,902
491051000000102,Seen in fast track suspected lung cancer clinic,1055761000000117,Preferred,903
491051000000102,Seen in fast track suspected lung cancer clinic,1055771000000112,Preferred,903
487221000000106,Seen in fast track suspected skin cancer clinic,1047241000000115,Preferred,904
487221000000106,Seen in fast track suspected skin cancer clinic,1047251000000117,Preferred,904
71251000119103,Family history of nonleukemic lymphatic malignancy (situation),3513463018,Preferred,905
71251000119103,Family history of nonleukemic lymphatic malignancy,3513464012,Preferred,905
71251000119103,Family history of non-leukemic lymphatic cancer,3513465013,Acceptable,905
487211000000100,Seen in fast track suspected lung cancer clinic,1047221000000110,Preferred,906
487211000000100,Seen in fast track suspected lung cancer clinic,1047231000000112,Preferred,906
395684007,Cancer information offered to significant other (procedure),1469624019,Preferred,907
395684007,Cancer information offered to significant other,1489340015,Preferred,907
395684007,Ca info offered to sig other,1494685011,Acceptable,907
293241000000109,Bowel cancer screening programme administration,514971000000119,Preferred,908
293241000000109,Bowel cancer screening programme administration,514981000000117,Preferred,908
109948008,"Overlapping malignant neoplasm of eye and adnexa, primary (disorder)",617409012,Preferred,909
109948008,Overlapping malignant neoplasm of eye and adnexa (primary),202855010,Preferred,909
109948008,"Cancer of the eye and adnexa, overlapping sites",3036054017,Acceptable,909
109948008,"Malignant neoplasm, overlapping lesion of eye and adnexa",1217367011,Acceptable,909
109948008,"Overlapping malignant neoplasm of eye and adnexa, primary",2659761013,Acceptable,909
293231000000100,Bowel cancer screening programme administration,514951000000111,Preferred,910
293231000000100,Bowel cancer screening programme administration,514961000000114,Preferred,910
848771000000101,QCancer pancreatic cancer risk assessment score,2199951000000115,Preferred,911
848771000000101,QCancer pancreatic cancer risk assessment score,2199961000000117,Preferred,911
431330007,Family history of breast cancer 1 gene mutation (situation),2742521016,Preferred,912
431330007,Family history of breast cancer 1 gene mutation,2769872013,Preferred,912
431330007,Family history of BRCA1 gene mutation,3035702014,Acceptable,912
431330007,Family history of breast cancer 1 (BRCA1) gene mutation,2769871018,Acceptable,912
715101000000108,Bowel cancer screening programme administration (record artifact),1557181000000116,Preferred,913
715101000000108,Bowel cancer screening programme administration,1564371000000117,Preferred,913
431331006,Family history of breast cancer 2 gene mutation (situation),2742522011,Preferred,914
431331006,Family history of breast cancer 2 gene mutation,2774124013,Preferred,914
431331006,Family history of BRCA2 gene mutation,3035888019,Acceptable,914
431331006,Family history of breast cancer 2 (BRCA2) gene mutation,2772737015,Acceptable,914
276571000000104,Urgent cancer referral - upper gastrointestinal,473901000000114,Preferred,915
276571000000104,Urgent cancer referral - upper gastrointestinal,473911000000111,Preferred,915
276561000000106,Urgent cancer referral - upper gastrointestinal,473881000000111,Preferred,916
276561000000106,Urgent cancer referral - upper gastrointestinal,473891000000113,Preferred,916
276341000000100,Fast track referral for suspected breast cancer (procedure),473441000000117,Preferred,917
276341000000100,Fast track referral for suspected breast cancer,473451000000119,Preferred,917
395628007,Cancer information offered to significant other (situation),2761399015,Preferred,918
395628007,Cancer information offered to significant other,1489285017,Preferred,918
716791000000105,Exception reporting - cancer quality indicators (finding),1571921000000112,Preferred,919
716791000000105,Exception reporting - cancer quality indicators,1569341000000112,Preferred,919
395581007,Cancer information offered to significant other (procedure),2744660011,Preferred,920
395581007,Cancer information offered to significant other,1489238011,Preferred,920
373814009,No anti-cancer treatment - advanced stage cancer (finding),1199114019,Preferred,921
373814009,No anti-cancer treatment - advanced stage cancer,1212264010,Preferred,921
771080008,Hereditary site-specific ovarian cancer syndrome (disorder),3704237014,Preferred,922
771080008,Hereditary site-specific ovarian cancer syndrome,3704238016,Preferred,922
771080008,"Ovarian cancer caused by germline mutations in various genes, usually associated with additional cancer risks. The most common are breast and ovarian cancer syndrome (HBOC) due to mutations in BRCA1 and BRCA2 genes and hereditary nonpolyposis colorectal cancer (HNPCC) due to mutations in DNA mismatch-repair genes. Mutations in STK11 gene, causing Peutz-Jeghers syndrome, are also associated with a risk of ovarian cancer (typically sex cord stromal neoplasm). Mutations in other genes, including RAD51C, RAD51D, PALB2, confer an elevated ovarian cancer risk in a minority of patients.",3704239012,Preferred,922
851181000000109,Re-excision of local recurrence of breast tumour (procedure),2205271000000117,Preferred,923
851181000000109,Re-excision of local recurrence of breast tumour,2205261000000112,Preferred,923
851181000000109,Re-excision of local recurrence of breast cancer,2205251000000114,Acceptable,923
394142009,Cancer primary healthcare multidisciplinary team (qualifier value),2747479014,Preferred,924
394142009,Cancer primary healthcare multidisciplinary team,1487967010,Preferred,924
373797007,Cancer diagnosis based on specific tumor markers (finding),2690075013,Preferred,925
373797007,Cancer diagnosis based on specific tumour markers,1207477018,Preferred,925
373797007,Cancer diagnosis based on specific tumor markers,1208289017,Acceptable,925
94347008,Secondary malignant neoplasm of intra-abdominal lymph nodes (disorder),838271015,Preferred,926
94347008,Secondary malignant neoplasm of intra-abdominal lymph nodes,156199014,Preferred,926
94347008,Cancer metastatic to intra-abdominal lymph nodes,3083565010,Acceptable,926
94347008,Metastatic malignant neoplasm to intra-abdominal lymph nodes,156202016,Acceptable,926
388544006,Cancer pagurus specific immunoglobulin E antibody measurement (procedure),2969064013,Preferred,927
388544006,Crab RAST,1482609019,Preferred,927
388544006,Cancer pagurus specific IgE antibody measurement,1493006016,Acceptable,927
388544006,Cancer pagurus specific immunoglobulin E antibody measurement,2968855013,Acceptable,927
388544006,Crab RAST test,134711000000113,Acceptable,927
388544006,Crab specific IgE antibody measurement,1493007013,Acceptable,927
388544006,f23 specific IgE antibody measurement,1493005017,Acceptable,927
94519005,Secondary malignant neoplasm of retroperitoneal lymph nodes (disorder),838479015,Preferred,928
94519005,Secondary malignant neoplasm of retroperitoneal lymph nodes,156641014,Preferred,928
94519005,Cancer metastatic to retroperitoneal lymph nodes,3036524019,Acceptable,928
94519005,Metastatic malignant neoplasm to retroperitoneal lymph nodes,156642019,Acceptable,928
109837002,Overlapping malignant neoplasm of small intestine (disorder),616259013,Preferred,929
109837002,Overlapping malignant neoplasm of small intestine,174515010,Preferred,929
109837002,"Cancer of the small intestine, overlapping sites",3035935012,Acceptable,929
109837002,"Malignant neoplasm, overlapping lesion of small intestine",1219535016,Acceptable,929
395104009,Cancer primary healthcare multidisciplinary team (qualifier value),1469044012,Preferred,930
395104009,Cancer primary healthcare multidisciplinary team,1488803011,Preferred,930
1108821000000109,Cancer Appetite and Symptom Questionnaire (assessment scale),2774811000000112,Preferred,931
1108821000000109,CASQ - Cancer Appetite and Symptom Questionnaire,2774801000000110,Preferred,931
393192000,Cancer primary healthcare multidisciplinary team (qualifier value),2735318014,Preferred,932
393192000,Cancer primary healthcare multidisciplinary team,1487138013,Preferred,932
25501000000106,No anti-cancer treatment - advanced stage cancer (finding),64461000000116,Preferred,933
25501000000106,No anti-cancer treatment - advanced stage cancer,63191000000119,Preferred,933
395595005,Cancer care plan discussed with significant other (procedure),2763546015,Preferred,934
395595005,Cancer care plan discussed with significant other,1489252013,Preferred,934
892211000000108,Fast track referral for suspected lower GI cancer,2297461000000118,Preferred,935
892211000000108,Fast track referral for suspected lower GI cancer,2297471000000113,Preferred,935
490991000000102,Seen in fast track suspected breast cancer clinic,1055641000000114,Preferred,936
490991000000102,Seen in fast track suspected breast cancer clinic,1055651000000112,Preferred,936
395674006,Cancer care plan discussed with partner in relationship (situation),2868921010,Preferred,937
395674006,Cancer care plan discussed with partner in relationship,2872188014,Preferred,937
395674006,Cancer care plan discussed with significant other,1489331019,Acceptable,937
395671003,Cancer diagnosis discussed with partner in relationship (situation),2869809019,Preferred,938
395671003,Cancer diagnosis discussed with partner in relationship,2873072019,Preferred,938
395671003,Cancer diagnosis discussed with significant other,1489328015,Acceptable,938
395640007,Cancer care plan discussed with significant other (procedure),2744270019,Preferred,939
395640007,Cancer care plan discussed with significant other,1489297016,Preferred,939
94642006,Secondary malignant neoplasm of tracheobronchial lymph nodes (disorder),838629011,Preferred,940
94642006,Secondary malignant neoplasm of tracheobronchial lymph nodes,156931014,Preferred,940
94642006,Cancer metastatic to tracheobronchial lymph nodes,3035943019,Acceptable,940
94642006,Metastatic malignant neoplasm to tracheobronchial lymph nodes,156932019,Acceptable,940
395634000,Cancer diagnosis discussed with significant other (situation),2746590012,Preferred,941
395634000,Cancer diagnosis discussed with significant other,1489291015,Preferred,941
487151000000107,Seen in fast track suspected breast cancer clinic,1047101000000110,Preferred,942
487151000000107,Seen in fast track suspected breast cancer clinic,1047111000000112,Preferred,942
395589009,Cancer diagnosis discussed with significant other (procedure),2738582018,Preferred,943
395589009,Cancer diagnosis discussed with significant other,1489246012,Preferred,943
758851000000101,Not eligible for bowel cancer screening programme (finding),1673271000000113,Preferred,944
758851000000101,Not eligible for bowel cancer screening programme,1673281000000110,Preferred,944
758861000000103,Not eligible for bowel cancer screening programme,1673291000000112,Preferred,945
758861000000103,Not eligible for bowel cancer screening programme,1673301000000111,Preferred,945
94243009,Secondary malignant neoplasm of central nervous system (disorder),838146010,Preferred,946
94243009,Secondary malignant neoplasm of central nervous system,155921013,Preferred,946
94243009,Cancer metastatic to CNS (central nervous system),3035724014,Acceptable,946
94243009,Metastatic malignant neoplasm to central nervous system,155924017,Acceptable,946
774581000000102,Did not attend fast track suspected cancer clinic (finding),1730351000000111,Preferred,947
774581000000102,Did not attend fast track suspected cancer clinic,1730361000000114,Preferred,947
774591000000100,Did not attend fast track suspected cancer clinic,1730371000000119,Preferred,948
774591000000100,Did not attend fast track suspected cancer clinic,1730381000000117,Preferred,948
25461000000106,Cancer diagnosis based on specific tumour markers (finding),64431000000114,Preferred,949
25461000000106,Cancer diagnosis based on specific tumour markers,63151000000110,Preferred,949
260879005,International Union Against Cancer stage grouping (attribute),2914790015,Preferred,950
260879005,UICC stage grouping,388533019,Preferred,950
260879005,International Union Against Cancer (UICC) stage grouping,2619991013,Acceptable,950
260879005,International Union Against Cancer stage grouping,2913283017,Acceptable,950
80529009,CA 125 measurement (procedure),821699019,Preferred,951
80529009,CA 125 measurement,133614015,Preferred,951
80529009,Carbohydrate antigen 125 level,128111000000119,Acceptable,951
276551000000108,Fast track referral for suspected upper gastrointestinal cancer (procedure),473861000000119,Preferred,952
276551000000108,Fast track referral for suspected upper gastrointestinal cancer,473871000000114,Preferred,952
276551000000108,Fast track referral for suspected upper GI (gastrointestinal) cancer,1676131000000112,Acceptable,952
848701000000109,QCancer gastro-oesophageal cancer risk calculator (assessment scale),2199811000000114,Preferred,953
848701000000109,QCancer gastro-oesophageal cancer risk calculator,2199821000000115,Preferred,953
382431000000103,Seen in fast track suspected breast cancer clinic (finding),753751000000119,Preferred,954
382431000000103,Seen in fast track suspected breast cancer clinic,753761000000116,Preferred,954
863701000000105,Provision of written information about skin cancer,2233291000000114,Preferred,955
863701000000105,Provision of written information about skin cancer,2233301000000113,Preferred,955
25021000000109,No anti-cancer treatment - poor performance status (finding),64081000000117,Preferred,956
25021000000109,No anti-cancer treatment - poor performance status,62551000000113,Preferred,956
717129004,Claus Model Lifetime Breast Cancer Risk Assessment (assessment scale),3308475014,Preferred,957
717129004,Claus Model,3308479015,Preferred,957
717129004,Claus Model Lifetime Breast Cancer Risk Assessment,3308476010,Acceptable,957
851221000000104,Wide re-excision of local recurrence of breast tumour (procedure),2205351000000118,Preferred,958
851221000000104,Wide re-excision of local recurrence of breast tumour,2205341000000116,Preferred,958
851221000000104,Wide excision of local recurrence of breast cancer,2205361000000115,Acceptable,958
94396003,Secondary malignant neoplasm of lymph nodes of multiple sites (disorder),838330012,Preferred,959
94396003,Secondary malignant neoplasm of lymph nodes of multiple sites,156339017,Preferred,959
94396003,Cancer metastatic to lymph nodes of multiple sites,3036446012,Acceptable,959
94396003,Metastatic malignant neoplasm to lymph nodes of multiple sites,156340015,Acceptable,959
373813003,No anti-cancer treatment - poor performance status (finding),1199113013,Preferred,960
373813003,No anti-cancer treatment - poor performance status,1212263016,Preferred,960
863691000000105,Provision of written information about skin cancer (procedure),2233271000000110,Preferred,961
863691000000105,Provision of written information about skin cancer,2233281000000112,Preferred,961
31881000119108,Family history of breast cancer gene BRCA mutation (situation),3515818010,Preferred,962
31881000119108,Family history of breast cancer gene BRCA mutation,3515819019,Preferred,962
31881000119108,Family history of BRCA gene mutation,3513469019,Acceptable,962
427196009,National Cancer Institute histologic grading system (staging scale),2914837014,Preferred,963
427196009,National Cancer Institute (NCI) histologic grading system,2674213016,Preferred,963
427196009,National Cancer Institute histologic grading system,2914410015,Acceptable,963
373816006,No anti-cancer treatment - significant co-morbidity (finding),1199116017,Preferred,964
373816006,No anti-cancer treatment - significant co-morbidity,1212266012,Preferred,964
293271000000103,Bowel cancer screening programme polyp surveillance,515031000000116,Preferred,965
293271000000103,Bowel cancer screening programme polyp surveillance,515041000000113,Preferred,965
382161000000102,Advice given about bowel cancer screening programme (situation),753151000000115,Preferred,966
382161000000102,Advice given about bowel cancer screening programme,753161000000117,Preferred,966
293261000000105,Bowel cancer screening programme polyp surveillance,515011000000112,Preferred,967
293261000000105,Bowel cancer screening programme polyp surveillance,515021000000118,Preferred,967
276431000000102,Fast track referral for suspected urological cancer (procedure),473621000000114,Preferred,968
276431000000102,Fast track referral for suspected urological cancer,473631000000111,Preferred,968
276401000000108,Fast track referral for suspected colorectal cancer (procedure),473561000000117,Preferred,969
276401000000108,Fast track referral for suspected colorectal cancer,473571000000112,Preferred,969
25141000000101,No anti-cancer treatment - significant co-morbidity (finding),65181000000117,Preferred,970
25141000000101,No anti-cancer treatment - significant co-morbidity,62691000000116,Preferred,970
771474005,Gastric adenocarcinoma and proximal polyposis of stomach (disorder),3706371017,Preferred,971
771474005,Gastric adenocarcinoma and proximal polyposis of stomach,3706373019,Preferred,971
771474005,Familial fundic gland polyposis with gastric cancer,3706374013,Acceptable,971
771474005,GAPPS - gastric adenocarcinoma and proximal polyposis of stomach,3706372012,Acceptable,971
771474005,"A rare hereditary gastric cancer with characteristics of proximal gastric polyposis and increased risk of early-onset, intestinal-type adenocarcinoma of the gastric body, without duodenal or colorectal polyposis.",3706375014,Preferred,971
1034391000000109,Discharge from secondary care breast cancer service,2611391000000111,Preferred,972
1034391000000109,Discharge from secondary care breast cancer service,2611401000000114,Preferred,972
412734009,BRCA1 gene mutation positive (finding),2468187015,Preferred,973
412734009,BRCA1 gene mutation positive,2474292019,Preferred,973
412734009,"Breast cancer 1, early onset gene mutation positive",2871914019,Acceptable,973
412736006,BRCA1 gene mutation negative (finding),2468189017,Preferred,974
412736006,BRCA1 gene mutation negative,2474294018,Preferred,974
412736006,"Breast cancer 1, early onset gene mutation negative",2871097013,Acceptable,974
1034381000000107,Discharge from secondary care breast cancer service (finding),2611371000000112,Preferred,975
1034381000000107,Discharge from secondary care breast cancer service,2611381000000114,Preferred,975
412738007,BRCA2 gene mutation positive (finding),2468191013,Preferred,976
412738007,BRCA2 gene mutation positive,2474295017,Preferred,976
412738007,"Breast cancer 2, early onset gene mutation positive",2872218012,Acceptable,976
412739004,BRCA2 gene mutation negative (finding),2468192018,Preferred,977
412739004,BRCA2 gene mutation negative,2474296016,Preferred,977
412739004,"Breast cancer 2, early onset gene mutation negative",2872933014,Acceptable,977
186709004,Human immunodeficiency virus with secondary cancers (disorder),569782014,Preferred,978
186709004,Human immunodeficiency virus with secondary cancers,287014015,Preferred,978
87776000,Intra-arterial infusion of antineoplastic agent (procedure),830320019,Preferred,979
87776000,Intra-arterial infusion of antineoplastic agent,145527011,Preferred,979
87776000,Intra-arterial infusion of cancer chemotherapy agent,145528018,Acceptable,979
848801000000103,Assessment using QCancer lung cancer risk calculator (procedure),2200021000000117,Preferred,980
848801000000103,Assessment using QCancer lung cancer risk calculator,2200011000000111,Preferred,980
192521000000106,GP out of hours service notified of cancer care plan,274401000000118,Preferred,981
192521000000106,GP out of hours service notified of cancer care plan,281681000000119,Preferred,981
189021000000106,GP out of hours service notified of cancer care plan,276821000000117,Preferred,982
189021000000106,GP out of hours service notified of cancer care plan,284101000000115,Preferred,982
180421000000105,General practitioner out of hours service notified of cancer care plan (finding),1678311000000115,Preferred,983
180421000000105,General practitioner out of hours service notified of cancer care plan,1678301000000117,Preferred,983
180421000000105,GP (general practitioner) OOH (out of hours) service notified of cancer care plan,1678291000000116,Acceptable,983
175151000000108,Cancer emotional and psychosocial support and advice,245591000000112,Preferred,984
175151000000108,Cancer emotional and psychosocial support and advice,234241000000117,Preferred,984
71241000119100,Family history of malignant hematopoietic neoplasm (situation),3438795016,Preferred,985
71241000119100,Family history of malignant haematopoietic neoplasm,3438797012,Preferred,985
71241000119100,Family history of cancer of the haematopoietic system,3438798019,Acceptable,985
71241000119100,Family history of cancer of the hematopoietic system,3438799010,Acceptable,985
71241000119100,Family history of malignant hematopoietic neoplasm,3438796015,Acceptable,985
710881000000102,Advice given about breast cancer screening programme,1553791000000114,Preferred,986
710881000000102,Advice given about breast cancer screening programme,1553801000000113,Preferred,986
708699002,Stool DNA-based colorectal cancer screening positive (finding),3036245013,Preferred,987
708699002,Stool DNA-based colorectal cancer screening positive,3036398013,Preferred,987
170491000000102,Cancer emotional and psychosocial support and advice,248151000000115,Preferred,988
170491000000102,Cancer emotional and psychosocial support and advice,237021000000114,Preferred,988
413736002,Cancer emotional and psychosocial support and education (regime/therapy),2572957012,Preferred,989
413736002,Cancer emotional and psychosocial support and education,2576384017,Preferred,989
413736002,Cancer emotional and psychosocial support and advice,2533542012,Acceptable,989
1034421000000103,Discharge from secondary care prostate cancer service (finding),2611451000000110,Preferred,990
1034421000000103,Discharge from secondary care prostate cancer service,2611461000000113,Preferred,990
912921000000102,Urine prostate cancer antigen 3 targeted genetic test,2346201000000115,Preferred,991
912921000000102,Urine prostate cancer antigen 3 targeted genetic test,2346211000000118,Preferred,991
848821000000107,Assessment using QCancer renal cancer risk calculator (procedure),2200061000000113,Preferred,992
848821000000107,Assessment using QCancer renal cancer risk calculator,2200051000000110,Preferred,992
912911000000108,Urine prostate cancer antigen 3 targeted genetic test (procedure),2346181000000119,Preferred,993
912911000000108,Urine prostate cancer antigen 3 targeted genetic test,2346191000000117,Preferred,993
382651000000108,Seen in fast track suspected colorectal cancer clinic (finding),754211000000113,Preferred,994
382651000000108,Seen in fast track suspected colorectal cancer clinic,754221000000119,Preferred,994
382841000000109,Seen in fast track suspected urological cancer clinic (finding),754601000000113,Preferred,995
382841000000109,Seen in fast track suspected urological cancer clinic,754611000000110,Preferred,995
382851000000107,Seen in fast track suspected urological cancer clinic,754621000000116,Preferred,996
382851000000107,Seen in fast track suspected urological cancer clinic,754631000000119,Preferred,996
382861000000105,Seen in fast track suspected urological cancer clinic,754641000000111,Preferred,997
382861000000105,Seen in fast track suspected urological cancer clinic,754651000000114,Preferred,997
862021000000105,Bowel cancer screening programme telephone invitation,2229241000000117,Preferred,998
862021000000105,Bowel cancer screening programme telephone invitation,2229251000000119,Preferred,998
491041000000100,Seen in fast track suspected colorectal cancer clinic,1055741000000118,Preferred,999
491041000000100,Seen in fast track suspected colorectal cancer clinic,1055751000000115,Preferred,999
862011000000104,Bowel cancer screening programme telephone invitation (procedure),2229221000000112,Preferred,1000
862011000000104,Bowel cancer screening programme telephone invitation,2229231000000114,Preferred,1000
112241000119107,Cervical cancer Papanicolaou smear screening declined (situation),3320494010,Preferred,1001
112241000119107,Cervical cancer Papanicolaou smear screening declined,3320495011,Preferred,1001
487201000000102,Seen in fast track suspected colorectal cancer clinic,1047201000000118,Preferred,1002
487201000000102,Seen in fast track suspected colorectal cancer clinic,1047211000000116,Preferred,1002
1034431000000101,Discharge from secondary care prostate cancer service,2611471000000118,Preferred,1003
1034431000000101,Discharge from secondary care prostate cancer service,2611481000000116,Preferred,1003
294301000000103,Bowel cancer detected by national screening programme (disorder),517411000000114,Preferred,1004
294301000000103,Bowel cancer detected by national screening programme,517421000000115,Preferred,1004
840301000000108,Establishing focus of care with specialist cancer team,2180591000000114,Preferred,1005
840301000000108,Establishing focus of care with specialist cancer team,2180601000000115,Preferred,1005
94361000000105,Breast cancer detected by national screening programme (disorder),469541000000114,Preferred,1006
94361000000105,Breast cancer detected by national screening programme,143091000000118,Preferred,1006
280521000000108,Fast track referral for suspected head and neck cancer (procedure),482181000000115,Preferred,1007
280521000000108,Fast track referral for suspected head and neck cancer,482191000000118,Preferred,1007
449205006,Nottingham histologic grading system (staging scale),2898868010,Preferred,1008
449205006,Nottingham histologic grading system,2901507016,Preferred,1008
449205006,Nottingham histologic grading system for breast cancer,2901508014,Acceptable,1008
840291000000109,Establishing focus of care with specialist cancer team (procedure),2180571000000110,Preferred,1009
840291000000109,Establishing focus of care with specialist cancer team,2180581000000112,Preferred,1009
1098871000119109,Family history of hereditary nonpolyposis colon cancer (situation),3043254019,Preferred,1010
1098871000119109,Family history of hereditary nonpolyposis colon cancer,3043199019,Preferred,1010
111030006,Howel-Evans' syndrome (disorder),627560010,Preferred,1011
111030006,Howel-Evans' syndrome,175960014,Preferred,1011
111030006,Diffuse palmoplantar keratoderma with esophageal cancer,202934012,Acceptable,1011
111030006,Diffuse palmoplantar keratoderma with oesophageal cancer,357698012,Acceptable,1011
111030006,Howel Evans syndrome,3036100017,Acceptable,1011
111030006,Howel-Evans-Clark syndrome,357696011,Acceptable,1011
111030006,Keratoderma with carcinoma of esophagus,357699016,Acceptable,1011
111030006,Keratoderma with carcinoma of oesophagus,357697019,Acceptable,1011
445180002,Breast cancer genetic marker of susceptibility negative (finding),2869488015,Preferred,1012
445180002,Breast cancer genetic marker of susceptibility negative,2872655015,Preferred,1012
862031000000107,Bowel cancer screening programme invitation letter sent (finding),2229261000000116,Preferred,1013
862031000000107,Bowel cancer screening programme invitation letter sent,2229271000000111,Preferred,1013
276311000000101,Fast track referral for suspected gynaecological cancer (procedure),473381000000115,Preferred,1014
276311000000101,Fast track referral for suspected gynaecological cancer,473391000000118,Preferred,1014
848831000000109,Assessment using QCancer ovarian cancer risk calculator (procedure),2200081000000116,Preferred,1015
848831000000109,Assessment using QCancer ovarian cancer risk calculator,2200071000000118,Preferred,1015
1034401000000107,Discharge from secondary care colorectal cancer service (finding),2611411000000111,Preferred,1016
1034401000000107,Discharge from secondary care colorectal cancer service,2611421000000117,Preferred,1016
1034411000000109,Discharge from secondary care colorectal cancer service,2611431000000115,Preferred,1017
1034411000000109,Discharge from secondary care colorectal cancer service,2611441000000112,Preferred,1017
862041000000103,Bowel cancer screening programme invitation letter sent,2229281000000113,Preferred,1018
862041000000103,Bowel cancer screening programme invitation letter sent,2229291000000110,Preferred,1018
848711000000106,QCancer gastro-oesophageal cancer risk assessment score,2199831000000118,Preferred,1019
848711000000106,QCancer gastro-oesophageal cancer risk assessment score,2199841000000110,Preferred,1019
445333001,Breast cancer genetic marker of susceptibility positive (finding),2870217012,Preferred,1020
445333001,Breast cancer genetic marker of susceptibility positive,2871750016,Preferred,1020
382621000000103,Seen in fast track suspected head and neck cancer clinic (finding),754151000000118,Preferred,1021
382621000000103,Seen in fast track suspected head and neck cancer clinic,754161000000115,Preferred,1021
487191000000104,Seen in fast track suspected head and neck cancer clinic,1047181000000117,Preferred,1022
487191000000104,Seen in fast track suspected head and neck cancer clinic,1047191000000115,Preferred,1022
1090551000000108,Assessment using Mental Adjustment to Cancer Scale (procedure),2731981000000112,Preferred,1023
1090551000000108,Assessment using MAC (Mental Adjustment to Cancer) Scale,2731971000000110,Preferred,1023
491031000000109,Seen in fast track suspected head and neck cancer clinic,1055721000000113,Preferred,1024
491031000000109,Seen in fast track suspected head and neck cancer clinic,1055731000000110,Preferred,1024
491011000000101,Seen in fast track suspected gynaecological cancer clinic,1055681000000118,Preferred,1025
491011000000101,Seen in fast track suspected gynaecological cancer clinic,1055691000000116,Preferred,1025
2301000119106,Family history of malignant neoplasm of ovary in first degree relative (situation),3424145014,Preferred,1026
2301000119106,Family history of malignant neoplasm of ovary in first degree relative,3424146010,Preferred,1026
2301000119106,Family history of cancer of ovary in first degree relative,3424147018,Acceptable,1026
2301000119106,Family history of ovarian cancer in first degree relative,3424148011,Acceptable,1026
90051000000102,Excepted from cancer quality indicators: Informed dissent (finding),1555011000000118,Preferred,1027
90051000000102,Excepted from cancer quality indicators: Informed dissent,139191000000116,Preferred,1027
103091000000106,Excepted from cancer quality indicators: Informed dissent,184251000000111,Preferred,1028
103091000000106,Excepted from cancer quality indicators: Informed dissent,159921000000116,Preferred,1028
487171000000103,Seen in fast track suspected gynaecological cancer clinic,1047141000000113,Preferred,1029
487171000000103,Seen in fast track suspected gynaecological cancer clinic,1047151000000111,Preferred,1029
98181000000105,Excepted from cancer quality indicators: Informed dissent,185631000000119,Preferred,1030
98181000000105,Excepted from cancer quality indicators: Informed dissent,146271000000119,Preferred,1030
382511000000105,Seen in fast track suspected gynaecological cancer clinic (finding),753921000000110,Preferred,1031
382511000000105,Seen in fast track suspected gynaecological cancer clinic,753931000000112,Preferred,1031
294311000000101,Bowel cancer detected through national screening programme,517431000000118,Preferred,1032
294311000000101,Bowel cancer detected through national screening programme,517441000000110,Preferred,1032
848791000000102,Assessment using QCancer colorectal cancer risk calculator (procedure),2200001000000114,Preferred,1033
848791000000102,Assessment using QCancer colorectal cancer risk calculator,2199991000000111,Preferred,1033
717601000000107,Excepted from cancer quality indicators - informed dissent (finding),1570711000000113,Preferred,1034
717601000000107,Excepted from cancer quality indicators - informed dissent,1570131000000116,Preferred,1034
848841000000100,Assessment using QCancer pancreatic cancer risk calculator (procedure),2200101000000110,Preferred,1035
848841000000100,Assessment using QCancer pancreatic cancer risk calculator,2200091000000119,Preferred,1035
373251000000108,No response to bowel cancer screening programme invitation (finding),733591000000115,Preferred,1036
373251000000108,No response to bowel cancer screening programme invitation,733601000000114,Preferred,1036
46228005,Prescription for alteration of hormonal balance for cancer (procedure),783554018,Preferred,1037
46228005,Prescription for alteration of hormonal balance for cancer,77091019,Preferred,1037
294321000000107,Bowel cancer detected through national screening programme,517451000000113,Preferred,1038
294321000000107,Bowel cancer detected through national screening programme,517461000000111,Preferred,1038
25471000000104,Cancer diagnosis based on metastatic histological evidence (finding),64441000000117,Preferred,1039
25471000000104,Cancer diagnosis based on metastatic histological evidence,63161000000113,Preferred,1039
399414003,Multidisciplinary care conference for cancer care planning (procedure),1767334015,Preferred,1040
399414003,Multidisciplinary care conference for cancer care planning,1778851017,Preferred,1040
373799005,Cancer diagnosis based on metastatic histological evidence (finding),1199099010,Preferred,1041
373799005,Cancer diagnosis based on metastatic histological evidence,1212249010,Preferred,1041
487231000000108,No response to bowel cancer screening programme invitation,1047261000000119,Preferred,1042
487231000000108,No response to bowel cancer screening programme invitation,1047271000000114,Preferred,1042
919701000000100,No family history of breast cancer meeting National Institute of Health and Care Excellence Clinical Guideline 164 referral criteria (situation),2361051000000111,Preferred,1043
919701000000100,No FH of breast cancer meeting NICE CG164 referral criteria,2361061000000114,Preferred,1043
439818007,Knowledge level about cancer prevention and early detection (observable entity),2788103015,Preferred,1044
439818007,Knowledge level about cancer prevention and early detection,2790525017,Preferred,1044
713613007,Hereditary nonpolyposis colon cancer gene mutation positive (finding),3290437011,Preferred,1045
713613007,Hereditary nonpolyposis colon cancer gene mutation positive,3290474010,Preferred,1045
103081000000109,Excepted from cancer quality indicators: Patient unsuitable,178511000000112,Preferred,1046
103081000000109,Excepted from cancer quality indicators: Patient unsuitable,150411000000112,Preferred,1046
98171000000108,Excepted from cancer quality indicators: Patient unsuitable,174881000000112,Preferred,1047
98171000000108,Excepted from cancer quality indicators: Patient unsuitable,146261000000114,Preferred,1047
884521000000106,Bowel Cancer Screening Programme bowel scope screening test (procedure),2280201000000119,Preferred,1048
884521000000106,Bowel Cancer Screening Programme bowel scope screening test,2280211000000117,Preferred,1048
896121000000107,No FH of breast cancer meeting NICE CG126 referral criteria,2305821000000111,Preferred,1049
896121000000107,No FH of breast cancer meeting NICE CG126 referral criteria,2305831000000113,Preferred,1049
884531000000108,Bowel Cancer Screening Programme bowel scope screening test,2280221000000111,Preferred,1050
884531000000108,Bowel Cancer Screening Programme bowel scope screening test,2280231000000113,Preferred,1050
936911000000104,No FH of breast cancer meeting NICE CG164 referral criteria,2401461000000112,Preferred,1051
936911000000104,No FH of breast cancer meeting NICE CG164 referral criteria,2399881000000112,Preferred,1051
90041000000100,Excepted from cancer quality indicators: Patient unsuitable (finding),1555021000000112,Preferred,1052
90041000000100,Excepted from cancer quality indicators: Patient unsuitable,139181000000118,Preferred,1052
838071000000100,Provision of written information about screening for cancer (procedure),2175391000000119,Preferred,1053
838071000000100,Provision of written information about screening for cancer,2175381000000116,Preferred,1053
896111000000101,No family history of breast cancer meeting National Institute of Health and Care Excellence Clinical Guideline 126 referral criteria (situation),2305801000000119,Preferred,1054
896111000000101,No FH of breast cancer meeting NICE CG126 referral criteria,2305811000000117,Preferred,1054
884601000000103,Bowel scope (flexible sigmoidoscopy) screen: cancer detected (finding),2280361000000112,Preferred,1055
884601000000103,Bowel scope (flexible sigmoidoscopy) screen: cancer detected,2280371000000117,Preferred,1055
293191000000109,Did not attend bowel cancer screening programme nurse clinic (finding),514871000000110,Preferred,1056
293191000000109,Did not attend bowel cancer screening programme nurse clinic,514881000000112,Preferred,1056
1000561000000108,Urine prostate cancer antigen 3 targeted genetic test (observable entity),2530021000000115,Preferred,1057
1000561000000108,Urine PCA3 (prostate cancer antigen 3) targeted genetic test,2577261000000116,Preferred,1057
293201000000106,Did not attend bowel cancer screening programme nurse clinic,514891000000114,Preferred,1058
293201000000106,Did not attend bowel cancer screening programme nurse clinic,514901000000110,Preferred,1058
293211000000108,Did not attend bowel cancer screening programme nurse clinic,514911000000112,Preferred,1059
293211000000108,Did not attend bowel cancer screening programme nurse clinic,514921000000118,Preferred,1059
716511000000108,Excepted from cancer quality indicators - patient unsuitable (finding),1571641000000110,Preferred,1060
716511000000108,Excepted from cancer quality indicators - patient unsuitable,1569061000000110,Preferred,1060
1108841000000102,Cancer Appetite and Symptom Questionnaire total score (observable entity),2774851000000111,Preferred,1061
1108841000000102,CASQ (Cancer Appetite and Symptom Questionnaire) total score,2774841000000113,Preferred,1061
368501000000107,Bowel cancer screening programme: faecal occult blood result,714691000000114,Preferred,1062
368501000000107,Bowel cancer screening programme: faecal occult blood result,714701000000114,Preferred,1062
836771000000103,National Cancer Institute breast cancer risk assessment tool,2172631000000119,Preferred,1063
836771000000103,National Cancer Institute breast cancer risk assessment tool,2172641000000111,Preferred,1063
836761000000105,National Cancer Institute breast cancer risk assessment tool (assessment scale),2172611000000110,Preferred,1064
836761000000105,National Cancer Institute breast cancer risk assessment tool,2172621000000116,Preferred,1064
368491000000101,Bowel cancer screening programme: faecal occult blood result,714671000000110,Preferred,1065
368491000000101,Bowel cancer screening programme: faecal occult blood result,714681000000112,Preferred,1065
25011000000103,Cancer diagnosis based on primary site histological evidence (finding),65051000000110,Preferred,1066
25011000000103,Cancer diagnosis based on primary site histological evidence,62541000000110,Preferred,1066
368481000000103,Bowel cancer screening programme: faecal occult blood result (observable entity),714651000000118,Preferred,1067
368481000000103,Bowel cancer screening programme: faecal occult blood result,714661000000115,Preferred,1067
36821000000105,Referred to cancer primary healthcare multidisciplinary team,87041000000116,Preferred,1068
36821000000105,Referred to cancer primary healthcare multidisciplinary team,87031000000113,Preferred,1068
1106431000000109,Arbitrary concentration of cancer antigen 125 in serum (observable entity),2769081000000115,Preferred,1069
1106431000000109,CA 125 arbitrary concentration in serum,2801451000000115,Preferred,1069
1106431000000109,CA-125 (cancer antigen 125) arbitrary concentration in serum,2769071000000117,Acceptable,1069
1106431000000109,CA-125 arbitrary concentration in serum,2769061000000112,Acceptable,1069
36811000000104,Referred to cancer primary healthcare multidisciplinary team,87021000000111,Preferred,1070
36811000000104,Referred to cancer primary healthcare multidisciplinary team,87011000000117,Preferred,1070
25221000000104,Referred to cancer primary healthcare multidisciplinary team (procedure),64261000000115,Preferred,1071
25221000000104,Referred to cancer primary healthcare multidisciplinary team,62821000000118,Preferred,1071
373800009,Cancer diagnosis based on primary site histological evidence (finding),1199100019,Preferred,1072
373800009,Cancer diagnosis based on primary site histological evidence,1212250010,Preferred,1072
1099611000119109,Hereditary non-polyposis colon cancer gene mutation positive (finding),3427497018,Preferred,1073
1099611000119109,Hereditary non-polyposis colon cancer gene mutation positive,3427498011,Preferred,1073
1099611000119109,HNPCC (hereditary non-polyposis colon cancer) gene mutation positive,3427499015,Acceptable,1073
884611000000101,Bowel scope (flexible sigmoidoscopy) screen: cancer detected,2280381000000115,Preferred,1074
884611000000101,Bowel scope (flexible sigmoidoscopy) screen: cancer detected,2280391000000118,Preferred,1074
1106411000000101,Arbitrary concentration of cancer antigen 125 in plasma (observable entity),2769031000000119,Preferred,1075
1106411000000101,CA 125 arbitrary concentration in plasma,2801461000000117,Preferred,1075
1106411000000101,CA-125 (cancer antigen 125) arbitrary concentration in plasma,2769021000000116,Acceptable,1075
1106411000000101,CA-125 arbitrary concentration in plasma,2769011000000110,Acceptable,1075
154051000119101,Family history of malignant neoplasm of colon over age 50 (situation),3513471019,Preferred,1076
154051000119101,Family history of malignant neoplasm of colon over age 50,3513472014,Preferred,1076
767444009,Germline BRCA-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast (disorder),3671354012,Preferred,1077
767444009,"Germline BRCA-mutated, HER2-negative metastatic breast cancer",3671349015,Preferred,1077
767444009,Germline BRCA-mutated human epidermal growth factor receptor 2 negative metastatic carcinoma of breast,3671353018,Acceptable,1077
767444009,"gBRCA-mutated, HER2(-) metastatic breast carcinoma",3671350015,Acceptable,1077
722425009,Reactive oxygen species 1 positive non-small cell lung cancer (disorder),3332004012,Preferred,1078
722425009,Reactive oxygen species 1 positive non-small cell lung cancer,3332005013,Preferred,1078
722425009,ROS1 positive NSCLC - reactive oxygen species 1 positive non-small cell lung cancer,3332008010,Acceptable,1078
836791000000104,National Cancer Institute breast cancer risk assessment score (observable entity),2172681000000115,Preferred,1079
836791000000104,National Cancer Institute breast cancer risk assessment score,2172671000000117,Preferred,1079
247141000000103,Under care of cancer primary healthcare multidisciplinary team (finding),1154161000000113,Preferred,1080
247141000000103,Under care of cancer primary healthcare multidisciplinary team,1156781000000113,Preferred,1080
767310001,Family history of malignant neoplasm of breast at under age 50 in second degree female relative (situation),3670565013,Preferred,1081
767310001,Family history of malignant neoplasm of breast at under age 50 in second degree female relative,3670566014,Preferred,1081
767310001,Family history of female breast cancer diagnosed before age 50,3670567017,Acceptable,1081
143451000119105,Family history of malignant neoplasm of breast at under age 50 in second degree relative (situation),3513479017,Preferred,1082
143451000119105,Family history of malignant neoplasm of breast at under age 50 in second degree relative,3513480019,Preferred,1082
701615002,Alternating electric field antimitotic cancer treatment system (physical object),2993420011,Preferred,1083
701615002,Alternating electric field antimitotic cancer treatment system,2993419017,Preferred,1083
845141000000102,Provision of written information about personal cancer journey (procedure),2192211000000115,Preferred,1084
845141000000102,Provision of written information about personal cancer journey,2192201000000117,Preferred,1084
892201000000106,Fast track referral for suspected lower gastrointestinal cancer (procedure),2297441000000119,Preferred,1085
892201000000106,Fast track referral for suspected lower gastrointestinal cancer,2297451000000116,Preferred,1085
406067005,College of American Pathologists Cancer Checklist; Lung: Biopsy (record artifact),2572952018,Preferred,1086
406067005,College of American Pathologists Cancer Checklist; Lung: Biopsy,2157790017,Preferred,1086
2291000119105,Family history of malignant neoplasm of ovary in second degree relative (situation),3467614019,Preferred,1087
2291000119105,Family history of malignant neoplasm of ovary in second degree relative,3467615018,Preferred,1087
2291000119105,Family history of cancer of the ovary in second degree relative,3467616017,Acceptable,1087
845871000000102,Discharge from cancer primary healthcare multidisciplinary team (procedure),2193921000000111,Preferred,1088
845871000000102,Discharge from cancer primary healthcare multidisciplinary team,2193931000000113,Preferred,1088
423183009,College of American Pathologists Cancer Checklist; Bone: Biopsy (record artifact),2639837019,Preferred,1089
423183009,College of American Pathologists Cancer Checklist; Bone: Biopsy,2643854015,Preferred,1089
845881000000100,Discharge from cancer primary healthcare multidisciplinary team,2193941000000116,Preferred,1090
845881000000100,Discharge from cancer primary healthcare multidisciplinary team,2193951000000118,Preferred,1090
486871000000106,Bowel cancer screening programme faecal occult blood test normal,1046471000000112,Preferred,1091
486871000000106,Bowel cancer screening programme faecal occult blood test normal,1046481000000114,Preferred,1091
382171000000109,Advice given about the national bowel cancer screening programme,753171000000112,Preferred,1092
382171000000109,Advice given about the national bowel cancer screening programme,753181000000114,Preferred,1092
774601000000106,Did not attend fast track suspected gynaecological cancer clinic (finding),1730391000000115,Preferred,1093
774601000000106,Did not attend fast track suspected gynaecological cancer clinic,1730401000000117,Preferred,1093
375211000000108,Bowel cancer screening programme faecal occult blood test normal (finding),737921000000115,Preferred,1094
375211000000108,Bowel cancer screening programme faecal occult blood test normal,737931000000118,Preferred,1094
426757001,French Federation of Cancer Centers Sarcoma Group grading system (staging scale),2914906010,Preferred,1095
426757001,French Federation of Cancer Centers Sarcoma Group (FNCLCC) grading system,2674212014,Preferred,1095
426757001,French Federation of Cancer Centers Sarcoma Group grading system,2914702017,Acceptable,1095
426757001,Fdration Nationale des Centres de Lutte Contre le Cancer (FNCLCC) Sarcoma Group grading system,3723828019,Acceptable,1095
774611000000108,Did not attend fast track suspected gynaecological cancer clinic,1730411000000115,Preferred,1096
774611000000108,Did not attend fast track suspected gynaecological cancer clinic,1730421000000114,Preferred,1096
488291000000105,Bowel cancer screening programme faecal occult blood test normal,1049751000000116,Preferred,1097
488291000000105,Bowel cancer screening programme faecal occult blood test normal,1049761000000118,Preferred,1097
382181000000106,Advice given about the national bowel cancer screening programme,753191000000111,Preferred,1098
382181000000106,Advice given about the national bowel cancer screening programme,753201000000113,Preferred,1098
382811000000108,Seen in fast track suspected upper gastrointestinal cancer clinic (finding),754541000000112,Preferred,1099
382811000000108,Seen in fast track suspected upper gastrointestinal cancer clinic,754551000000110,Preferred,1099
406041000,College of American Pathologists Cancer Checklist; Vagina: Biopsy (record artifact),2572745010,Preferred,1100
406041000,College of American Pathologists Cancer Checklist; Vagina: Biopsy,2157764015,Preferred,1100
382831000000100,Seen in fast track suspected upper gastrointestinal cancer clinic,754581000000116,Preferred,1101
382831000000100,Seen in fast track suspected upper gastrointestinal cancer clinic,754591000000119,Preferred,1101
406064003,College of American Pathologists Cancer Checklist; Kidney: Biopsy (record artifact),2572949014,Preferred,1102
406064003,College of American Pathologists Cancer Checklist; Kidney: Biopsy,2157787011,Preferred,1102
921511000000100,Notification to general practitioner of cancer care plan in place (procedure),2365031000000118,Preferred,1103
921511000000100,Notification to general practitioner of cancer care plan in place,2365021000000115,Preferred,1103
1108831000000106,Assessment using Cancer Appetite and Symptom Questionnaire (procedure),2774831000000116,Preferred,1104
1108831000000106,Assessment using CASQ (Cancer Appetite and Symptom Questionnaire),2774821000000118,Preferred,1104
405826006,BRCA2 mutation carrier detection test (procedure),2149656017,Preferred,1105
405826006,BRCA2 mutation carrier detection test,2157600015,Preferred,1105
405826006,"Breast cancer 2, early onset gene mutation carrier detection test",2872826013,Acceptable,1105
74599000,No microscopic confirmation - clinically malignant tumor (cancer) (finding),815115018,Preferred,1106
74599000,No microscopic confirmation - clinically malignant tumour (cancer),200468015,Preferred,1106
74599000,No microscopic confirmation - clinically malignant tumor (cancer),123900012,Acceptable,1106
382821000000102,Seen in fast track suspected upper gastrointestinal cancer clinic,754561000000113,Preferred,1107
382821000000102,Seen in fast track suspected upper gastrointestinal cancer clinic,754571000000118,Preferred,1107
405823003,BRCA1 mutation carrier detection test (procedure),2149653013,Preferred,1108
405823003,BRCA1 mutation carrier detection test,2157597016,Preferred,1108
405823003,"Breast cancer 1, early onset gene mutation carrier detection test",2870872019,Acceptable,1108
488301000000109,Bowel cancer screening programme faecal occult blood test abnormal,1049771000000113,Preferred,1109
488301000000109,Bowel cancer screening programme faecal occult blood test abnormal,1049781000000110,Preferred,1109
251491000000108,Under the care of cancer primary healthcare multidisciplinary team,413181000000111,Preferred,1110
251491000000108,Under the care of cancer primary healthcare multidisciplinary team,413191000000113,Preferred,1110
254381008,American Urological Association staging system for prostate cancer (tumor staging),645263015,Preferred,1111
254381008,American Urological Association staging system for prostate cancer,378688015,Preferred,1111
375241000000109,Bowel cancer screening programme faecal occult blood test abnormal (finding),737981000000119,Preferred,1112
375241000000109,Bowel cancer screening programme faecal occult blood test abnormal,737991000000117,Preferred,1112
52691008,No microscopic confirmation - clinically metastatic tumor (cancer) (finding),790728014,Preferred,1113
52691008,No microscopic confirmation - clinically metastatic tumour (cancer),198407012,Preferred,1113
52691008,No microscopic confirmation - clinically metastatic tumor (cancer),87684010,Acceptable,1113
406055008,College of American Pathologists Cancer Checklist; Stomach: Biopsy (record artifact),2572839010,Preferred,1114
406055008,College of American Pathologists Cancer Checklist; Stomach: Biopsy,2157778019,Preferred,1114
274471000000105,Under the care of cancer primary healthcare multidisciplinary team,464281000000116,Preferred,1115
274471000000105,Under the care of cancer primary healthcare multidisciplinary team,464291000000119,Preferred,1115
848811000000101,Assessment using QCancer gastro-oesophageal cancer risk calculator (procedure),2200041000000112,Preferred,1116
848811000000101,Assessment using QCancer gastro-oesophageal cancer risk calculator,2200031000000115,Preferred,1116
406068000,College of American Pathologists Cancer Checklist; Lung: Resection (record artifact),2572953011,Preferred,1117
406068000,College of American Pathologists Cancer Checklist; Lung: Resection,2157791018,Preferred,1117
406023008,College of American Pathologists Cancer Checklist; Anus: Resection (record artifact),2572814018,Preferred,1118
406023008,College of American Pathologists Cancer Checklist; Anus: Resection,2157747018,Preferred,1118
486881000000108,Bowel cancer screening programme faecal occult blood test abnormal,1046491000000111,Preferred,1119
486881000000108,Bowel cancer screening programme faecal occult blood test abnormal,1046501000000117,Preferred,1119
423372007,College of American Pathologists Cancer Checklist; Bone: Resection (record artifact),2639836011,Preferred,1120
423372007,College of American Pathologists Cancer Checklist; Bone: Resection,2643853014,Preferred,1120
406062004,College of American Pathologists Cancer Checklist; Heart: Resection (record artifact),2572947011,Preferred,1121
406062004,College of American Pathologists Cancer Checklist; Heart: Resection,2157785015,Preferred,1121
406066001,College of American Pathologists Cancer Checklist; Liver: Resection (record artifact),2572951013,Preferred,1122
406066001,College of American Pathologists Cancer Checklist; Liver: Resection,2157789014,Preferred,1122
320551000000104,Serial faecal occult blood normal - bowel cancer screening programme,586071000000113,Preferred,1123
320551000000104,Serial faecal occult blood normal - bowel cancer screening programme,586081000000110,Preferred,1123
320541000000102,Serial faecal occult blood normal - bowel cancer screening programme,586051000000116,Preferred,1124
320541000000102,Serial faecal occult blood normal - bowel cancer screening programme,586061000000118,Preferred,1124
406027009,College of American Pathologists Cancer Checklist; Ureter: Resection (record artifact),2572818015,Preferred,1125
406027009,College of American Pathologists Cancer Checklist; Ureter: Resection,2157751016,Preferred,1125
373796003,"Cancer diagnosis based on investigations, without a tissue diagnosis (finding)",1199096015,Preferred,1126
373796003,"Cancer diagnosis based on investigations, without a tissue diagnosis",1212247012,Preferred,1126
406021005,College of American Pathologists Cancer Checklist; Anus: Excisional Biopsy (record artifact),2572812019,Preferred,1127
406021005,College of American Pathologists Cancer Checklist; Anus: Excisional Biopsy,2532763018,Preferred,1127
24991000000107,"Cancer diagnosis based on investigations, without a tissue diagnosis (finding)",64061000000114,Preferred,1128
24991000000107,"Cancer diagnosis based on investigations, without a tissue diagnosis",62521000000115,Preferred,1128
406036008,College of American Pathologists Cancer Checklist; Esophagus: Biopsy (record artifact),2573009010,Preferred,1129
406036008,College of American Pathologists Cancer Checklist; Esophagus: Biopsy,2157759019,Preferred,1129
406048006,College of American Pathologists Cancer Checklist; Thyroid: Resection (record artifact),2572964014,Preferred,1130
406048006,College of American Pathologists Cancer Checklist; Thyroid: Resection,2157771013,Preferred,1130
406056009,College of American Pathologists Cancer Checklist; Stomach: Resection (record artifact),2572840012,Preferred,1131
406056009,College of American Pathologists Cancer Checklist; Stomach: Resection,2157779010,Preferred,1131
422817006,College of American Pathologists Cancer Checklist; Soft Tissue: Biopsy (record artifact),2639839016,Preferred,1132
422817006,College of American Pathologists Cancer Checklist; Soft Tissue: Biopsy,2643856018,Preferred,1132
884621000000107,Bowel scope (flexible sigmoidoscopy) screen: suspected cancer detected (finding),2280401000000115,Preferred,1133
884621000000107,Bowel scope (flexible sigmoidoscopy) screen: suspected cancer detected,2280411000000118,Preferred,1133
766707003,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutation (disorder),3662331016,Preferred,1134
766707003,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutation,3662332011,Preferred,1134
143691000119102,Family history of breast cancer gene mutation in first degree relative (situation),3078549018,Preferred,1135
143691000119102,Family history of breast cancer gene mutation in first degree relative,3078338013,Preferred,1135
143691000119102,Family history of breast cancer gene (BRCA) mutation in first degree relative,3289332013,Acceptable,1135
421870003,College of American Pathologists Cancer Checklist; Appendix: Resection (record artifact),2615618012,Preferred,1136
421870003,College of American Pathologists Cancer Checklist; Appendix: Resection,2618296016,Preferred,1136
320591000000107,Serial faecal occult blood abnormal - bowel cancer screening programme,586151000000115,Preferred,1137
320591000000107,Serial faecal occult blood abnormal - bowel cancer screening programme,586161000000117,Preferred,1137
406034006,College of American Pathologists Cancer Checklist; Endometrium: Biopsy (record artifact),2573007012,Preferred,1138
406034006,College of American Pathologists Cancer Checklist; Endometrium: Biopsy,2157757017,Preferred,1138
320601000000101,Serial faecal occult blood abnormal - bowel cancer screening programme,586171000000112,Preferred,1139
320601000000101,Serial faecal occult blood abnormal - bowel cancer screening programme,586181000000114,Preferred,1139
103921000119100,Sampling of vagina for Papanicolaou smear after hysterectomy for malignant disease done (situation),3005905016,Preferred,1140
103921000119100,Sampling of vagina for Papanicolaou smear after hysterectomy for malignant disease done,3005909010,Preferred,1140
103921000119100,Vaginal Papanicolaou smear with history of hysterectomy for cancer done,3005903011,Acceptable,1140
375121000000106,Bowel cancer screening programme faecal occult blood testing kit spoilt (finding),737741000000113,Preferred,1141
375121000000106,Bowel cancer screening programme faecal occult blood testing kit spoilt,737751000000111,Preferred,1141
406037004,College of American Pathologists Cancer Checklist; Esophagus: Resection (record artifact),2572741018,Preferred,1142
406037004,College of American Pathologists Cancer Checklist; Esophagus: Resection,2157760012,Preferred,1142
860781000000108,Provision of written information about bowel cancer screening programme (procedure),2226231000000116,Preferred,1143
860781000000108,Provision of written information about bowel cancer screening programme,2226241000000113,Preferred,1143
488261000000104,Bowel cancer screening programme faecal occult blood testing kit spoilt,1049691000000117,Preferred,1144
488261000000104,Bowel cancer screening programme faecal occult blood testing kit spoilt,1049701000000117,Preferred,1144
860791000000105,Provision of written information about bowel cancer screening programme,2226251000000111,Preferred,1145
860791000000105,Provision of written information about bowel cancer screening programme,2226261000000114,Preferred,1145
486841000000100,Bowel cancer screening programme faecal occult blood testing kit spoilt,1046411000000119,Preferred,1146
486841000000100,Bowel cancer screening programme faecal occult blood testing kit spoilt,1046421000000113,Preferred,1146
375181000000107,Bowel cancer screening programme faecal occult blood test result unclear (finding),737861000000117,Preferred,1147
375181000000107,Bowel cancer screening programme faecal occult blood test result unclear,737871000000112,Preferred,1147
406075004,College of American Pathologists Cancer Checklist; Peritoneum: Resection (record artifact),2572792014,Preferred,1148
406075004,College of American Pathologists Cancer Checklist; Peritoneum: Resection,2157795010,Preferred,1148
701617005,Alternating electric field antimitotic cancer treatment system generator (physical object),2993424019,Preferred,1149
701617005,Alternating electric field antimitotic cancer treatment system generator,2993423013,Preferred,1149
486861000000104,Bowel cancer screening programme faecal occult blood test result unclear,1046451000000115,Preferred,1150
486861000000104,Bowel cancer screening programme faecal occult blood test result unclear,1046461000000117,Preferred,1150
488281000000108,Bowel cancer screening programme faecal occult blood test result unclear,1049731000000111,Preferred,1151
488281000000108,Bowel cancer screening programme faecal occult blood test result unclear,1049741000000119,Preferred,1151
423000007,College of American Pathologists Cancer Checklist; Soft Tissue: Resection (record artifact),2639838012,Preferred,1152
423000007,College of American Pathologists Cancer Checklist; Soft Tissue: Resection,2643855019,Preferred,1152
1101361000000103,Bowel cancer screening programme liquid faecal immunochemical test normal (finding),2757051000000111,Preferred,1153
1101361000000103,Bowel cancer screening programme liquid faecal immunochemical test normal,2757041000000113,Preferred,1153
884631000000109,Bowel scope (flexible sigmoidoscopy) screen: suspicion of cancer detected,2280421000000112,Preferred,1154
884631000000109,Bowel scope (flexible sigmoidoscopy) screen: suspicion of cancer detected,2280431000000114,Preferred,1154
409713006,College of American Pathologists Cancer Checklist; Neuroblastoma: Resection (record artifact),2572969016,Preferred,1155
409713006,College of American Pathologists Cancer Checklist; Neuroblastoma: Resection,2532796016,Preferred,1155
486851000000102,Bowel cancer screening programme faecal occult blood test technical failure,1046431000000110,Preferred,1156
486851000000102,Bowel cancer screening programme faecal occult blood test technical failure,1046441000000118,Preferred,1156
488271000000106,Bowel cancer screening programme faecal occult blood test technical failure,1049711000000115,Preferred,1157
488271000000106,Bowel cancer screening programme faecal occult blood test technical failure,1049721000000114,Preferred,1157
406018008,College of American Pathologists Cancer Checklist; Adrenal gland: Resection (record artifact),2572809017,Preferred,1158
406018008,College of American Pathologists Cancer Checklist; Adrenal gland: Resection,2532761016,Preferred,1158
1101371000000105,Bowel cancer screening programme liquid faecal immunochemical test abnormal (finding),2757071000000119,Preferred,1159
1101371000000105,Bowel cancer screening programme liquid faecal immunochemical test abnormal,2757061000000114,Preferred,1159
1099601000119106,Family history of genetic mutation for hereditary nonpolyposis colon cancer (situation),3430931017,Preferred,1160
1099601000119106,Family history of genetic mutation for Lynch syndrome,3430932012,Preferred,1160
1099601000119106,Family history of genetic mutation for HNPCC (hereditary nonpolyposis colon cancer),3430935014,Acceptable,1160
1099601000119106,Family history of genetic mutation for hereditary non-polyposis colon cancer,3430933019,Acceptable,1160
1099601000119106,Family history of genetic mutation for hereditary nonpolyposis colon cancer,3430934013,Acceptable,1160
373261000000106,No response to invitation - bowel cancer screening programme administration,733611000000111,Preferred,1161
373261000000106,No response to invitation - bowel cancer screening programme administration,733621000000117,Preferred,1161
375151000000101,Bowel cancer screening programme faecal occult blood test technical failure (finding),737801000000116,Preferred,1162
375151000000101,Bowel cancer screening programme faecal occult blood test technical failure,737811000000119,Preferred,1162
406039001,College of American Pathologists Cancer Checklist; Uveal Melanoma: Resection (record artifact),2572743015,Preferred,1163
406039001,College of American Pathologists Cancer Checklist; Uveal Melanoma: Resection,2157762016,Preferred,1163
703228009,Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder),3007455016,Preferred,1164
703228009,Non-small cell lung cancer with mutation in epidermal growth factor receptor,3007690015,Preferred,1164
79598005,International Federation of Gynecology and Obstetrics cervical cancer stage 0 (finding),2914239017,Preferred,1165
79598005,FIGO CC stage 0,132055011,Preferred,1165
79598005,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage 0,2621173019,Acceptable,1165
79598005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage 0,2621172012,Acceptable,1165
79598005,International Federation of Gynecology and Obstetrics cervical cancer stage 0,2914891012,Acceptable,1165
406052006,College of American Pathologists Cancer Checklist; Pleura/Pericardium: Biopsy (record artifact),2572836015,Preferred,1166
406052006,College of American Pathologists Cancer Checklist; Pleura/Pericardium: Biopsy,2157775016,Preferred,1166
836781000000101,Assessment using National Cancer Institute breast cancer risk assessment tool (procedure),2172661000000112,Preferred,1167
836781000000101,Assessment using National Cancer Institute breast cancer risk assessment tool,2172651000000114,Preferred,1167
15540006,International Federation of Gynecology and Obstetrics cervical cancer stage I (finding),3029235015,Preferred,1168
15540006,FIGO CC stage I,3029269019,Preferred,1168
15540006,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage I,3029347012,Acceptable,1168
15540006,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage I,3029258017,Acceptable,1168
15540006,International Federation of Gynecology and Obstetrics cervical cancer stage I,3029294018,Acceptable,1168
25654007,International Federation of Gynecology and Obstetrics cervical cancer stage Ib (finding),3029232017,Preferred,1169
25654007,International Federation of Gynaecology and Obstetrics cervical cancer stage Ib,3029299011,Preferred,1169
25654007,FIGO CC stage Ib,3029376010,Acceptable,1169
25654007,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage Ib,3029327016,Acceptable,1169
25654007,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ib,3029233010,Acceptable,1169
25654007,International Federation of Gynecology and Obstetrics cervical cancer stage Ib,3029323017,Acceptable,1169
81822003,International Federation of Gynecology and Obstetrics cervical cancer stage IV (finding),2974941012,Preferred,1170
81822003,FIGO CC stage IV,135735014,Preferred,1170
81822003,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IV,2621106014,Acceptable,1170
81822003,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IV,2621105013,Acceptable,1170
81822003,International Federation of Gynecology and Obstetrics cervical cancer stage IV,2974876013,Acceptable,1170
68240008,International Federation of Gynecology and Obstetrics cervical cancer stage II (finding),2975012012,Preferred,1171
68240008,FIGO CC stage II,113352015,Preferred,1171
68240008,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage II,2621057010,Acceptable,1171
68240008,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage II,2621058017,Acceptable,1171
68240008,International Federation of Gynecology and Obstetrics cervical cancer stage II,2974924010,Acceptable,1171
406053001,College of American Pathologists Cancer Checklist; Testis: Radical Orchiectomy (record artifact),2572837012,Preferred,1172
406053001,College of American Pathologists Cancer Checklist; Testis: Radical Orchiectomy,2157776015,Preferred,1172
406043002,College of American Pathologists Cancer Checklist; Uterine Cervix: Cone Biopsy (record artifact),2572959010,Preferred,1173
406043002,College of American Pathologists Cancer Checklist; Uterine Cervix: Cone Biopsy,2157766018,Preferred,1173
49219005,International Federation of Gynecology and Obstetrics cervical cancer stage Ia (finding),3029266014,Preferred,1174
49219005,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage Ia,3029279017,Preferred,1174
49219005,FIGO CC stage Ia,3029324011,Acceptable,1174
49219005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ia,3029282010,Acceptable,1174
49219005,International Federation of Gynecology and Obstetrics cervical cancer stage Ia,3029354018,Acceptable,1174
406033000,College of American Pathologists Cancer Checklist; Colon and Rectum: Resection (record artifact),2573006015,Preferred,1175
406033000,College of American Pathologists Cancer Checklist; Colon and Rectum: Resection,2157756014,Preferred,1175
701616001,Alternating electric field antimitotic cancer treatment system transducer array (physical object),2993422015,Preferred,1176
701616001,Alternating electric field antimitotic cancer treatment system transducer array,2993421010,Preferred,1176
52708004,International Federation of Gynecology and Obstetrics cervical cancer stage III (finding),2975048014,Preferred,1177
52708004,FIGO CC stage III,87710019,Preferred,1177
52708004,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage III,2620898013,Acceptable,1177
52708004,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage III,2620897015,Acceptable,1177
52708004,International Federation of Gynecology and Obstetrics cervical cancer stage III,2974953011,Acceptable,1177
703230006,Non-small cell lung cancer without mutation in epidermal growth factor receptor (disorder),3007975016,Preferred,1178
703230006,Non-small cell lung cancer without mutation in epidermal growth factor receptor,3007342018,Preferred,1178
50237009,International Federation of Gynecology and Obstetrics endometrial cancer stage I (finding),2975010016,Preferred,1179
50237009,FIGO EC stage I,83682013,Preferred,1179
50237009,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage I,2620881013,Acceptable,1179
50237009,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I,2620880014,Acceptable,1179
50237009,International Federation of Gynecology and Obstetrics endometrial cancer stage I,2975050018,Acceptable,1179
406031003,College of American Pathologists Cancer Checklist; Colon and Rectum: Excisional Biopsy (Polypectomy) (record artifact),2573004017,Preferred,1180
406031003,College of American Pathologists Cancer Checklist; Colon and Rectum: Excisional Biopsy (Polypectomy),2532765013,Preferred,1180
421411003,College of American Pathologists Cancer Checklist; Prostate Gland: Needle Biopsy (record artifact),2615719012,Preferred,1181
421411003,College of American Pathologists Cancer Checklist; Prostate Gland: Needle Biopsy,2618399014,Preferred,1181
1218761000000105,National Health Service Bowel Cancer Screening Programme replacement faecal immunochemical test kit requested (situation),2123921000000118,Preferred,1182
1218761000000105,NHS Bowel Cancer Screening Programme replacement faecal immunochemical test kit requested,2123911000000112,Preferred,1182
1218761000000105,NHS Bowel Cancer Screening Programme replacement FIT (faecal immunochemical test) kit requested,2795501000000119,Acceptable,1182
1218761000000105,NHS Bowel Cancer Screening Programme replacement faecal blood test kit requested,2795511000000117,Acceptable,1182
1239881000000109,Provision of information about cancer support services available in primary care (procedure),2801791000000118,Preferred,1183
1239881000000109,Provision of information about cancer support services available in primary care,2801801000000119,Preferred,1183
406051004,College of American Pathologists Cancer Checklist; Pleura/Pericardium: Resection (record artifact),2572883018,Preferred,1184
406051004,College of American Pathologists Cancer Checklist; Pleura/Pericardium: Resection,2157774017,Preferred,1184
30382004,International Federation of Gynecology and Obstetrics endometrial cancer stage II (finding),2975098010,Preferred,1185
30382004,FIGO EC stage II,50852014,Preferred,1185
30382004,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage II,2620487018,Acceptable,1185
30382004,International Federation of Gynaecology and Obstetrics endometrial cancer stage II,2975080011,Acceptable,1185
30382004,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage II,2620486010,Acceptable,1185
30382004,International Federation of Gynecology and Obstetrics endometrial cancer stage II,3084794010,Acceptable,1185
34537009,International Federation of Gynecology and Obstetrics endometrial cancer stage IV (finding),2974854016,Preferred,1186
34537009,FIGO EC stage IV,57639016,Preferred,1186
34537009,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IV,2620640019,Acceptable,1186
34537009,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IV,2620641015,Acceptable,1186
34537009,International Federation of Gynecology and Obstetrics endometrial cancer stage IV,2975070012,Acceptable,1186
406019000,College of American Pathologists Cancer Checklist; Ampulla of Vater: Ampullectomy (record artifact),2572810010,Preferred,1187
406019000,College of American Pathologists Cancer Checklist; Ampulla of Vater: Ampullectomy,2157743019,Preferred,1187
406074000,College of American Pathologists Cancer Checklist; Pancreas (Exocrine): Resection (record artifact),2572791019,Preferred,1188
406074000,College of American Pathologists Cancer Checklist; Pancreas (Exocrine): Resection,2157794014,Preferred,1188
87977001,International Federation of Gynecology and Obstetrics cervical cancer stage Ib occ (finding),3029359011,Preferred,1189
87977001,FIGO CC stage Ib occ,3029268010,Preferred,1189
87977001,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage Ib occ,3029370016,Acceptable,1189
87977001,International Federation of Gynaecology and Obstetrics cervical cancer stage Ib occ,3029307017,Acceptable,1189
87977001,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ib occ,3029246017,Acceptable,1189
87977001,International Federation of Gynecology and Obstetrics cervical cancer stage Ib occ,3029222012,Acceptable,1189
782823001,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome (disorder),3756077015,Preferred,1190
782823001,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,3756078013,Preferred,1190
782823001,"A rare inherited cancer-predisposing syndrome with characteristics of early development of cutaneous telangiectasia, mild dental and nail anomalies, patchy alopecia over the affected skin areas and increased lifetime risk for oropharyngeal cancer. Other types of cancer have also been reported. There is evidence the disease is caused by heterozygous mutation in the ATR gene on chromosome 3q23.",3756079017,Preferred,1190
1101391000000109,Bowel cancer screening programme liquid faecal immunochemical test sample rejected (finding),2757111000000113,Preferred,1191
1101391000000109,Bowel cancer screening programme liquid faecal immunochemical test sample rejected,2757101000000111,Preferred,1191
406073006,"College of American Pathologists Cancer Checklist; Pancreas (Endocrine): Excisional Biopsy (Enucleation), Resection (record artifact)",2572790018,Preferred,1192
406073006,"College of American Pathologists Cancer Checklist; Pancreas (Endocrine): Excisional Biopsy (Enucleation), Resection",2532778013,Preferred,1192
80975007,International Federation of Gynecology and Obstetrics endometrial cancer stage III (finding),2975034014,Preferred,1193
80975007,FIGO EC stage III,134327018,Preferred,1193
80975007,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage III,2621108010,Acceptable,1193
80975007,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage III,2621109019,Acceptable,1193
80975007,International Federation of Gynecology and Obstetrics endometrial cancer stage III,2974915018,Acceptable,1193
60275007,International Federation of Gynecology and Obstetrics endometrial cancer stage I B (finding),2975036011,Preferred,1194
60275007,FIGO EC stage I B,100135017,Preferred,1194
60275007,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage I B,2621070018,Acceptable,1194
60275007,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I B,2621071019,Acceptable,1194
60275007,International Federation of Gynecology and Obstetrics endometrial cancer stage I B,2975023011,Acceptable,1194
46756001,International Federation of Gynecology and Obstetrics endometrial cancer stage I A (finding),2913339012,Preferred,1195
46756001,FIGO EC stage I A,77932014,Preferred,1195
46756001,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage I A,2620766010,Acceptable,1195
46756001,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I A,2620767018,Acceptable,1195
46756001,International Federation of Gynecology and Obstetrics endometrial cancer stage I A,2913566013,Acceptable,1195
406046005,College of American Pathologists Cancer Checklist; Major Salivary Glands: Resection (record artifact),2572962013,Preferred,1196
406046005,College of American Pathologists Cancer Checklist; Major Salivary Glands: Resection,2157769013,Preferred,1196
708415001,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIB (finding),3034854015,Preferred,1197
708415001,FIGO EC stage IIIB,3033792017,Preferred,1197
708415001,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IIIB,3033339014,Acceptable,1197
708415001,International Federation of Gynaecology and Obstetrics endometrial cancer stage IIIB,3034861016,Acceptable,1197
708415001,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIB,3034161018,Acceptable,1197
708415001,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIB,3034833010,Acceptable,1197
406079005,College of American Pathologists Cancer Checklist; Carcinoma of the Skin: Resection (record artifact),2573143015,Preferred,1198
406079005,College of American Pathologists Cancer Checklist; Carcinoma of the Skin: Resection,2157799016,Preferred,1198
708435000,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIC2 (finding),3034848016,Preferred,1199
708435000,FIGO EC stage IIIC2,3034258011,Preferred,1199
708435000,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IIIC2,3034324017,Acceptable,1199
708435000,International Federation of Gynaecology and Obstetrics endometrial cancer stage IIIC2,3034849012,Acceptable,1199
708435000,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIC2,3033871011,Acceptable,1199
708435000,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIC2,3034853014,Acceptable,1199
708432002,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIC1 (finding),3034827018,Preferred,1200
708432002,FIGO EC stage IIIC1,3033464011,Preferred,1200
708432002,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IIIC1,3034235013,Acceptable,1200
708432002,International Federation of Gynaecology and Obstetrics endometrial cancer stage IIIC1,3034862011,Acceptable,1200
708432002,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIC1,3033743011,Acceptable,1200
708432002,International Federation of Gynecology and Obstetrics endometrial cancer stage IIIC1,3034847014,Acceptable,1200
1101381000000107,Bowel cancer screening programme liquid faecal immunochemical test technical failure (finding),2757091000000115,Preferred,1201
1101381000000107,Bowel cancer screening programme liquid faecal immunochemical test technical failure,2757081000000117,Preferred,1201
406081007,College of American Pathologists Cancer Checklist; Kidney: Resection for Wilms Tumor (record artifact),2573145010,Preferred,1202
406081007,College of American Pathologists Cancer Checklist; Kidney: Resection for Wilms Tumour,2154052014,Preferred,1202
406081007,College of American Pathologists Cancer Checklist; Kidney: Resection for Wilms Tumor,2155075011,Acceptable,1202
384261000000104,Bowel cancer screening programme faecal occult blood testing incomplete participation,758181000000118,Preferred,1203
384261000000104,Bowel cancer screening programme faecal occult blood testing incomplete participation,758191000000116,Preferred,1203
384251000000102,Bowel cancer screening programme faecal occult blood testing incomplete participation,758161000000110,Preferred,1204
384251000000102,Bowel cancer screening programme faecal occult blood testing incomplete participation,758171000000115,Preferred,1204
384241000000100,Bowel cancer screening programme faecal occult blood testing incomplete participation (finding),758141000000114,Preferred,1205
384241000000100,Bowel cancer screening programme faecal occult blood testing incomplete participation,758151000000112,Preferred,1205
1110871000000109,Quality and Outcomes Framework cancer quality indicator-related care invitation (procedure),2779731000000114,Preferred,1206
1110871000000109,QOF (Quality and Outcomes Framework) cancer quality indicator-related care invitation,2779721000000112,Preferred,1206
406038009,College of American Pathologists Cancer Checklist; Extrahepatic Bile Ducts: Resection (record artifact),2572742013,Preferred,1207
406038009,College of American Pathologists Cancer Checklist; Extrahepatic Bile Ducts: Resection,2157761011,Preferred,1207
406040004,College of American Pathologists Cancer Checklist; Vulva: Excisional Biopsy/Resection (record artifact),2572744014,Preferred,1208
406040004,College of American Pathologists Cancer Checklist; Vulva: Excisional Biopsy/Resection,2157763014,Preferred,1208
927791000000105,Notification to general practitioner out of hours service of cancer care plan in place (procedure),2378171000000119,Preferred,1209
927791000000105,Notification to general practitioner out of hours service of cancer care plan in place,2378161000000114,Preferred,1209
406020006,College of American Pathologists Cancer Checklist; Ampulla of Vater: Pancreaticoduodenectomy (record artifact),2572811014,Preferred,1210
406020006,College of American Pathologists Cancer Checklist; Ampulla of Vater: Pancreaticoduodenectomy,2532762011,Preferred,1210
406029007,College of American Pathologists Cancer Checklist; Brain/Spinal Cord: Biopsy/Resection (record artifact),2573002018,Preferred,1211
406029007,College of American Pathologists Cancer Checklist; Brain/Spinal Cord: Biopsy/Resection,2157753018,Preferred,1211
406042007,"College of American Pathologists Cancer Checklist; Vagina: Excisional Biopsy, Resection (record artifact)",2572958019,Preferred,1212
406042007,"College of American Pathologists Cancer Checklist; Vagina: Excisional Biopsy, Resection",2532769019,Preferred,1212
406049003,College of American Pathologists Cancer Checklist; Thymoma and Thymic Carcinoma: Biopsy (record artifact),2572965010,Preferred,1213
406049003,College of American Pathologists Cancer Checklist; Thymoma and Thymic Carcinoma: Biopsy,2157772018,Preferred,1213
406061006,College of American Pathologists Cancer Checklist; Gastrointestinal Lymphoma: Resection (record artifact),2572946019,Preferred,1214
406061006,College of American Pathologists Cancer Checklist; Gastrointestinal Lymphoma: Resection,2157784016,Preferred,1214
406069008,"College of American Pathologists Cancer Checklist; Non-Hodgkin Lymphoma: Biopsy, Resection (record artifact)",2572954017,Preferred,1215
406069008,"College of American Pathologists Cancer Checklist; Non-Hodgkin Lymphoma: Biopsy, Resection",2532777015,Preferred,1215
406077007,College of American Pathologists Cancer Checklist; Prostate Gland: Radical Prostatectomy (record artifact),2573141018,Preferred,1216
406077007,College of American Pathologists Cancer Checklist; Prostate Gland: Radical Prostatectomy,2157797019,Preferred,1216
254368001,United Kingdom children's cancer study group central nervous system tumor staging system (tumor staging),645248018,Preferred,1217
254368001,United Kingdom children's cancer study group central nervous system tumour staging system,378663011,Preferred,1217
254368001,United Kingdom children's cancer study group central nervous system tumor staging system,378662018,Acceptable,1217
254369009,United Kingdom children's cancer study group Langerhans cell histiocytosis staging system (tumor staging),645250014,Preferred,1218
254369009,United Kingdom children's cancer study group Langerhans cell histiocytosis staging system,378665016,Preferred,1218
254369009,UKCC - United Kingdom children's cancer study group Langerhans cell histiocytosis staging system,378664017,Acceptable,1218
708368008,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB2 (finding),3034796011,Preferred,1219
708368008,FIGO CC stage IB2,3033558018,Preferred,1219
708368008,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IB2,3033669013,Acceptable,1219
708368008,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB2,3033388014,Acceptable,1219
708340009,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB1 (finding),3034795010,Preferred,1220
708340009,FIGO CC stage IB1,3034121019,Preferred,1220
708340009,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IB1,3033576013,Acceptable,1220
708340009,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB1,3033544015,Acceptable,1220
708331005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA2 (finding),3034794014,Preferred,1221
708331005,FIGO CC stage IA2,3034065012,Preferred,1221
708331005,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IA2,3033574011,Acceptable,1221
708331005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA2,3033488013,Acceptable,1221
406060007,College of American Pathologists Cancer Checklist; Gallbladder: Resection/Cholecystectomy (record artifact),2572945015,Preferred,1222
406060007,College of American Pathologists Cancer Checklist; Gallbladder: Resection/Cholecystectomy,2157783010,Preferred,1222
708387002,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIB (finding),3034799016,Preferred,1223
708387002,FIGO CC stage IIB,3033821013,Preferred,1223
708387002,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IIB,3033340011,Acceptable,1223
708387002,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIB,3034275017,Acceptable,1223
708400002,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVA (finding),3034802013,Preferred,1224
708400002,FIGO CC stage IVA,3033734019,Preferred,1224
708400002,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IVA,3033373016,Acceptable,1224
708400002,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVA,3033819015,Acceptable,1224
708404006,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVB (finding),3034803015,Preferred,1225
708404006,FIGO CC stage IVB,3034316010,Preferred,1225
708404006,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IVB,3034230015,Acceptable,1225
708404006,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVB,3033537012,Acceptable,1225
708327004,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA1 (finding),3034793015,Preferred,1226
708327004,FIGO CC stage IA1,3033349012,Preferred,1226
708327004,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IA1,3033808018,Acceptable,1226
708327004,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA1,3033830017,Acceptable,1226
461341000000104,United Kingdom children's cancer study group Langerhans cell histiocytosis staging system (tumor staging),923031000000119,Preferred,1227
461341000000104,United Kingdom children's cancer study group Langerhans cell histiocytosis staging system,817551000000111,Preferred,1227
461341000000104,UKCC - United Kingdom children's cancer study group Langerhans cell histiocytosis staging system,817561000000114,Acceptable,1227
708395003,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIB (finding),3034801018,Preferred,1228
708395003,FIGO CC stage IIIB,3033872016,Preferred,1228
708395003,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IIIB,3033410013,Acceptable,1228
708395003,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIB,3033597014,Acceptable,1228
406054007,College of American Pathologists Cancer Checklist; Testis: Retroperitoneal Lymphadenectomy (record artifact),2572838019,Preferred,1229
406054007,College of American Pathologists Cancer Checklist; Testis: Retroperitoneal Lymphadenectomy,2157777012,Preferred,1229
708381001,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA1 (finding),3034797019,Preferred,1230
708381001,FIGO CC stage IIA1,3033599012,Preferred,1230
708381001,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IIA1,3033813019,Acceptable,1230
708381001,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA1,3033976017,Acceptable,1230
708383003,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA2 (finding),3034798012,Preferred,1231
708383003,FIGO CC stage IIA2,3033467016,Preferred,1231
708383003,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IIA2,3033437010,Acceptable,1231
708383003,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA2,3033277017,Acceptable,1231
384754004,pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) (finding),2982703015,Preferred,1232
384754004,pT2: Tumour of lung as per AJCC 6th Edition definition (lung),1772726019,Preferred,1232
384754004,pT2: Tumor of lung as per AJCC 6th Edition definition (lung),1774012018,Acceptable,1232
384754004,pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung),2982918012,Acceptable,1232
384754004,pT2: Tumour of lung as per American Joint Committee on Cancer 6th Edition definition (lung),3035706012,Acceptable,1232
384756002,pT4: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) (finding),2982646012,Preferred,1233
384756002,pT4: Tumour of lung as per AJCC 6th Edition definition (lung),1772728018,Preferred,1233
384756002,pT4: Tumor of lung as per AJCC 6th Edition definition (lung),1774014017,Acceptable,1233
384756002,pT4: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung),2982898012,Acceptable,1233
384756002,pT4: Tumour of lung as per American Joint Committee on Cancer 6th Edition definition (lung),3035822016,Acceptable,1233
406065002,"College of American Pathologists Cancer Checklist; Kidney: Nephrectomy, Partial or Radical (record artifact)",2572950014,Preferred,1234
406065002,"College of American Pathologists Cancer Checklist; Kidney: Nephrectomy, Partial or Radical",2157788018,Preferred,1234
708393005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIA (finding),3034800017,Preferred,1235
708393005,FIGO CC stage IIIA,3034153011,Preferred,1235
708393005,International Federation of Gynaecology and Obstetrics cervical cancer (FIGO CC) stage IIIA,3034055018,Acceptable,1235
708393005,International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIA,3033728014,Acceptable,1235
273446001,European Organization for Research and Treatment of Cancer - Quality of life questionnaire (assessment scale),2915204012,Preferred,1236
273446001,EORTC - Quality of life questionnaire,408867018,Preferred,1236
273446001,European Organisation for Research and Treatment of Cancer (EORTC) - Quality of life questionnaire,2620258017,Acceptable,1236
273446001,European Organization for Research and Treatment of Cancer (EORTC) - Quality of life questionnaire,2620257010,Acceptable,1236
273446001,European Organization for Research and Treatment of Cancer - Quality of life questionnaire,2913974017,Acceptable,1236
443941007,"Edition of American Joint Commission on Cancer, Cancer Staging Manual used for TNM staging (observable entity)",2837173019,Preferred,1237
443941007,"Edition of American Joint Commission on Cancer, Cancer Staging Manual used for TNM staging",2840986011,Preferred,1237
708443005,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVA (finding),3034804014,Preferred,1238
708443005,FIGO EC stage IVA,3033523015,Preferred,1238
708443005,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IVA,3034099010,Acceptable,1238
708443005,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVA,3034164014,Acceptable,1238
708446002,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVB (finding),3034805010,Preferred,1239
708446002,FIGO EC stage IVB,3034290018,Preferred,1239
708446002,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IVB,3033761019,Acceptable,1239
708446002,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVB,3033501019,Acceptable,1239
444256004,"American Joint Commission on Cancer, Cancer Staging Manual, 6th edition neoplasm staging system (tumor staging)",2836681014,Preferred,1240
444256004,"American Joint Commission on Cancer, Cancer Staging Manual, 6th edition neoplasm staging system",2841612013,Preferred,1240
444256004,"American Joint Commission on Cancer, Cancer Staging Manual, 6th edition tumor staging system",2841613015,Acceptable,1240
444256004,"American Joint Commission on Cancer, Cancer Staging Manual, 6th edition tumour staging system",2841663013,Acceptable,1240
443830009,"American Joint Commission on Cancer, Cancer Staging Manual, 7th edition neoplasm staging system (tumor staging)",2837168013,Preferred,1241
443830009,"American Joint Commission on Cancer, Cancer Staging Manual, 7th edition neoplasm staging system",2840917010,Preferred,1241
443830009,"American Joint Commission on Cancer, Cancer Staging Manual, 7th edition tumor staging system",2840918017,Acceptable,1241
443830009,"American Joint Commission on Cancer, Cancer Staging Manual, 7th edition tumour staging system",2840919013,Acceptable,1241
708533009,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA (finding),3034691012,Preferred,1242
708533009,International Federation of Gynaecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA,3034695015,Preferred,1242
708533009,FIGO EC stage IIIA,3034690013,Acceptable,1242
708533009,International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA,3034699014,Acceptable,1242
406063009,College of American Pathologists Cancer Checklist; Hodgkin Lymphoma: Biopsy/Staging Procedure (record artifact),2572948018,Preferred,1243
406063009,College of American Pathologists Cancer Checklist; Hodgkin Lymphoma: Biopsy/Staging Procedure,2157786019,Preferred,1243
406058005,College of American Pathologists Cancer Checklist; Melanoma of the Skin: Excision; Re-Excision (record artifact),2572884012,Preferred,1244
406058005,College of American Pathologists Cancer Checklist; Melanoma of the Skin: Excision; Re-Excision,2157781012,Preferred,1244
1101401000000107,No response to bowel cancer screening programme liquid faecal immunochemical testing invitation (finding),2757131000000117,Preferred,1245
1101401000000107,No response to bowel cancer screening programme liquid faecal immunochemical testing invitation,2757121000000119,Preferred,1245
406024002,"College of American Pathologists Cancer Checklist; Urinary bladder, Ureter, Renal Pelvis: Biopsy (record artifact)",2572815017,Preferred,1246
406024002,"College of American Pathologists Cancer Checklist; Urinary bladder, Ureter, Renal Pelvis: Biopsy",2532764012,Preferred,1246
406047001,College of American Pathologists Cancer Checklist; Trophoblast: Dilation and Curettage/Resection (record artifact),2572963015,Preferred,1247
406047001,College of American Pathologists Cancer Checklist; Trophoblast: Dilation and Curettage/Resection,2157770014,Preferred,1247
406022003,College of American Pathologists Cancer Checklist; Anus: Local Excision (Transanal Disk Excision) (record artifact),2572813012,Preferred,1248
406022003,College of American Pathologists Cancer Checklist; Anus: Local Excision (Transanal Disk Excision),2157746010,Preferred,1248
406032005,College of American Pathologists Cancer Checklist; Rectum: Local Excision (Transanal Disk Excision) (record artifact),2573005016,Preferred,1249
406032005,College of American Pathologists Cancer Checklist; Rectum: Local Excision (Transanal Disk Excision),2157755013,Preferred,1249
895181000000102,Meets NICE CG164 familial breast cancer referral criteria for assessment and management in secondary care,2303651000000116,Preferred,1250
895181000000102,Meets NICE CG164 familial breast cancer referral criteria for assessment and management in secondary care,2303661000000118,Preferred,1250
406050003,"College of American Pathologists Cancer Checklist; Thymoma and Thymic Carcinoma: Thymectomy, Other Procedure (record artifact)",2572966011,Preferred,1251
406050003,"College of American Pathologists Cancer Checklist; Thymoma and Thymic Carcinoma: Thymectomy, Other Procedure",2157773011,Preferred,1251
409740006,College of American Pathologists Cancer Checklist; Primitive Neuroectodermal Tumor / Ewing Sarcoma: Resection (record artifact),2572903017,Preferred,1252
409740006,College of American Pathologists Cancer Checklist; Primitive Neuroectodermal Tumour / Ewing Sarcoma: Resection,2469157015,Preferred,1252
409740006,College of American Pathologists Cancer Checklist; Primitive Neuroectodermal Tumor / Ewing Sarcoma: Resection,2469631017,Acceptable,1252
373167007,pN3b: Tumor of breast with metastasis as per American Joint Committee on Cancer 6th Edition definition (breast) (finding),2982717012,Preferred,1253
373167007,pN3b: Tumour of breast with metastasis as per AJCC 6th Edition definition (breast),2154751013,Preferred,1253
373167007,pN3b: Tumor of breast with metastasis as per AJCC 6th Edition definition (breast),2155756010,Acceptable,1253
373167007,pN3b: Tumor of breast with metastasis as per American Joint Committee on Cancer 6th Edition definition (breast),2982932014,Acceptable,1253
373167007,pN3b: Tumour of breast with metastasis as per American Joint Committee on Cancer 6th Edition definition (breast),3035857018,Acceptable,1253
406078002,"College of American Pathologists Cancer Checklist; Retinoblastoma: Enucleation, Partial or Complete Exenteration (record artifact)",2573142013,Preferred,1254
406078002,"College of American Pathologists Cancer Checklist; Retinoblastoma: Enucleation, Partial or Complete Exenteration",2532780019,Preferred,1254
406044008,"College of American Pathologists Cancer Checklist; Uterine Cervix: Colpectomy, Hysterectomy, Pelvic Exenteration (record artifact)",2572960017,Preferred,1255
406044008,"College of American Pathologists Cancer Checklist; Uterine Cervix: Colpectomy, Hysterectomy, Pelvic Exenteration",2157767010,Preferred,1255
406026000,"College of American Pathologists Cancer Checklist; Renal pelvis: Resection/Nephroureterectomy, Partial or Complete (record artifact)",2572817013,Preferred,1256
406026000,"College of American Pathologists Cancer Checklist; Renal pelvis: Resection/Nephroureterectomy, Partial or Complete",2157750015,Preferred,1256
406035007,"College of American Pathologists Cancer Checklist; Endometrium: Hysterectomy, With or Without Other Organs or Tissues (record artifact)",2573008019,Preferred,1257
406035007,"College of American Pathologists Cancer Checklist; Endometrium: Hysterectomy, With or Without Other Organs or Tissues",2157758010,Preferred,1257
406057000,"College of American Pathologists Cancer Checklist; Small Intestine: Polypectomy, Segmental Resection, Pancreaticoduodenectomy, Partial or Complete, With or Without Partial Gastrectomy (Whipple Resection) (record artifact)",2572841011,Preferred,1258
406057000,"College of American Pathologists Cancer Checklist; Small Intestine: Polypectomy, Segmental Resection, Pancreaticoduodenectomy, Partial or Complete, With or Without Partial Gastrectomy (Whipple Resection)",2532770018,Preferred,1258
421714007,"College of American Pathologists Cancer Checklist; Prostate Gland: Transurethral Prostatic Resection, Enucleation Specimen (record artifact)",2914619011,Preferred,1259
421714007,"College of American Pathologists Cancer Checklist; Prostate Gland:Transurethral Prostatic Resection (TUR), Enucleation Specimen",2618400019,Preferred,1259
421714007,"College of American Pathologists Cancer Checklist; Prostate Gland: Transurethral Prostatic Resection, Enucleation Specimen",2913366012,Acceptable,1259
895171000000104,Meets National Institute of Health and Care Excellence clinical guideline 164 familial breast cancer referral criteria for assessment and management in secondary care (finding),2303631000000111,Preferred,1260
895171000000104,Meets NICE clinical guideline CG164 familial breast cancer referral criteria for assessment and management in secondary care,2303671000000113,Preferred,1260
143351000000108,Quality and Outcomes Framework cancer quality indicator-related care invitation using preferred method of communication (procedure),1628181000000113,Preferred,1261
143351000000108,QOF (Quality and Outcomes Framework) cancer quality indicator-related care invitation using preferred method of communication,1628171000000111,Preferred,1261
999003171000000101,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1B In situ diagnosis simple reference set (foundation metadata concept),999007141000000116,Preferred,1262
999003171000000101,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1B In situ diagnosis simple reference set,999007131000000113,Preferred,1262
999003181000000104,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1C Uncertain diagnosis simple reference set (foundation metadata concept),999007161000000115,Preferred,1263
999003181000000104,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1C Uncertain diagnosis simple reference set,999007151000000118,Preferred,1263
999003161000000108,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set (foundation metadata concept),999007121000000111,Preferred,1264
999003161000000108,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set,999007111000000117,Preferred,1264
406028004,"College of American Pathologists Cancer Checklist; Bone Marrow: Blood Film, Aspirate, Cell Block, Trephine Biopsy, Touch Imprint (record artifact)",2572819011,Preferred,1265
406028004,"College of American Pathologists Cancer Checklist; Bone Marrow: Blood Film, Aspirate, Cell Block, Trephine Biopsy, Touch Imprint",2157752011,Preferred,1265
406025001,"College of American Pathologists Cancer Checklist; Urinary bladder: Cystectomy, Partial, Total, or Radical; Anterior Exenteration (record artifact)",2572816016,Preferred,1266
406025001,"College of American Pathologists Cancer Checklist; Urinary bladder: Cystectomy, Partial, Total, or Radical; Anterior Exenteration",2157749015,Preferred,1266
999003201000000100,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 2 Benign neoplasms diagnosis simple reference set (foundation metadata concept),999007201000000111,Preferred,1267
999003201000000100,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 2 Benign neoplasms diagnosis simple reference set,999007191000000114,Preferred,1267
396970009,pT4: Extraocular tumor extension which includes sites as per American Joint Committee on Cancer 6th Edition definition (retinoblastoma) (finding),2982657019,Preferred,1268
396970009,pT4: Extraocular tumour extension which includes sites as per AJCC 6th Edition definition (retinoblastoma),1773001014,Preferred,1268
396970009,pT4: Extraocular tumor extension which includes sites as per AJCC 6th Edition definition (retinoblastoma),1774287013,Acceptable,1268
396970009,pT4: Extraocular tumor extension which includes sites as per American Joint Committee on Cancer 6th Edition definition (retinoblastoma),2982765013,Acceptable,1268
396970009,pT4: Extraocular tumour extension which includes sites as per American Joint Committee on Cancer 6th Edition definition (retinoblastoma),3035782011,Acceptable,1268
406076003,"College of American Pathologists Cancer Checklist; Prostate Gland: Needle Biopsy, Transurethral Prostatic Resection, Enucleation Specimen (record artifact)",2915063014,Preferred,1269
406076003,"College of American Pathologists Cancer Checklist; Prostate Gland: Needle Biopsy, Transurethral Prostatic Resection (TUR), Enucleation Specimen",2157796011,Preferred,1269
406076003,"College of American Pathologists Cancer Checklist; Prostate Gland: Needle Biopsy, Transurethral Prostatic Resection, Enucleation Specimen",2913509015,Acceptable,1269
406045009,College of American Pathologists Cancer Checklist; Upper Aerodigestive Tract and Minor Salivary Glands: Incisional and Excisional Biopsy/Resection (record artifact),2572961018,Preferred,1270
406045009,College of American Pathologists Cancer Checklist; Upper Aerodigestive Tract and Minor Salivary Glands: Incisional and Excisional Biopsy/Resection,2157768017,Preferred,1270
999003191000000102,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1D Central nervous system neoplasms diagnosis simple reference set (foundation metadata concept),999007181000000112,Preferred,1271
999003191000000102,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1D CNS (central nervous system) neoplasms diagnosis simple reference set,999007171000000110,Preferred,1271
406059002,"College of American Pathologists Cancer Checklist; Fallopian Tube: Unilateral Salpingectomy, Salpingo-oophorectomy, or Hysterectomy with Salpingo-oophorectomy (record artifact)",2572944016,Preferred,1272
406059002,"College of American Pathologists Cancer Checklist; Fallopian Tube: Unilateral Salpingectomy, Salpingo-oophorectomy, or Hysterectomy with Salpingo-oophorectomy",2157782017,Preferred,1272
999003211000000103,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 3 Anatomic structures of the central nervous system diagnosis simple reference set (foundation metadata concept),999007221000000119,Preferred,1273
999003211000000103,National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 3 Anatomic structures of the central nervous system diagnosis simple reference set,999007211000000113,Preferred,1273
397393003,pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) (finding),2982745018,Preferred,1274
397393003,pT3: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma),1773100012,Preferred,1274
397393003,pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma),1774386018,Acceptable,1274
397393003,pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma),2982626019,Acceptable,1274
397465003,pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma) (finding),2982699018,Preferred,1275
397465003,pT4: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma),1773108017,Preferred,1275
397465003,pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma),1774394013,Acceptable,1275
397465003,pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma),2982606018,Acceptable,1275
397465003,pT4: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by American Joint Committee on Cancer 6th Edition definition (thoracic mesothelioma),3035748017,Acceptable,1275
406080008,"College of American Pathologists Cancer Checklist; Rhabdomyosarcoma and Related Neoplasms: Excision, Local or Wide; Compartmentectomy; Excision, Radical; Amputation; Other (record artifact)",2573144014,Preferred,1276
406080008,"College of American Pathologists Cancer Checklist; Rhabdomyosarcoma and Related Neoplasms: Excision, Local or Wide; Compartmentectomy; Excision, Radical; Amputation; Other",2157800017,Preferred,1276
396320002,"pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri) (finding)",1764237017,Preferred,1277
396320002,"pT3a (IIIA): Tumour involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri)",1772799018,Preferred,1277
396320002,"pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri)",1774085012,Acceptable,1277
406070009,"College of American Pathologists Cancer Checklist; Ovary: Oophorectomy, Salpingo-oophorectomy, Subtotal Oophorectomy or Removal of Tumor in Fragments, Hysterectomy with Salpingo-oophorectomy (record artifact)",2572955016,Preferred,1278
406070009,"College of American Pathologists Cancer Checklist; Ovary: Oophorectomy, Salpingo-oophorectomy, Subtotal Oophorectomy or Removal of Tumour in Fragments, Hysterectomy with Salpingo-oophorectomy",2154049018,Preferred,1278
406070009,"College of American Pathologists Cancer Checklist; Ovary: Oophorectomy, Salpingo-oophorectomy, Subtotal Oophorectomy or Removal of Tumor in Fragments, Hysterectomy with Salpingo-oophorectomy",2155072014,Acceptable,1278
406030002,"College of American Pathologists Cancer Checklist; Breast: Excision Less Than Total Mastectomy (Includes Wire-Guided Localization Excisions); Total Mastectomy, Modified Radical Mastectomy, Radical Mastectomy (record artifact)",2573003011,Preferred,1279
406030002,"College of American Pathologists Cancer Checklist; Breast: Excision Less Than Total Mastectomy (Includes Wire-Guided Localisation Excisions); Total Mastectomy, Modified Radical Mastectomy, Radical Mastectomy",2154048014,Preferred,1279
406030002,"College of American Pathologists Cancer Checklist; Breast: Excision Less Than Total Mastectomy (Includes Wire-Guided Localization Excisions); Total Mastectomy, Modified Radical Mastectomy, Radical Mastectomy",2155071019,Acceptable,1279
369814002,"T3 (III): Endometrial tumor with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings (finding)",1457760013,Preferred,1280
369814002,"T3 (III): Endometrial tumour with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings",1206977019,Preferred,1280
369814002,"T3 (III): Endometrial tumor with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings",491374010,Acceptable,1280
